In Vitro Transformation of Non-established Bovine Fibroblasts by BPV4 and Cooperating Factors by Jaggar, Rhys Trevor
 
 
 
 
 
 
 
https://theses.gla.ac.uk/ 
 
 
 
 
Theses Digitisation: 
https://www.gla.ac.uk/myglasgow/research/enlighten/theses/digitisation/ 
This is a digitised version of the original print thesis. 
 
 
 
 
 
 
 
 
Copyright and moral rights for this work are retained by the author 
 
A copy can be downloaded for personal non-commercial research or study, 
without prior permission or charge 
 
This work cannot be reproduced or quoted extensively from without first 
obtaining permission in writing from the author 
 
The content must not be changed in any way or sold commercially in any 
format or medium without the formal permission of the author 
 
When referring to this work, full bibliographic details including the author, 
title, awarding institution and date of the thesis must be given 
 
 
 
 
 
 
 
 
 
 
 
 
 
Enlighten: Theses 
https://theses.gla.ac.uk/ 
research-enlighten@glasgow.ac.uk 
CONTENTS
Page
ACKNOWLEDGEMENTS 2
ABBREVIATIONS 3
ABSTRACT ! 5
INTRODUCTION 6
MATERIALS AND METHODS 75
RESULTS AND DISCUSSION 114
SUMMARY 207
REFERENCES 216
1
ProQuest Number: 11007416
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest 11007416
Published by ProQuest LLC(2018). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLC.
ProQuest LLC.
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106- 1346
ACKNOWLEDGEMENTS
I would like to thank my supervisor, Dr. M. Saveria Campo, and 
all the members of Group R6 of the Beatson Instiute for all their 
help over the last three years, without which this work would 
have been impossible.
I acknowledge Dr. Jonathon Gaukroger of Glasgow University 
Veterinary School, Department of Veterinary Pathology for the 
isolation- and subsequent provision of non-established foetal 
bovine fibroblasts; I also thank lain Doherty of the Beatson 
Institute for carrying out the injection of cells into athymic 
mice.
I thank my fellow Ph.D. students for helpful discussions.
Finally, I would iike to thank my parents for continuous 
support, both financial and pastoral, and the mountains of the 
world for providing peace and tranquility at times of apparent 
despair during the past three years.
Z
Abbreviations
A adenine
bp base pairs
BPV Bovine Papillomavirus
C cytosine
cm centim etres
ATP adenosine triphosphate
CTP cytosine triphosphate
GTP guanosine triphosphate
dNTP deoxynucleoside triphosphate (with
reference to the three above)
TTP thymidine triphosphate
UTP ur triphosphate
DNA deoxyribonucleic acid
EDl'A ethylenediaminetetra-acetic acid
G guanine
g grammes
HBS HEPES-buffered saline
HEPES N-2-hydroxyethyl piperazine-
N'-2-ethane sulphonic acid 
HPV Human Papillomavirus
hr hours
kb kilobase pairs
kDa kiloDaltons
pg microgrammes
jj. I m ic ro litres
pM m icromolar
mg m illigram m es
1
ml m il l i l i t re s
mm m illim e tres
mM m i 11 i m o I a r
min minutes
M molar
Mr molecular weight
MOPS 3-(N-morpholino)propane sulphonic
acid
neor neomycin resistant
ng nanograms
OAc acetate
ORF open reading frame
pers.comm. personal communication
pg picograms
RNA ribonucleic acid
rpm revolutions per minute
sec seconds
SDS sodium dodecyl sulphate
S/N supernatant
T thymine
TPA 12-O-tetradecanoyl phorbol-13-
acetate
T ris  tris(hydroxymethyl)aminomethane
TAE Tris Acetate/EDTA
tRNA transfer RNA
V Volts
% (v/v) volume in ml per 100ml water
%(w/v) weight in g per 100ml water
ABSTRACT
An in vitro assay system utilising non-established bovine 
fibroblasts derived from foetal palate was developed for the 
detection of BPV4-encoded transforming functions. This involved 
cotransfection of a dominant coselectable marker gene neo and 
recombinant BPV4 DNA linearised within the E1 ORF. The presence 
of BPV4 DNA resulted in the formation of colonies of diameter 
greater than 5mm (macrocolonies) which displayed a contact- 
inhibited phenotype.
Cloning of regions of BPV4 into two vectors, pSV2neo and 
pZIPneoSV(XI), indicated that macrocolony formation could be 
induced by two regions of the genorpe. The first, a 2.0kb Xholl 
fragment (nts 6487-1275) encoded two complete ORFs, namely E7 
and E8. A construct lacking 233bp (nts 906-1139), resulting in 
interruption of the E7 ORF, was inactive in this assay, indicating 
a requirement for the E7 ORF for induction of the phenotype. The 
second region, encoded by a 3.9kb Xholl fragment (nts 2597- 
6487), contained the E2,E3,E4,E5 and L2 ORFs. In this case, 
colonies contained cells showing a more elongated phenotype.
Cotransfections of linear BPV4 with an activated ras gene did 
not lead to a loss of contact-inhib ition. In contrast, 
overexpression of the 2.0kb fragment, in the presence of ras did 
lead to the formation of non-contact-inh ib ited neor 
macrocolonies. An intact E7 ORF was again required for this 
activ ity.In  the case of the 3.9kb construct, a single 
non-contact-inhibited colony was observed in constructs 
utilising the BPV4 promoters upon cotransfection with ras.
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1.1 Cancer research: an historical perspective
The collection of diseases known as cancer arise due to the 
uncontrolled proliferation of an individual cell type within a 
multicellular organism. Such a tumour often spreads subsequently 
to secondary sites within the body, leading rapidly to the death of 
the host organism. With the advances in clinical medicine and the 
subsequent eradication of many diseases of childhood and early 
adulthood over the past century, the number of clinical cases of 
human cancer has risen considerably. As a result, much research 
has been carried out concerning the biology of tumour induction 
and its subsequent treatment. This introduction will not consider 
clinical treatment, since it plays no part in the work to be 
described in this thesis.
The development of cancer is presumed to occur due to the 
cu m u la tive  effect of several hereditable, somatic mutations 
(defined here as anv change in the composition of the genetic 
material) within one individual cell, a theory first put forward by 
Boveri in 1907 and one which is still believed today. The two 
main questions researchers have been interested in over the 
subsequent eighty years are: firstly, what are these genetic 
changes at the molecular level? and secondly, what agents cause 
these changes to occur?
Research has proceeded using three broad strategies: firstly, a 
study of e p id e m io lo g y  (i.e. the statistical analysis of the 
variables which affect the frequency of tumour formation such as 
geography, diet, age, social habits, working practices etc) has 
predicted that the the number of somatic mutations required for
a
full human tumour development to be six or seven. It has also 
allowed the identification of certain aetiological agents, notably 
cigarette smoking in the induction of lung cancer and asbestos in 
the development of mesothelioma. Secondly, researchers have 
developed both in vivo animal model systems and in vitro tissue 
culture systems to mimic some of the processes occurring in the 
development of human tumours. Finally, the direct molecular 
analysis of human tumours has been coming to the forefront 
increasingly in order to test the relevance of results obtained 
using animal models to naturally occurring neoplasias.
In regard to the first question, three broad aetiological 
parameters have been shown to play a role in the development of 
tumours. The first is the group of agents known as viruses, 
originally defined as a tumour- inducing activity able to pass 
through filters which rendered solutions bacteriologically sterile 
(Rous (1911), Shope (1935)). Such viruses were initially 
demonstrated to be active in the development of acute and latent 
leukaemias in chickens and mice (later shown to be RNA tumour 
viruses or retroviruses), the development of benign epithelial 
tumours of the rabbit skin (a DNA tumour virus) and the 
development in female mice of mammary tumours after multiple 
pregnancies (another retrovirus). Their role in human disease, 
however, has taken longer to prove, but the role of Hepatitis B 
virus in the development of hepatocellular carcinoma, that of 
Epstein-Barr Virus in the development of Burkitt’s lymphoma and 
nasophar ngeal carcinom a, those of certa in Human 
Papillomaviruses (HPVs) in the development of certain epithelial 
carcinomas and that of HTLV-I in the development of human
m
leukaemia are now well established.
The second group are those known as the environmental agents. 
These include chemical compounds and short wavelength 
radiation. These were originally identified using epidemiological 
studies, but more recently, animal models have been used to test 
( their activity in the development of a wide range of tumour types. 
Thus ultraviolet light (often as a result of several doses of 7 
days' sun in the Mediterranean) has been shown to be a factor in 
the development of malignant melanoma in humans, whereas 
nickel was shown to be a causative agent of nasal sinus cancer 
found among miners early this century.
The third factor is more a passive one: that of genetic 
susceptibility. It is well known that predisposition to certain 
cancers is hereditable: the best examples are those of childhood 
retinoblastoma and Wilrps' tumour.
With this knowledge, experimenters were then able to develop 
animal model systems with well-defined stages in the 
progression to malignancy. Perhaps the best known is that of the 
mouse skin: using chemical carcinogens, four distinct states 
could be identified, as shown in Figure 1.1: norm al tissue, 
b e n ig n  tumours, primary carcinom as and m e ta s ta t ic  
d e p o s its . The discovery that a large percentage of benign 
tumours regressed naturally, and that such processes were 
mediated by the immune system, brought a fourth factor into 
disease development: that of the host immune status.
All these findings could be deduced from experiments on whole 
animals. In order to determine the mechanism of action of
11
Figure 1.1: Schematic representation of multistage 
carcinogenesis in vivo
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tumour-inducing agents, a knowledge of the molecular nature of 
the mutations they induce was required. From the discovery that 
DNA was the genetic material in 1944 (Avery et al .), over thirty 
years of intense research into molecular biology elapsed before 
the identification of the first human oncogene (defined here as 
genes whose activation contributes to the tumorigenic 
phenotype). This proved to be the human analogue (human 
c-H a-ras) of the gene found to be responsible for the induction 
of sarcomas in mice by the retrovirus Harvey Murine Sarcoma 
Virus (Ha-MSV). In this case, the mechanism of activation proved 
to be a point mutation resulting in a single amino acid change in 
the protein concerned (Santos et al . (1982)).
As a result of this discovery, the human analogues of the other 
retroviral oncogenes have also been studied and over the last ten 
years, more than twenty such oncogenes have been characterised 
and an amalgamation of the studies of oncogene function and 
normal cell growth in vitro has occurred, with the realisation 
that these oncogenes are genes involved in the response of cells 
to external growth-regulatory signals. It has become apparent 
that cellular division is preceded by the transduction of external 
mitogenic signals from the cell surface to the nucleus, leading to 
subsequent DNA synthesis and cell division. Several proteins are 
involved in this process and many appear to be encoded by cellular 
proto-oncogenes, i.e. those genes which may become oncogenes 
upon activation.
With the identification of such genes and their modes of 
activation, a myriad of diagnostic markers for clinical disease 
status and prognosis have been developed. These genes, however,
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appear to be only a subset of those involved in the tumorigenic 
process, for it has become apparent, initially through the study of 
hereditary tumours, that loss of gene activity also plays a role, 
sometimes critical, in the development of tumours. Many tumours 
exhibit characteristic, non-random losses of chromosomes, but 
the best characterised example of gene loss to date is that of 
retinoblastoma (reviewed by Weinberg (1988)), where inheritance 
of only a single functional allele encoding the 105kDa protein 
referred to as Rb predisposes such people to the development of 
full retinoblastoma within the first 5 years of age, the 
development of which correlates with loss of this second Rb 
allele. Very recently it has become clear that a study of the 
interactions between the products of oncogenes and the so-called 
tumour suppressor genes will also occur, since it has been 
shown that the products of oncogenes of HPVs associated with 
human genital carcinomas may associate with the Rb gene product 
in vitro , although inactivation of the protein has not yet been 
proven. The identification of tumour suppressor genes and studies 
on their function will be one of the major efforts in the field of 
tumour biology over the next decade.
From this body of data, it has become clear that activation of 
individual oncogenes appears to be associated with the 
development of only a subset of tumour types. Furthermore, 
certain tumour types, such as retinoblastoma, develop only at 
certain stages in life (in this example, only in childhood). This 
indicates a role for epigenetic factors in tumour development. 
This has led to a study of the expression of proto-oncogenes 
during the process of normal cell differentiation (the maturation
1A
of a self-renewing stem cell to form mature cells, either capable 
or incapable of further division) and the means by which oncogene 
activation may subvert such a process.
It has also become clear that other epigenetic factors concern 
the rate at which activating mutations occur. It has been found 
that metabolism of chemicals within cells, either the 
inactivation of carcinogens or the activation of pro-carcinogens, 
or the import and export of such molecules in and out of cells, 
occurs at differing rates within individuals and may play a role in 
differing susceptibilities towards tumour formation. Another 
factor to consider is the rate of repair of such activating 
mutations: the DNA replication machinery has been shown to have 
a finite accuracy and that such mistakes as it does make are 
picked up by DNA repair systems. Loss of such activities gives 
rise to certain heritable diseases such as Xeroderma 
pigmentosum, which arises due to the a loss of the ability to 
repair the thymidine dimers induced by ultraviolet light and 
which leads to development of skin tumours at an early age.
This project has been concerned with the role of a bovine 
member of the papillomavirus family in the development of 
cancer of the Upper Alimentary Canal in cattle. To place this in 
context, I w ill now give a brief historical review of 
papillomavirus research in general.
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1.2 Historical context of papillomavirus research
Papillomaviruses are circular double stranded DNA viruses 
which cause benign epithelial, and occasionally fibroblastic, 
lesions in a species- and site-specific manner, more commonly 
known as warts. In certain cases, including some human lesions, 
these may progress to carcinoma. They are thus of interest both 
scientifically and clinically to cancer researchers.
The papillomaviruses are now enjoying a second phase of 
intensive research concerning their life cycle and the association 
of some members of the family with epithelial malignancies.
During the 1930s, -40s and early -50s, much research was 
carried out on Cottontail Rabbit Papillomavirus (CRPV) and its 
role in the development of skin malignancies in both the 
cottontail rabbit of the American Midwest and in domestic
rabbits (for review, see Kreider and Bartlett (1981)). In those 
early days of tumour biology, this system offered several 
attractive features, when considering the small number of
workers active in the field:
(a): The skin was v is ib le  and thus a distinct series of
characteristic phenotypes prior to invasive carcinoma could be 
discerned, unlike the leukaemias, where only the end point was 
detectable.
(b): The isolation of CRPV from naturally occurring papillomas, 
the scarification and inoculation of rabbits with virus and the 
topical application of chemical carcinogens such as tar were all
IS
simple processes technically.
(c): Virus isolates were of high titre and were stable for long 
periods; thus continuous hunting for natural isolates in the wild 
was unnecessary.
With this system, it was possible to demonstrate that 
scarification of skin and inoculation of CRPV led to the 
development of benign papillomas in both cottontails and 
domestic rabbits in the skin, but not in other sites of epithelial 
tissue (Kidd and Parsons (1936)). No virus, or very poor titres 
could be recovered from papillomas of domestic rabbits (Shope 
(1935)). This was a problem, since it was also rapidly found that 
cottontails did not thrive in captivity and were thus unsuitable 
for the experimental procedures which took up to 18 months. 
Routine production of virus stocks in the laboratory was 
therefore not trivial.
By keeping the rabbits in captivity for periods up to two years, 
development of carcinomas could be monitored and a 
characteristic spectrum of papilloma fates could be discerned 
statistically, as shown in Figure 1.2. In the case of the domestic 
rabbits, 10 - 40% regressed, 20 - 30% persisted indefinitely 
while 40 - 60% progressed to carcinoma within 1 2 - 1 8  months. 
This spectrum suggested that secondary events distinct from 
virus infection were necessary, firstly to allow indefinite 
persistence and secondly in the development of carcinoma. In 
1936, Rous and Kidd showed that topical application of tar to 
benign papillomas accelerated the onset of carcinoma
12
Figure 1.2: Spectrum of tumour formation in CRPV- 
associated carcinogenesis in domestic rabbits
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development, thus demonstrating for the first time a synergistic 
action betwen a virus and chemical carcinogens in the 
development of malignancy. Furthermore, they demonstrated that 
scarification and virus inoculation of rabbits previously treated 
with tar led to the direct development of carcinoma, thus showing 1 
that, at least in this system, the order of genetic changes 
required for carcinoma development was not crucial(Rous and 
Beard (1935), Rous and Kidd (1936)). Analysis of carcinomas also 
showed that virus production could not take place under such 
conditions (Kidd and Rous (1940)). (Already, therefore, the 
principle of strict conditions of tissue- and host specificity as 
well as the state of differentiation permissive for virus 
production was recognized, although not expressed in such modern 
jargon).
Due to the long latency period prior to carcinoma formation, 
researchers were interested in developing methods for 
maintaining a record of the carcinomas through t im e / Two 
important systems resulted; the transplantable carcinomas VX2 
and VX7, which have now been propagated serially through 
animals for over 30 years, and cell lines derived from these 
carcinomas, as well as from CRPV-induced papillomas, which 
have been similarly propagated in tissue culture. With the advent 
of more modern techniques, these lines have been invaluable in 
the analysis of the molecular biology of CRPV-associated 
carcinogenesis and are a telling reminder that the full fruit of 
given experimental systems may not be apparent for 1 or even 2 
generations.
Towards the end of the 1950s most of the fundamental
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principles of tumour development at an organism level had been 
worked out. With the discovery of DNA as the genetic material 
(Avery et al. (1944)) and subsequent determination of its 
structure and means of replication (Watson and Crick (1953), 
Meselson and Stahl (1958)), biology was moving towards the 
molecular era. With the rapid advances in the understanding of the 
principles regarding gene expression, the focus of research turned 
to questions concerning expression of individual viral genes and 
their role in tumour formation. For systematic analysis of viral 
systems, this required a method of generating viral mutants and 
recovery of such mutants as infectious viral particles. It was at 
this point that papillomavirus research dwindled and was not to 
raise its head again in a large-scale manner for nearly twenty 
years: despite many varied attempts, no method could be found, in 
vitro or in vivo , to generate infectious virus from mutant DNA. 
Since such methods h^d been developed for other DNA tumour 
viruses such as SV40, polyomavirus and adenovirus, the 
once-mighty CRPV dwindled in importance throughout the 1960s 
and early 1970s.
Two important events heralded the return of papillomavirus 
research from the late 1970s to the present day: a medical reason 
and a scientific technical advance. The discovery by Harald zur 
Hausen's group of an aetiological association of HPVs 16 and 18 
with cervical cancer (Durst et al . (1983), Boshart et al . (1984)), 
one of the largest killers of women worldwide and which presents 
currently at *500,000 per year, focussed the need for more 
detailed knowledge concerning these viruses, whilst the methods 
developed initially by Alex van der Eb's laboratory for the
introduction of cloned DNA into tissue culture cells (Graham and 
van der Eb (1973)) allowed the analysis, in controlled in vitro 
experiments, of the phenotypic properties of mutant viral DNAs 
produced using recombinant DNA technology.
At this stage, however, the only well-defined culture systems 
were those of established mouse fibroblasts and primary rodent 
embryo fibroblasts and attempts to induce focus formation with 
the HPVs or CRPV were inefficient or unsuccesful. It turned out, 
however, that another animal papillomavirus, namely Bovine 
Papillomavirus Type 1 (BPV1), d id  transform such cells
efficiently (Dvoretzky et al . (1980)), and as a result, this virus 
has served as the prototype for the molecular analysis of PVs in 
vitro . It has long been realised, however, that this virus was not 
perhaps typical of the genital HPVs, since it showed a more 
relaxed spectrum of host- and tissue specificity in vivo , 
producing both fibroblastic and epithelial proliferations in 
infected cattle. Moreover, in its natural host it failed to produce 
malignant ep ithe lia l lesions. Nevertheless, much useful 
information has been derived from this virus and adapted as more 
information concerning the HPVs has emerged. With the 
standardisation of keratinocyte culture methods, the development 
of collagen raft systems which partially mimic stratified 
epithelium (Kopan et al .(1987)) and transformation assays 
sensitive to HPV gene functions (Matlashewski et a! (1987b), 
Schlegel et a t . (1988)), research on HPVs has burgeoned within 
the 3 years of my Ph.D. Nevertheless, the impossibility of 
performing controlled experiments on humans is a serious gap in 
desired knowledge, and thus animal model systems will continue
£1
to provide insights into papillomavirus functions. In this regard, 
it is interesting to mention two other animal models which, I 
believe, will continue to be studied in the future. The first, as yet 
still embryonic, are the two mouse papillomaviruses (those of the 
European harvest mouse Micromys minutus (Sundberg et al
.(1987)) and the hairless mouse Mus musculus (Tilbrook et al 
.(1989))), which will hopefully provide a well-defined genetic 
backgound, the battery of gene probes unavailable in the CRPV 
system and the ease of manipulation of the genetic background in 
defined ways using transgenic technology. The second, BPV4 
(Jarrett et al . (1978a)), provides a large animal model which, 
unlike BPV1, d o e s  show strict tissue specificity and is 
associated with malignant lesions of epithelial origin in the wild. 
It is with the latter system that this project was concerned.
In the next section, I will set out briefly the areas of 
papillomavirus research about which knowledge is desired: I will 
then follow this up with reviews of the progress made in pursuit 
of such goals and will finally provide a background to the project 
I have been working on during the past three years.
1.3 Fields of research within the PV field
Since this project is not concerned with clinical aspects of 
papillomavirus research, I will concentrate solely on aspects 
concerning the understanding of the role of such viruses in
tumour formation and not on any means of using such
understanding in the development of treatments for sufferers or
potential development of vaccines to prevent tumour formation.
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The first major field of research concerns the detection of 
papillomavirus infection, if necessary by the identification of 
novel strains of virus, and the analysis of the means by which
such viruses are transmitted from individual to individual.
!
The second major area of desired knowledge concerns the 
process of virus production in infected cells. Specifically this 
involves the analysis of viral gene expression at the levels of RNA 
and protein, viral DNA replication and virion assembly and the 
effect that such processes have on the differentiation 
programmes of the host cells in which they occur. Also of 
interest is the basis for the strict host- and tissue-specificity of 
individual viruses concerning virus production, more specifically 
involving cell-surface virus receptors and tissue-specific factors 
influencing the viral life cycle.
The third major area of interest concerns the host response to
productive viral infection, with regard to the role of the immune
\
system in the rejection of benign papillomas.
The fourth major area concerns the secondary changes 
occurring within infected cells which result in the progression to 
carcinoma. Of interest here are changes in patterns of viral and 
cellular gene expression, and the effects these have both on the 
cellular differentiation process and the response of the immune 
system to such cells.
Clearly, in order to answer such questions, strategies must be 
designed concerning the approaches to be taken in order to allow 
the posing of specific scientific questions. These have often 
depended on the technology available at a given time and may also 
include the development of new technical tools. The review which
22
now follows of progress made towards the understanding of the 
previously described areas of papillomavirus research tries to 
bear in mind the strategies which have been employed and the 
reasons for such decisions.
1.4 Papillomavirus detection and transmission
Papillomaviruses were initially detected in animal systems by:
(a): Functional assays of tumour induction after filtration of 
extracts derived from homogenised benign papillomas or after 
purification of virus on caesium chloride gradients.
(b): Visualisation of virus particles in electron micrographs 
of the upper layers of such papillomas.
Analysis of such virions indicated that they were icosahedral 
units of diameter *55nm. They contained a circular, 
double-stranded DNA molecule of *8kb within a coat of 72 
identical capsomeres.
These methods, however, failed to detect viruses with low 
levels of virion production in the tissue of interest and DNA from 
presumed viruses (which have not, as yet, been isolated in virion 
form) such as HPVs 16 and 18 were isolated by detection using 
Southern blot hybridisation under non-stringent conditions. This 
technique has a detection limit of *0.1 copies of DNA per cell, and 
thus performing such analysis on DNA derived from biopsies was 
unable to detect any infection where viral DNA was present only
2A
in a small percentage of epithelial stem- or basal cells. Detection 
of such infections has now become possible with the development 
of the Polymerase Chain Reaction (PCR) and results on clinically 
normal individuals of a variety of ages indicates that HPV 
infection, as for another human DNA tumour virus, Epstein-Barr 
Virus (EBV), appears to be a very common event, which leads on to 
clinical conditions only under certain circumstances in a small 
percentage of cases.
The clinical manifestations, particularly development of benign 
papillomas and progression to carcinomas, appear io occur in a 
species-, tissue- and site-specific manner for each individual 
virus. The viruses may be split into two groups, the true 
epitheliotropic viruses, including all the major HPVs, which are 
associated with clinical lesions only in epithelial tissues, and the 
fibropapillomaviruses, notably BPVs 1, 2 and 5, the Deer 
papillomavirus (DPV) and the European Elk Papillomavirus (EEPV), 
which, in addition to productive epithelial papillomas, also induce 
non-productive lesions in the underlying fibroblastic tissue. The 
former may be further subdivided into viruses associated with 
skin- and mucosal epithelium, as^shown in Table 1.1 for the HPVs. 
It is noteworthy that the latency periods for progression are long, 
indicating rare secondary genetic alterations being required for 
such a process.
The mode of transmission of the viruses has not been 
absolutely defined in many cases. Nevertheless, the geographical 
correlation of CRPV-induced papillomas with the presence of 
mosquitos indicates a possible agent, and such insects have
23
Table 1.1: Lesions associated with HPV infection
in vivo (from Broker and Botchan (1986))
Type D isease O ncongenic  potentia l
1 deep plantar and palm ar m yrm ecia benign
2 common w arts  (verrucae vulgares), 
some associated with anogenital 
condylom ata
benign
3 , 10, 28 juvenile flat w arts  (verrucae
planae); associated with som e types of 
epiderm odysplasia verruciform is and  
genital in fections and
rarely malignant
some com m on warts _
4 plantar w arts and com m on w arts benign
5, 8 pityriasis-versicolor macules; 3 0 %  progress to
epiderm odysplasia verruciform is in 
patients with congenital ce ll-m edia ted  
immune defic iency and those undergoing  
im m unosuppression for transp lantation
malignancy
6, 11 ano genital condylom ata acum inata; 
atypical (flat) c .a . (particularly  
H P V -11 ); dysplasias and in traepithelia l 
neoplasias, g rades  I and II; 
penile warts; juvenile and adult- 
onset laryngeal papillom as  
(particularly H P V -11 )
usually benign
7 com mon w arts  of m eat and anim al handlers benign
9 . 12, 14 epiderm odysplasia verruciform is H P V -12, -1 7 , and -2 0  lesions,
15, 17 basiliom a (type 2 0 ) at least, can progress
1 9 - 2 5 , to carcinom as
3 6 . 4 0
13, 32 oral focal epithelial hyperplasia possib le progression
(H ec k 's  d isease) ^ to carcinom a
16, 18, 31 high-grade dysplasias, in traepithelia l high corelation
3 3 , 3 5 , 3 9 neoplasias and carcinom as (C IS )  of with genital and
genital m ucosa; Bow enoid  papu losis, 
B ow en ’s d isease; laryngeal, eso phagea l, 
and probably som e bronchial carc inom as
oral carcinom as
26 cutaneous w art, patient with  
immune defic ienc ies
unknown
27 cutaneous w art, renal 
transplant rec ip ient
unknown
29 cutaneous, in term ed iate  w arts unknown
3 0 , 4 0 larynx carc inom a
34 nongenital B o w e n 's  d isease carcinom a-in-situ
37 keratoacanthom a benign
3 8 in a m elanom a m alignant
41 m ultiple condylom ata and cutaneous  
flat warts
benign
42 genital warts benign
proven c a p a b l e  of transmitting the virus in laboratory 
experiments. The BPVs are presumed to be spread within herds by 
abrasion on commonly touched agents such as barbed wire. The 
association of HPVs 16 and 18 with genital cancers of both males 
and females suggests that these viruses are primarily spread 
with sexual intercourse, an hypothesis consistent with the facts 
firstly that nuns never contract cervical cancer (Rigoni-Stern 
(1842)) and secondly that spouses of known patients show an 
increased risk for contracting the disease. The fact, however, 
that many young, prepubertal children have been shown to be 
latently infected with HPVs implies that controlling virus spread 
may prove to be impossible, unless means of inhibiting virus 
production can be developed. As yet, no-one has unequivocally 
defined the site(s) of productive infection for the carcinogenic 
HPVs; such an approach, therefore, requires several more years of 
scientific study.
1.5 Early work concerning the productive viral life 
cycle in vivo
When considering the study of the productive life cycle, 
researchers were interested in analysing the mechanism of virai 
DNA replication and subsequent virion assembly. Most work has 
been done on the animal systems of BPV1 and CRPV: this is due to 
the highly productive infections associated with these viruses 
and their ease of induction when using experimental animals. Of 
the human viruses, only HPV1 has been analysed in any detail; the 
others have as yet not been addressed due to small size of
21
samples and the methods of treatment not often involving 
surgery.
When considering the physiological effects of PV infection, it 
is necessary to describe briefly the events which occur during the 
process of epithelial differentiation. The epithelium is a 
stratified layer of cells which may conveniently be divided into 
distinct layers on the basis of their differing growth properties 
and expression of certain genes. A diagramatic form is shown in 
Figure 1.3: the basal layer, separated from the underlying dermal 
layer by the basement membrane, is presumed to contain two 
types of cell: quiescent stem cells, which are stimulated into 
cycle only in response to tissue wounding, and basal cells, which 
divide continuously in order to replace the dead cells lost on the 
epithelial surface. One of the two daughter cells is presumed to 
be committed to differentiate, which involves the sequential 
passage, over a period of *= fourteen days, through the epithelial 
layer and concomitant expression of the epithelial marker genes. 
The s u p ra b a s a l layer contains cells already committed to 
differentiate and which in general will not divide further. During 
the passage through the stralum spinosum , stratum aranulosum. 
and in the case of cutaneous epithelium, to the quiescent s tra tum 
corneum . expression of distinctive,increasingly high molecular 
weight keratins occurs (Franke et al . (1986)), the precise nature 
of which appears to be distinct for each type of epithelium.
Analysis of histological sections of papillomas indicated that 
these lesions showed many varied morphological and histological 
features (Croissant et al .(1985)), which will not be reviewed in 
detail here: a few general points will however be made.
Figure 1.3: Schematic representation of epithelial differentiation
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Early on, it was discovered from EM pictures of papilloma 
sections that virus production only occurs in fully differentiated 
epithelial cells i.e. those unable to divide again. This makes sense 
in terms of virus survival, since it can no longer be maintained 
within these host cells. Using in situ hybridisation techniques, it 
was also shown that viral DNA synthesis occurred predominantly 
in the stratum granulosum (Orth et al . (1971)), in contrast to 
cellular DNA synthesis, which occurs predominantly in the basal 
layer. Southern blotting of DNA isolated from papillomas 
indicated an overall copy number of *100 - 1000 per cell and that 
all this DNA appeared to be episomal (Amtmann et al . (1980)).
These results are derived by end-point measurements: of more 
interest was the role of cellular and viral gene expression in the 
induction of such 'phenomena. The relative lack of sensitivity of 
such techniques, however, made analysis of viral transcription by 
in situ hybridisation very difficult or impossible and thus 
research in this area has been limited to the analysis of RNA 
isolated from tumours as a whole, using Northern blotting and, 
more recently, primer extension and S1 nuclease analysis 
(Stenlund et al .(1985)) as well as the generation- and analysis by 
DNA sequencing of cDNA libraries (Baker and Howley (1987)).
Using such techniques, however, it was shown that 
transcription was limited to one strand of the viral DNA 
(Amtmann and Sauer (1982)) and that extensive splicing patterns 
existed. Furthermore, the identification of the region of the 
genome encoding the virion proteins was found by comparision of 
transcrip ts  from productive papillom as, non-productive 
fibropapillomas and in vitro transformed cells, which are unable
IQ
to express virion proteins (Engel et al .(1983), Baker and Howley
(1987)). The analysis of such transcripts, however, would 
obviously be aided by a knowledge of the nucleotide sequence of 
the viruses, which would also allow several predictions to be 
made concerning viral genome products. Results of such analyses' 
are presented in the next section.
1.6 Genome organisation and transcription patterns
of papillomaviruses
The complete nucleotide sequence of at least ten
papillomaviruses is now known and these have revealed a common 
genome organisation (for review, see Giri and Danos (1986)).
Furthermore, sequence conservation between certain viruses of 
specific areas of the genome has been correlated with common 
properties of such viruses in vivo .
The genome organisation of BPV1 is shown in Figure 1.4. This 
shows that potential open reading frames (ORFs) exist in all three 
frames. Comparison of the BPV1 sequence with the initial 
transcriptional analyses showed that the genome could be split 
into three parts:
the Early region,
which is transcribed in both productive and non-productive
infections, as well as in in vitro transformed cells;
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the Late region,
which is only transcribed in productive papillomas;
and a region which initially was not found to hybridise to any 
transcripts at all and was thus initially termed:
the Non-Coding Region (NCR),
but which more recently has been shown to encode very small 
leader sequences in certain transcripts (Choe et al .(1989)), but 
which, more im portantly has been shown to contain 
transcriptional control sequences and is thus now more often 
referred to as the Long Control Region (LCR) or Upstream 
Regulatory Region (URR). The fact that this region was shown to
act as an enhancer element only in virally infected cells
/
indicated the presence of virally encoded transcription factors, 
which has subsequently been proven to be true (Spalholz et al 
.(1985)).
The transcriptional patterns, as presently understood, found 
within BPV1-induced papillomas and ID13 cells (C127 cells 
transformed by BPV1) are shown in Figure 1.5. These indicate 
immediately that assigning functions to 'Open Reading Frames' is 
not a trivial fact, since firstly many of these overlap and 
secondly many transcripts cover more than one such ORF. Ideally, 
therefore, analysis of gene function should come via the analysis 
of the activity of cDNAs in in vitro or in vivo assays. The great 
difficulty, however, in obtaining full-length viral cDNAs has made
2 3
Figure 1.5: Transcriptional patterns of Bovine Papillomavirus 
Type 1 in fibropapillomas and infected C127 cells 
(from Campo (1989))
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such an undertaking difficult except in a few cases and thus the 
easier analysis of genetically engineered viral mutants or 
subgenomic fragments has been followed, with the proviso that 
careful evaluation of such results is important. The field of PV 
transcription has been reviewed in great detail in a recent thesis 
(A.C. Stamps (1987)) and as this area does not cover a central 
theme of my work, will not be reviewed further here.
Obviously, the ultimate executors of viral functions are the 
virally encoded p ro te ins. The difficulty in identifying many such 
proteins either in vivo or in vitro was a block to research for 
nearly twenty years, since simple analysis of virally infected 
ce lls using trad itiona l methods of two dim ensional
electrophoresis did not yield informative results. With the
\
development of antibodies to bacterially produced fusion proteins 
or against synthetically produced peptides designed from viral 
DNA sequences, however, proteins have now be identified both in 
in vitro infected cells and in sections of naturally occurring 
tumour samples, but the low abundance of such proteins in in 
vitro infected cells has required detection by means of metabolic 
labelling, whereas the use of the immunoperoxidase staining 
method has allowed detection of proteins in tissue sections. The 
results of such methods will be described in later sections.
At this point, it should be emphasised that the analysis of 
individual viral gene functions in vivo is at present severely 
hampered by the inability to introduce mutant viruses into 
animals, either as packaged virions or as DNA molecules. The 
greatest challenge has thus been the development of artificial 
methods of generating infectious virus. In this regard, the work
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of Kreideref al (1985) in the development of methods of 
generating HPV11 virions by the infection of human cervical 
keratinocytes with virus in vitro and subsequent injection of
such cells into the renal capsule of athymic mice, leading to 
productive papilloma formation, is of interest. This system has 
recently been extended to bovine viruses (Gaukroger et al 
.(1989)), but its importance would be incomparably increased 
were methods devised to introduce DNA molecules into the tissue 
prior to injection, firstly since the HPVs associated with 
cervical cancer have never as yet been isolated as virions, and 
secondly to allow the possible generation of virions containing
i
mutated PV DNA. To date, no succesful reports exist, but the use 
of retroviral vectors may in the future allow this to occur. 
Another approach, at least for BPV1, may come using the 
transgenic mouse model system, recently reported by Lacy et a l . 
(1986).
1.7 Progression of PV-associated benign lesions to 
carcinoma
The progression of papillomas to carcinomas occurs naturally 
in a subset of PV-associated lesions. In all cases, such 
progression is associated with a loss of virion formation, but
researchers have been more interested in other phenomena
relating to this process.
In the study of the events involved in the progression of benign 
papillomas to carcinoma, three general approaches have been 
taken. Firstly, primary tumour samples have been analysed with
I S
respect to viral DNA status and gene expression, alterations in 
cellular gene expression and non-random gross chromosomal 
alterations, an approach which has been complemented with 
similar work on cell lines derived from such tumours. Secondly, 
specific alterations in viral gene expression have been induced in 
such cell lines and these have been correlated with phenotypic 
changes in cellular physiology. More recently, attempts have been 
made to develop transgenic mouse models to study each stage of 
the disease with an easily generated supply of tumours of all 
types. Each virus appears to have characteristics unique to its 
own system, but the following broad guidelines appear to hold 
true:
(a): Different patterns of viral gene expression are found in more 
malignant lesions.
(b): Endogenous cellular proto-oncogenes often become activated.
(c): Non-random chromosome losses appear to occur
(d): Host immunosuppression increases the risk factor for 
progression.
In the field of molecular changes which occur during the 
progression to carcinoma, the best studied examples are cervical 
lesions associated with HPVs 16 and 18. This is due to the wide 
range of cell lines derived from cervical carcinomas, the large 
epidemiological studies performed on human populations and the
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large available battery of oncogene probes, lack of which have
hampered progress of researchers in the bovine systems, who
have had to isolate such homologous probes themselves. The 
recent developent of a transgenic mouse model for
i
BPV1-associated tumorigenesis (Lacy et al .(1986)) may have 
found a way round this limitation.
In independent studies on HPV16- and -18-associated lesions, 
progression has been correlated with viral DNA integration (Choo 
et al .(1987), Schneider-Maunoury et al . (1987)), resulting in the 
non-random inactivation of the E1 and E2 ORFs, although episomes 
are also maintained in many tumours. Progression is also
correlated with an increase in E6 and E7 gene expression, 
possibly due to the loss of viral controlling genes but also 
possibly due to the loss of cellularly-encoded trans-repressors of 
viral gene expresssion. To my mind, this increase in expression of 
E6 and E7 is the key event, and the mechanism by which it is 
achieved may be variable. Of interest in this regard is a recent 
report indicating that deletions of sequences within the LCR have 
been found in episomal HPV16 molecules isolated from tumour 
material (Tidy et al .(1989)). It should be stressed, however, that 
the role of integration should be assessed primarily in tumour 
biopsies, since researchers have suggested that the passage of 
cells in tissue culture actively selects a g a in s t episomal 
maintenance.
Good evidence for the role of the HPV18 E7 gene in the 
m aintenance of the transformed phenotype comes from work 
performed on the cervical carcinoma cell line, C4-1 (von 
Knebel-Doberitz et al .(1988)). Introduction into this cell line of
aS
an antisense RNA construct to E7 leads to decreased proliferative 
capacity of the cells. No analysis, however, of the cellular 
response to differentiation stimuli was reported. The control of 
HPV18 gene expression by cellular factors has also been analysed 
in vitro . Using non-tumorigenic hybrids of HeLa x normal human 
fibroblasts, and tumorigenic segregants isolated from such 
hybrids, it was possible to show that 5-azacytidine, a potent DNA 
demethylation agent, could induce specific inhibition of HPV18 
gene expression in the nontumorigenic, but njoi the tumorigenic 
hybrids (Rosl et al .(1988)). Loss of HPV18 gene expression 
resulted in a decreased proliferative capacity. This indicated that 
HPV18 gene expression may be subject to negative regulation by 
cellular factors, but that this repressive activity has been lost in 
tumour cells. This view has been strengthened by the fact that 
such tumorigenic segregants show a specific, non-random loss of 
chromosomes 11 and 14 (Stanbridge et al .(1981)) and that 
reintroduction of chromosome 11 into such cells induces a non­
tumorigenic phenotype (Saxon et al .(1986)). The role of 
chromosome 11 loss in the progression of HPV-associated lesions 
may in fact be more general: similar results have recently been 
shown to hold true for the cell line SiHa (Koi et al .(1989)), which 
contains a single copy of integrated HPV16 and it is thus 
reasonable to assume that loss of chromosome 11 may contribute, 
at least in tissue culture systems, to the tumorigenic phenotype. 
A third line of evidence, as yet still in its early stages, involves 
the comparison of HPV transforming activity in two lines of 
human embryonic fibroblasts (Smits et al .(1988)): one, del-11, 
contains a deletion in the short arm of chromosome 11, whereas
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the other contains the normal diploid chromosome content. Using 
constructs containing E2 mutations, it was shown that after 
coselection for neomycin resistance, del-11 cells containing 
HPV16 were able to exhibit anchorage independent growth, 
whereas normal diploid fibroblasts containing HPV16 were not. 
This was correlated with high levels of HPV16 transcription in 
the del-11 derived lines, whereas in the normals, little or no 
transcription was detectable. This strengthens the view that 
chromosome 11 contains a repressor of HPV transcription in vitro 
and that loss of such a gene may be a factor in the progression of 
tumours in vivo .
Loss of other chromosomes may also be involved in the late 
stages of progression. In a second study on the hybrids used by 
Stanbridge, Klinger (1982) noted loss of chromosomes 2, 13 and 
17, but not 14, in addition to chromosome 11.
To my mind, however, studies with regard to chromosome 
loss(es) in human tumour progression are best performed now on 
freshly isolated tumour material. In this regard, using Restriction 
Fragment Length Polymorphism techniques, workers in Japan 
studying fresh tumour samples have demonstrated a consistent 
ioss of heterozygosity on the short arm of chromosome 3, 
indicating gene losses in this region (Yokata et al .(1989)). The 
fact that this was not identified at ail in the hybrid cell studies 
indicates the limitation of the approach using only one cell line.
A further indicator for the loss of chromosomes being involved 
in the progression to malignancy comes from results using a 
BPV1-containing line of transgenic mouse. Development of 
fibromatosis was associated with the excision and subsequent
±0.
episomal amplification of the BPV1 DNA, whereas non-random 
partial loss, ql translocation, of chromosome 14, as well as an 
internal chromosome 8 duplication, were shown to be found in the 
fibrosarcomas which subsequently developed (Lindgren et al 
.(1989)).These pieces of data indicate that loss of several tumour 
suppressor genes may be associated with progression in vivo . As 
yet their identity remains elusive. The isolation of the tumour 
suppressor gene on chromosome 11 may, however, be expected in 
the near future and those on the other chromosomes may well be 
isolated using other tumour systems. Acquisition of these probes 
will undoubtedly lead to a new set of markers with which to 
assess clinical progression, just as those of the oncogenes have 
been used in the past five years.
The third sphere of research in the progression of 
HPV-associated lesions has been concerning the activation of 
cellular proto-oncogenes. With the rapid expansion in oncogene 
probe availability, further screening will undoubtedly take place 
in the future, but to date, large-scale studies with positive 
results have been performed using only two probes: those of 
c-Ha-ras and c-myc. Two independent studies have shown an 
almost complete correlation of overexpression of the c-m yc  
oncogene with advanced stages of cervical carcinoma, this 
resulting often, but not exclusively, from gene amplification or 
rearrangement (Ocadiz et al .(1987), Riou et al .(1985)). In the 
case of the ras gene, three diagnostic aberrations have been 
detected which increase in frequency with progression of the 
disease: point mutational activation, loss of normal alleles and 
gene amplification (Riou et al .(1988)), although other
11
researchers indicate that they have found no such changes in 
HPV-associated human tumours (T. Crook, unpublished results). It 
is noteworthy that in a il cases where the mode of activation was 
point mutation, an overexpressed myc gene was also detected, 
indicating a cooperating effect between these two genes.
The final area concerning tumour progression concerns the role 
of immune surveillance. In humans, data has come primarily from 
studies on patients who have been immunosuppressed either for 
other medical reasons, notably allograft recipients, or due to a 
genetic disorder resulting in a lesion in the cell-mediated 
immune system. In the former case, patients show a much 
increased incidence of condyloma formation, development of 
HPV-associated anogenital carcinoma as well as skin carcinomas. 
The la tte r case, which causes the clinical syndrome 
Epidermodysplasia Verruciform is, results in the general 
development of skin warts associated with HPVs 3, 5, 8-10, 
12,14, 15, 17 and 19-29. The papillomas associated with HPVs 5, 
8 and 17 are known to progress to carcinomas in 30% of sufferers 
in areas exposed to sunlight (Orth et al .(1980)).
In animals, the best data comes from work concerning BPV4. All 
work concerning this virus, which formed the subject matter for 
this thesis, will be described at the end of this introduction.
1.8 Functions of Early region ORFs of BPV1: an in  
vitro an a ly s is
In order to analyse the functions of individual viral gene 
products one requires assay systems to observe phenotypes and a
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system capable of generating viral mutants. In the case of BPV1, 
such criteria were satisfied by the end of the 1970s. The two 
assays most used in the early days were both retrospective, 
end-point in vitro assays: the induction of morphologically 
transformed foci on the background of a confluent monolayer of 
normal cells (Dvoretzky et al . (1980)), and the analysis of viral 
DNA copy number and status with regard to episomal maintenance 
or integration into host chromosomes. Mutants were generated 
using recombinant DNA technology, resulting in the alteration of 
molecularly cloned viral DNA and, more recently, cDNAs.
Most early experiments used as recipient cells either NIH3T3 or 
C127 mouse fibroblasts: both are established cell lines and each 
may be transform ed effic iently  after transfection with 
recombinant BPV1 DNA, resulting in the formation of 
morphologically transformed foci, which upon expansion into cell 
iines proved to be tumorigenic in nude mice. Except in a few 
special cases mentioned later, however, the vast majority of 
recent work has been performed on the C127 cells, due to their 
lack of spontaneous transformation and the easier subsequent 
interpretation of data.
1.8.1 The transforming genes of BPV1
The results of a large body of work indicate that the main 
transforming protein of BPV1 in the C127 background, as detected 
by focus-forming assays, is that encoded by the E5 ORF. In the 
context of the full viral genome, however, mutations in other 
ORFs also lead to a loss of focus-forming activity. The most
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important example in this context is that of the E2 ORF: mutants 
in the 5' end of this ORF invariably abolish transformation 
(S a rve re t al .(1984)). The role of the E2 gene product has 
subsequently been shown to be that of a transactivator (Spalholz 
et al . (1985)), which binds to sequences in the Long Control 
Region (Androphy et al . (1987)) as a dimer (McBride et al 
.(1989)), inducing increased expression from several BPV1 
promoters and expression of the E5 gene product in 
particular(Prakash et al . (1988)).
More recently, two further E2 proteins have been discovered 
which actually inh ib it transformation. The first E2-TR, is a 3' 
truncation of the full length product, expressed from the nt3080 
promoter (Lambert et al . (1987) originally isolated as a cDNA 
which inhibited 5-10-fold BPV1-mediated transformation of 
C127 cells when cotransfected with wild-type DNA. The protein 
binds to DNA, but contains no transactivation domain. Two 
mechanisms of action have been proposed: firstly, E2TR might 
compete with the full length product for E2-responsive element 
binding sites; secondly, E2TR might inactivate the full-length 
product by the formation of inactive heterodimers (McBride et al 
.(1989)).
The second repressor is an E8-E2 fusion protein originally 
isolated in a search for cDNAs encoding a replication function! 
(Choe et al .(1989)) It shows similar properties to E2TR in the 
assays described, but the actual activities of these two 
molecules have yet to be determined. They are both, however, 
expressed in C127 cells transformed by BPV1 (Hubbert et a l .
(1988)) and thus E2TR is not an artefact of the cDNA cloning
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procedure, which often produces truncated cDNAs.
Four main bodies of evidence indicate unequivocally that the E5 
gene product, and not the overlapping E2 gene product is indeed 
the transform ing protein. Firstly, insertion of translation 
termination linkers (TtLs) into each individual ORF of a cDNA, 
C59, which contains ORFS E2, E3, E4 and E5 and which is 
expressed from the SV40 early promoter, indicates that only 
mutations in the E5 region abolish transformation (Yang et a l . 
(1985)). Secondly, the reconstruction of such mutants into hybrid 
SV40-BPV1 viruses and subsequent infection of C127 cells has 
shown that acute overgrowth of the monolayer within 48hrs is 
only abolished by mutations in the E5 ORF, but not in the E2 or E4 
ORFs (Settleman and DiMaio (1988)). Thirdly, E5 mutations within 
the context of the full viral genome abolish transforming 
activity in focus asays (DiMaio et al .(1986)). Finally, and perhaps 
most convincingly, the analysis of tranforming retroviruses 
isolated after transfection of the pZIPneoSV(X1) vector 
containing the 69T transforming region of BPV1 (Law et a l . 
(1981)) into psi2 cells indicates that the only ORF contained 
within the mRNA transcribed from such viruses is that of the E5 
ORF (Bergman et al .(1988)). The second assay described here has 
subsequently been used for an analysis of the E5 gene product by 
Site-Directed Mutagenesis (SDM).
A role for the E5 protein of BPV1 in in vivo transformation has 
recently been hinted at using a transgenic mouse model for 
BPV1-mediated tumour fbrmation. It could be shown that 
detectable levels of E5 protein could only be discerned in the 
fibrosarcomas (i.e. the malignant tumours) and not in the
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prem alignant fibromas, implying an association of E5
overexpression with the later stages of disease (Lindgren et a l .
(1989)).
The mechanism of action of the E5 protein was initially a 
mystery, since its predicted size was only 44 amino acids. The 
development of antipeptide antibodies specific for the E5 protein 
have localised the protein mainly to membrane fractions 
(Schlegel et al .(1986)). This work was done on cells 
overexpressing the protein, however, so the actual location
within an infected cell has yet to be demonstrated. The protein 
has been demonstrated to exist as a 15kDa homodimer (Schlegel 
and Wade-Glass (1987)) and SDM of the two cysteine residues at 
the C-terminal of the protein indicates that these residues 
mediate the dimerisation and that such dimerisation is essential 
for transforming activity (Horwitz et al . (1988)). Recent work 
has indicated that the protein acts by modulating the activity of 
growth factor receptors (Martin et al .(1989)). Introduction of 
high levels of human EGF-R using a retroviral vector into NIH3T3 
cells along with an E5 expression vector allowed efficient focus 
formation or growth in agar in the absence of EGF. In the absence 
of the E5 gene, such phenotypes required exposure of the cells to 
exogenous EGF. Further analysis indicated that the receptor is 
maintained in an activated, phosphorylated form at the cell
surface, presumably via an inhibition of the endocytotic 
down-regulatory mechanism. Analagous experiments involving the 
CSF-1 receptor indicate that this process may be a general one, 
and not specifically limited to the EGF receptor.
It was found fairly early on that transformation of C127 cells
by epitheliotropic HPVs was inefficient or non-detectable. 
Analysing the E5 regions of HPVs indicated that such viruses 
appeared not to have any recognisable E5 ORFs. Even before many 
HPVs were sequenced, however, a second BPV1-encoded 
transforming function had been defined in C127 focus assays, and 
this did show homology to recognisable ORFs predicted within the 
HPV genome sequences. This function was encoded by the E6 ORF 
and was originally uncovered only by overexpression of gene 
products of the 5' early region of BPV1 using a retroviral LTR 
construct (Schiller et al . (1984)). Interestingly, it was found 
that this activity was only discernible in C127 cells and not in 
NIH3T3 cells, unlike the E5 ORF, which was active in both cell 
lines.
A more recent analysis of E6 mutations within the context of 
the full viral genome (Neary and DiMaio (1989)) revealed that, in 
the presence of the E5 gene product, no effect on focus-forming 
activity was evident. Indeed, in the absence of E5 no foci could be 
induced. After coselection with a neomycin resistance gene, 
which allows the growth of colonies in the absence of 
surrounding normal cells, E5 mutants, but not E5 + E6 double 
mutants yielded ~50% of colonies with a morphologically 
transformed phenotype. This indicated, that in the context of the 
full viral genome, the E6 ORF contains a weak transforming 
activity which is masked by the presence of the E5 product in the 
assays used. A more striking result was obtained, however, when 
the foci obtained using Efe mutants were expanded and tested for 
tumorigenicity in nude mice: none were ever tumorigenic. A third 
assay for transformation, that of growth in agar has also been
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used to analyse such mutants. This showed that an intact E6 ORF 
is required for efficient anchorage-independent growth and also 
indicated an interesting phenomenon: interruption of the splice 
acceptor site required for the generation of the E6/E7 hybrid 
message actually increases the efficiency of agar growth. The 
role of the E6/E7 message will be discussed further later in this 
section.
How does the E6 protein act? The development of anti-E6 
antibodies has allowed the localisation of the protein to the 
nuclear and membrane fractions (Androphy et al .(1985)), and 
analysis by SDM of E6 gene function using the original C127 
transformation assay indicated that tight binding of the protein 
to the nuclear matrix correlates with its transforming activity 
(Androphy (unpublished)). The protein contains multiple 
cys-x-x-cys motifs, which have been shown in the transcription 
factor TFIIIA to be responsible for the binding of zinc (Miller et 
al . (1985)), and recently the E6 (and the E7) protein has been 
shown to bind zinc in a radioassay (Barbosa et al . (1989)). 
Finally, SDM of any of the cys residues within the protein 
abolishes its transforming function (Vousden et al .(1989a)). It 
seems likely, therefore, that the protein acts by altering the 
activity of cellular transcription factors, although it may also 
act within the context of full viral genome transformation to 
modulate vira l gene expression. As yet, no specific reports 
concerning this have been published.
N
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1.8.2 BPV1-encoded replication and plasmid maintenance 
functions
The second classical observation concerning papillomavirus 
replication was that the viral DNA was maintained as an episome 
and that specific DNA amplification took place during the
differentiation process in papillomas. From this, one can predict 
that specific plasmid maintenance functions must exist, either 
encoded by the virus or supplied by cellular factors, and that a 
virus-specific DNA replication activator must also be active in 
differentiating keratinocytes.
In order to test this, assays must be devised. From the
observation that infection of C127 cells with BPV1 virions 
resulted in foci containing 50 - 200 copies of episomally 
maintained DNA, it could be hypothesised that in this system, two 
functions were required: an initial replication function (R), which 
allowed amplification of the BPV1 DNA without being subject to 
the controls imposed on cellular DNA, and secondly a modulator 
function (M) which suppressed such replication activity and 
returned the BPV1 DNA to strict cell-cycie dependent replication. 
Whether these functions were also involved in piasmid 
maintenance was an open question.
Initial analysis of BPV1 sequences indicated that the plasmid
maintenance function was mediated by two sequences, PMS-1 and
PMS-2, which were only active in virus-infected cells (Lusky and
Botchan (1984)). These two sequences mapped to the LCR and the
E1 ORF respectively. Mutations in the E1 ORF all caused
integration of BPV1 DNA in transfection assays, without often
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affecting the transforming ability of the viral DNA (Lusky and 
Botchan (1985)). Mutations in the E7 ORF, however, caused a 
decrease in DNA copy number, without affecting the episomal 
state (Lusky and Botchan (1985)).
At this stage, more sensitive and rapid assays were required to 
probe deeper into the mechanisms concerning these phenomena. A 
transient DNA replication assay, taking advantage of the 
inhibition of the restriction enzyme Dpnl by methylation, allowed 
analysis of the early stages of BPV1 DNA replication after 
transfection of C127 cells (Lusky and Botchan (1986a)). This 
identified a replication function encoded by the 3' end of the E1 
ORF required for transient replication (Lusky and Botchan 
(1986b)) Furthermore, the inhibition of transient replication of 
wild-type DNA supertransfected into a line carrying a low 
copy-number mutant indicated the presence of a virally-encoded 
repressor of replication (Berg et al . (1986a)). Mutants able to 
replicate under such conditions were found to contain aberrations 
in the 5' end of the E1 ORF (Lusky and Botchan (1986b)). Such 
mutants were actually lethal in wild-type cells when selected 
under coselection for neomycin resistance and no foci were ever 
observed. This is consistent with loss of the modulator function 
resulting in runaway replication of BPV1 DNA and subsequent cell 
death. The ability of R" and M‘ mutants to complement one 
another in both replication and transformation assays indicates 
that the two functions are indeed distinct.
This assay system has certain similarities to the presumed 
vegetative cycle in vivo . The stable state resembles a latent 
infection, whereas the initial amplification is analagous to the
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differentiation- induced amplification of viral DNA. The critical 
difference is, of course, that in the latent state in vivo , only a 
single, or at most very low copy number of viral DNA is 
maintained, whereas in the in vitro model system, the stable
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state maintains 50-200 copies.
One attempt to study the parameters affecting the switch from 
a stable state to an amplifying one, using this crude model 
system, has been published so far (Berg et al (1986b)). Using an 
E7" mutant which displays a low copy number phenotype, the 
authors studied the effect of transfecting a cDNA expressing an 
E6/E7 protein into cells either along with the E7' mutant or after 
such a mutant had been established in the cells. They found that 
transfection into stably established cells only caused a partial 
reamplification, whereas cotransfection of the two plasmids 
induced a wild-type phenotype. These results indicate, but do not 
prove, that expression of the E6/E7 gene product is required 
b e fo re  the expression of E1M to allow induction of full 
amplification of the BPV1 DNA. This data is also consistent with 
the expression of E6/E7 augmenting the activity of the E1R 
protein, while the E1M protein may repress the activity of both.
A second, more interesting study (Burnett et ai .(1989)) 
concerned the comparison of properties of virally-transformed 
C127 cells under conditions of exponential growth or maintenance 
of such cells in a quiescent state. After maintenance of 
BPV1-transformed C127 cells for up to 1 month in serum-free 
medium, readdition of serum led to two phenotypically observable 
events: firstly an overall 8-16 fold amplification of viral DNA 
copy number within 48hrs, and secondly the formation of
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non-dividing 'giant1 cells, which displayed both enlarged nuclear 
and cytoplasmic components. In situ hybridisation analysis 
indicated that most of the amplification occurred in these 
non-dividing cells. Such phenotypes were not observable either in 
contro l C127 cu ltures or in ce lls transform ed by 
replication-defective mutants of BPV1. Interestingly, a cell line 
harbouring a mutant BPV1, generated spontaneously in tissue 
culture, which contained a 277bp deletion in the early poly(A) 
site and the 3' enhancer, displayed these phenotypes at confluence 
in the absence of serum starvation/restimulation.
What does this mean? The data is consistent with a model 
whereby a specific replication function is specifically expressed 
only at confluence. In the case of wild-type viral DNA, however, it 
might be the case that any M protein expressed prior to 
confluence might override such a signal by prior binding to viral 
DNA. Upon serum stimulation, inactivation of M might occur, 
allowing runaway replication to occur, leading to 'giant' cell 
formation. In the case of the viral mutant, one might postulate 
that in the absence of the 377bp sequence, replication function 
activity cannot be inhibited even in the presence of serum, thus 
leading to giant cell formation when simply maintained at 
confluence. This system shows potential for much more detailed 
studies concerning BPV DNA replication mechanisms becoming 
possible.
1.9 HPV-mediated transformation in vitro
The identification and analysis of transforming functions of
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HPVs in vitro has lagged behind that of BPV1: firstly simply due 
to the more recent isolation, cloning and sequencing of many of 
the HPVs and secondly due to their lack of activity in the C127 
and NIH3T3 focus assays used originally. Recently, methods have 
been devised to detect HPV transforming functions within 
the background of established mouse fibroblasts, but other 
systems utilising primary cultures of epithelial, and occasionally 
fibroblastic origin have now been developed and these have 
actually yielded more information than those involving NIH3T3, 
C127 or the established rat line 3Y1. Before this work is 
described, however, it should be stressed that aiL of this work 
has been published since the start of my project in late 1986.
The primary aim of tissue culture assays for HPVs was to 
discriminate between viruses such as HPVs 6 and 11, which are 
primarily associated with benign cervical lesions in vivo , and 
those such as HPVs 16, 18, 31, 33 and 35 which are associated 
more often with malignancies. Three such assays have been used 
and their results will now be discussed.
The firs t assay simply involved transfecting primary 
keratinocytes derived from the susceptible genital tissues of 
both male and female with HPV DNA and subsequent analysis of 
growth properties in vitro (Durst et al . (1987), Woodworth et a t . 
(1988), Pecoraro et al . (1989)). Simple passaging of such cells 
induces senescence w ith in 3 months in mock- or 
HPV6-transfected cells, but not in those transfected with 
HPVs16 or18. It was found that the phenotype induced by HPVs 16 
and 18 required interruption of the E1 ORF, which correlates well 
with the interruption of the E1 ORF in the integrated forms of
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HPVs found in the later stages of disease development in vivo . It 
is also noteworthy that coselection experiments involving 
selection for neomycin resistance yield essentially similar 
results (Kaur and McDougall (1988), Pirisi et a! . (1988), 
W oodworth et al .(1989)) Karyotypic analysis of such 
immortalised cell lines indicates aneuploidy, but no reports of 
consistent chromosomal loss or duplication are available. The 
implication, therefore, is that expression of HPV16 or 18 genes 
leads to a destabilisation of DNA replication fidelity, which may 
in some instances lead to development of the immortalised 
phenotype.
Analysis of any of these cell lines in nude mouse 
tum origenicity assays led to negative results and thus 
researchers tried to devise assays in which HPV functions, 
perhaps in cooperation with other factors, could induce such a 
phenotype. Since it had been shown that c-Ha-ras and c-myc  
gene activation was often found in cervical carcinomas (Riou et 
a l , (1987)), cotransfection assays were devised to test
cooperation between HPVs and such oncogenes in vitro . The best 
characterised is that of primary Baby Rat Kidney (BRK) epithelial 
cells (Matlashewski et al . (1987a)). Using this system, workers 
in the laboratories of Crawford, Howley and Pater have shown
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that morphologijplly transformed foci may be obtained after 
cotransfection of oncogenic, but not non-oncogenic, HPVs and the 
activated c-H a-ras  oncogene, either on a background of a 
confluent monolayer or more efficiently by the use of selection 
for neomycin resistance, provided that efficient expression of the 
HPV early genes is achieved. This has been induced either by
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cloning the HPV DNA downstream of retroviral LTRs (Storey et a l .
(1988)), by treating cells with dexamethasone (Pater et al 
.(1988)) or progesterone or via cotransfection of an HPV16 E2 
expression vector (Lees et a l . (1990)). Expansion of such foci into 
cell lines and injection of these cells into nude mice induces 
tumours efficiently.
This system has subsequently been used to identify the HPV 
gene function responsible for the phenotype and this has been 
mapped to the E7 ORF (Phelps et a l . (1988), Storey et al . (1988)), 
a result initially surprising since the BPV1 E6, but not the E7, 
gene is transforming in C127 assays. The E7 ORF and the E6 ORF 
are thought to be derived from a common ancestral gene (Cole and 
Danos (1988)) and thus the fact that the oncogenic HPV E7 genes 
are transforming in this assay may not in fact be surprising in 
retrospect. After the identification of E7 activity in this system, 
SDM has been used to show that the cys-x-x-cys domain at the 
C-terminus of the protein is essential for activity (Storey et al 
.(1990)), thus pointing to a fundamentally similar mechanism of 
transformation of HPV E7 gene products and the E6 gene product 
of BPV1 and allowing the obvious prediction that the HPV16 E7 
protein binds zinc.
It has further been shown, using E7 constructs employing the 
inducible Mouse Mammary Tumour Virus (MMTV) promoter, that 
continued expression of E7 is required for the maintenance of the 
transformed phenotype in such assays (Crook et al . (1989)). 
Indeed, such cells senesce if the E7 remains turned off for more 
than 3 days. This correlates well with the data of von 
Knebel-Doberitz et al . (1988), who showed using antisense RNA
constructs that abolition of HPV18 E7 expression caused 
decreased growth of the C4-1 cervical carcinoma cell line.
A further interesting result was obtained by the cloning of the 
E7 genes of HPV6 and -11 into expression vectors(Storey et al .(in 
press)). Cotransfection with pSV2neo and activated c-Ha-ras  
led to the formation of neomycin-resistant foci, but at a 
frequency 50-100-fold less than that observed for the oncogenic 
HPVs. Only a subset of such foci could be expanded, and therefore 
these lines may have arisen from rare cellular changes which may 
be induced by oncogenic HPV E7 gene products but not by those of 
HPVs 6 and 11. The indication is therefore that the E7 gene 
products of benign HPVs display a subset of the activities 
associated with the analogous proteins of the oncogenic HPVs, 
thus leading to less frequent association with tumours in vivo .
Using a slight modification of this system, two further 
questions have been addressed: namely, are any other oncogenes 
capable of cooperating with HPVs and secondly, what is the 
response of the immune system to the presence of such cells? 
Deriving the primary cells from baby BALB/C mice (BMK cells) 
instead of from Fischer rats allows the injection of cells into 
syngeneic, immunocompetent animals as well as into nude 
animals. Using this modified system it was shown that v-fos, 
but not activated c-myc was capable of cooperation with HPVs in 
the induction of foci and subsequent tumours in nude mice (Crook 
et al . (1988)). When injected into immunocompetent animals, 
however, a difference was observed: whilst the HPV + ras foci 
still induced tumours, none could be induced after transformation 
with HPV + fos. This appears to indicate that escape from
immune surveillance is a function of cellular changes and not a 
result of altered viral expression, but this is by no means certain.
What, therefore, is the role of c - m y c  activation in the 
tumorigenic process? Clearly, in vivo , the overexpression of the 
gene is correlated with late stages of cervical carcinoma: it was 
therefore considered likely that the lack of activity of c-myc in 
the assays described must be due to the design of the 
experiments. This has been shown to be the case recently. 
Cotransfection of an HPV16 plasmid pW12 with pSV-cmyc (a 
construct lacking exon 1, thus leading to overexpression of the 
protein) into BMK cells lead to efficient induction of foci after 
selection for neomycin resistance, which upon expansion proved 
to be tumorigenic in mice (T. Crook, unpublished results). It was 
found that treatment with dexamethasone d e c re a se d  the 
efficiency of focus formation. This indicates that overexpression 
of HPV early genes in the presence of c-myc overexpression may 
well be lethal to cells in vitro . A second piece of evidence for 
c-myc overexpression in the progression of tumours comes from 
the observation that transfection of cells containing HPV16 and 
v-fos, whose tumorigenicity is dependent on continued treatment 
w ith dexam ethasone, with pSV-cmyc leads to a 
dexamethasone-independent tumorigenic phenotype and also 
decreases the number of cells required to be injected into 
syngeneic animals in order to induce tumours.
This system has thus reproduced many of the observations 
found in primary tumour samples. It remains to be seen whether 
it can be used to examine the role of the other HPV genes in the 
transformation process.
Having identified the E7 protein as a transforming gene of 
oncogenic HPVs, workers have tried to define a function for this 
protein. The way forward was shown by the bringing together of 
three observations: firstly that the HPV16 E7 gene was shown to 
possess activities similar to the adenovirus E1a region, in that it 
could both activate transcription from the Adenovirus E2 
promoter and cooperate with the activated c-Ha-ras gene in the 
transformation of primary cells (Phelps et al . (1988)); secondly, 
a highly conserved domain within the E7 ORFs of oncogenic HPVs 
was identical to domains in adenovirus E1a shown to be required 
for immortalising activity; and thirdly, it was shown that the 
protein product of E1a interacts with the 105kDa product of the 
retinoblastoma susceptibility gene (Rb), a protein shown to be 
associated with DNA on affinity columns (Lee et al . (1987)). 
Inactivation of both alleles of this gene has been shown to be the 
crucial determ inant in the development of childhood 
retinoblastoma (for review, see Weinberg (1988)) and thus this 
gene has been assigned to the long-predicted group of tumour 
suppressor-, growth suppressor- or antioncogenes. It has now 
been shown that E7s from oncogenic HPVs are capable of binding 
Rb in vitro (Dyson et al . (1988)), which would presumably 
inactivate the protein in intact cells but as yet, the status of Rb 
activity in HPV-associated cancers has not been determined. 
However, SDM of the conserved region of HPV E7 analagous to the 
region of E1a shown to be necessary for Rb binding has shown 
that mutation of these sites causes loss of activity in either the 
Ad E2 promoter transactivation assay or the BRK ras cooperation 
assay (Phelps et al . (unpublished)), thus strongly implicating a
functional role for Rb binding in the transformation process.
W hether Rb inactivation actually occurs during the 
immortalisation process of human keratinocytes is unknown as 
yet, but evidence from another assay indicates that E7 alone is 
unable to induce the immortalised phe!notype in this more 
homologous system. This assay, devised by Schlegel (Schlegel et 
al . (1988)), has three facets, involving sequential selection for 
s tim u la tio n  of ce llu la r p ro life ra tio n , resistance to 
diffe rentia tion inducers and finally immortalisation after 
transfection of primary keratinocytes with linear HPV DNA. The 
discrimination between oncogenic and non-oncogenic HPVs occurs 
at the second stage and it is noteworthy that the percentage of 
colonies resistant to differentiation is very low, even when using 
the oncogenic HPVs (although for the non-oncogenic viruses there 
is absolutely no continued growth), indicating a rare second event 
being selected for at this stage. It was found that transfection of 
a region encoding solely the E6 and E7 ORFs was sufficient to 
produce immortalised clones (Munger et al . (1989)), whereas
interruption of e ither of these ORFs, or introduction of clones
containing only one of the two ORFs allowed formation of
colonies resistant to d ifferentia tion inducers but n o t 
immortalisation. This indicates that E6 has functions similar to 
E7 in this assay, yet it is completely inactive in the BRK
cooperation assay. It may be that both E6 and E7 interact with 
d istinct tumour suppressor genes and that inactivation of both 
genes is required for the immortalisation of human keratinocytes. 
This double requirement would be consistent with the fact that 
spontaneous immortalisation of human keratinocytes has never
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been observed, but at present this is mere speculation and not 
scientific fact.
Such assays have been informative in many respects, but they 
do not address the question of how HPV gene expression affects 
differentiation in the context of a stratified epithelium. From 
histological sections of biopsy material, it has been possible to 
define a number of stages between benign and frankly malignant 
tumours on the basis of the extent of the epithelium showing 
non-differentiated basal-like cells in the upper layers. These 
have been termed Cervical Intraepithelial Neoplasia grades I to III 
(CIN I - III). In the past two years, a novel method of keratinocyte 
cultivation has been developed using collagen rafts (Kopan et a l . 
(1987)), which allows a mimicking of epidermal differentiation, 
and thus cell lines derived from each type of naturally occurring 
lesion may be analysed. Analysis of cells transfected with HPV16 
showed traits such as parabasal cell crowding and enlarged nuclei 
in the upper layer characteristic of CIN I (McCance et al . (1988)). 
Undoubtedly, such an assay system will be used extensively in the 
future for the analysis of HPV gene function.
It was mentioned at the start of this section that assays for 
HPV gene function using established cell lines have now been 
developed. It has become clear that expression of HPV genes from 
their own promoters in cells such as NIH3T3, C127 or rat 3Y1 is 
inefficient. Full transformation of such cells has been achieved 
using re trov ira l vector constructs containing HPV16 
(Matlashewski et al . (1987a)). In general, information derived 
from study on such cell lines has been similar to that derived 
from the systems previously mentioned, albeit more difficult to
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detect, and thus only novel findings will be discussed here. The 
most interesting finding is that the E2-E5 region of HPV16, when 
expressed from a retroviral LTR, contains a weak transforming 
activity in an NIH3T3 assay (Vousden et al . (1989b)). This assay 
involved prior selection with the neomycin resistance gene and ' 
subsequent maintenance of the monolayer at confluence, scoring 
subsequently for focus formation. Using this region of DNA, focus 
formation was 50% that of the E6/E7: in both cases, however the 
efficiency was pitifully low. Such foci were unable to grow in 
agar, unlike those induced by E6/E7. What this result means, if 
anything, is unclear - obviously focus formation requires a 
second, rare event to occur, but to my mind, better systems for 
study of such phenomena should be sought - searching for 0.4 
foci/jag plasmid DNA in NIH3T3 cells is not the most productive 
form of research ever undertaken!
One final direction of work relevant to this thesis concerns the 
tissue-specificity of HPV action. The discussion prior to this has 
described transfection of primary epithelial cells, but not that of 
primary fibroblasts. Pirisi et al .(1987) showed that transfection 
of an HPV16-containing plasmid extended the lifespan of human 
foreskin fibroblasts, but that rare (unidentified) secondary 
events were required to prevent subsequent senescence. This 
work was extended by Watanabe et al .(1989) who showed, using 
human embryonal lung fibroblasts, that both the E6 and E7 ORFs 
were required for an extension of in vitro lifespan, but the 
question of subsequent senescence was not addressed.
Two other studies are worthy of mention. Both involve 
cotransfection of HPV16 and activated c -H a -ra s  sequences, one
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into primary Rat Embryo Fibroblasts (REFs) and the other into 
what turned out to be human fibroblasts derived from the cervix. 
In the former (Chester and McCance (1989)), full focus induction 
was achieved and such foci, upon expansion, were tumorigenic in 
nude mice. In the latter case (Matlashewski ef a\ (-(988)), cells 
were selected solely on the basis of extended lifespan and such 
cells were not tumorigenic. Since in the case of primary Syrian 
hamster fibroblasts, specific chromosome loss has been shown to 
occur during the selection procedure, it may be that such losses 
do not occur so readily in cells of human origin, or alternatively 
that a greater number of gene losses are required to render human 
cells tumorigenic. The clear indication from this work, however, 
is that the tissue-specificity of HPVs may partly be due to the 
differing activities of their transforming proteins in different 
tissues and not solely due to different levels of expression.
1.10 P ro p o se d  m o de l fo r  PV life  c y c le  in e p ith e lia l 
c e l l s
In this section, I will attempt to bring together a large body of 
data into a model for PV-induced papillomatosis consistent with 
that which is known at present. To a certain extent this is 
speculative, but so is research work itself. The following facts 
are worthy of mention:
1. Within the epithelium, there exists a pool of predominantly 
non-dividing stem cells, which are presumably stimulated to 
divide in response to localised wounding to allow repopulation of
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a depleted area of epithelium.
2. Many PVs are known to reside latently within cells. 
Development of papillomas during transmission often results 
from concurrent trauma at the site of infection (e.g. BPVs and 
CRPV).
3. Many viruses across the entire range of living organisms have 
two modes of existence:
(a): a la te n t existence (referred to as lyso ge ny  i n
bacteriophages)
(b): a productive cycle.
4. In several cases, different programmes of viral gene 
expression have been identified in the two different modes of 
viral existence:
(a): In bacteriophage lambda, predominance of cl expression 
leads to the lysogenic state, where no other phage gene products 
are expressed, whereas predominant expression of c ro  leads to 
subsequent expression of further transactivators, virus-specific 
DNA replication and phage production (Ptashne et a l . (1980)).
(b): In the case of EBV, at least 7 viral gene products have
been characterised as being latent infection antigens (EBNAs 1-6
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and LMP), whereas far more extensive gene expression is 
discernible during productive infection (Sugden (1989)).
From experiments performed in tissue culture, two, and 
possibly three BPV1 gene products may be proposed to be latency 
proteins:
(a): E2TR - this represses BPV-mediated transformation of 
C127 cells (Lambert et al .(1987)), binds to DNA sites previously 
identified as E2-dependent enhancers and thus presumably 
represses transcription from all promoters activated by the 
full-length E2 gene product (P97 and P2443 and possibly others 
as well). The as yet uncharacterised E8 -E2 fusion protein (Choe et 
al .(1989)) may also have a role in such a scheme. In the case of 
HPV 16, the full-length E2 gene product may well be a repressor 
itself, since an E2 binding site resides between the CCAAT- and 
TATA boxes implicated in transcription from the early promoter.
(b): E1M - this protein inhibits BPV-specific DNA replication, 
but appears to permit cell-cycle associated replication. 
Furthermore, E1M mutants have increased transcription rates 
from the P97 promoter (Lambert and Howley (1988)), a promoter 
which transcribes genes associated with the BPV DNA 
amplification during the productive cycle. It is presumed that E1M 
binding to PMS-1 and/or PMS-2 maintains the viral DNA in an 
episomal form, although no evidence for this has been published 
to date. Expression of such a protein in infected stem cells might 
lead to stable maintenance of a single- or a few episomal copies 
of PV DNA.
The activity of many transcription factors has been shown to be 
modulated by phosphorylation. E2TR has been shown to be a 
nuclear protein (Hubbert et al .(1988)), and the E1M product has 
also been shown to be phosphorylated (Thorner et al .(1988)). It 
may therefore be the case that these proteins are inactivated by 
phosphorylation, and thus that agents inducing such events may 
act as promoters in the multistage carcinogenesis model. [It is of 
interest that TPA, a known tumour promoter, stimulates 
transcription of latent BPV1 genomes in tissue culture (Amtmann 
and Sauer (1982)), and that such stimulation leads to a return of 
the transformed phenotype. Furthermore, TPA has been shown to 
induce phosphorylation of the previously identified transcription 
factor AP1 (Curran and Franza (1988)), leading to subsequent 
alterations in the pattern of cellular gene expression].
The proposed model for the virus life cycle is as follows:
In the absence of any cooperating factors, papillomavirus 
infection does not lead to any noticeable phenotype. The viral DNA 
is maintained stably, however, in stem cells and/or basal cells, 
but no virus-specific DNA synthesis takes place. Such a situation 
is maintained stably by the expression of a subset of viral 
proteins, as yet not completely identified. The critical event for 
p a p illo m a  (here I imply benign lesions and not necessariv 
productive infections) formation is stimulation of gene 
expression from the early promoter, leading to expression of E6 , 
E6/E7 and, as a result of the latter, E1R, resulting in cellular 
hyperproliferation and PV-specific DNA replication. Expression of
some critical differentiation marker mav lead to expression of 
the viral capsid proteins, leading to virion assembly in the 
quiescent stratum granulosum/corneum. How this might be 
achieved is left open: thus in the case of BPV1, activation of E2 
gene expression is the most obvious course, and one presumes 
that the wounding response, induced by the abrasive mode of 
infection, leads to such stimulation. In the case of HPVs, 
however, activation might result from the infection of such cells 
by a second virus: it is noteworthy that activation of the HPV18 
URR in vitro has been induced by transactivators of Herpes 
Simplex Virus Type 2 (HSV-2), a virus which has also been 
associated with cervical lesions in vivo (Gius and Laimins 
(1989)).
In the final section of this introduction, I will describe firstly 
the knowledge concerning the role of Bovine Papillomavirus Type 
4 (BPV4) in the development of epithelial tumours of the Upper 
Alimentary Canal (UAC) in cattle, the state of knowledge as I 
started my Ph.D. project in late 1986 and finally the initial aims 
of that project.
1.11 BPV4 and C ancer o f the  u p p e r a lim e n ta ry  canal 
in  c a tt le
In the Western Highlands of Scotland there is a focus of cancers 
of the UAC in cattle, which represents a significant economic 
problem. Extensive research indicated the cooperation of two 
factors working over a period of at least 7 years (Jarrett et a l .
(1978a)):
(a): Bovine Papillomavirus Type 4 (BPV4 )
(b): the prolonged ingestion of bracken fern (which is known 
to contain mutagens and immunosuppressants).
The virus has been characterised (Campo et al .(1980)) and 
shown to be a member of the B subgroup of BPVs: these are 
strictly epitheliotropic viruses of molecular weight «7.2kb and 
which show no cross-hybridisation to members of the A subgroup, 
namely the bovine fibropapillomaviruses whose prototype is BPV1 
(Jarrett (1985)).
Reproduction of the field results in animal experiments (see 
Campo and Jarrett (1987)) indicated firstly that infection of 
s c a rifie d  epithelium with BPV4 led to formation of benign 
papillomas within a period of months, which regressed naturally 
due to a host immune response. Secondly, it was found that 
concom itant treatm ent of infected animals with the 
immunosuppressant azathioprine led to far more widespread and 
persistent papillomatosis; the development of malignant UAC 
tumours, however, could not be monitored since cattle died from 
bladder cancers within two years. Thirdly, feeding of cattle 
infected with BPV4 on bracken fern led also to far more 
widespread and persistent papillomatosis and to date, two cases 
fed with the bracken have led to the development of carcinoma.
Analysis of nucleic acids from papillomas and carcinomas from 
both field cases and experimental animals gave the extremely
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surprising result that although BPV4 DNA was present as high 
copy number episomes in papillomas, no viral DNA could be 
detected in 99% of the transforming papillomas or carcinomas 
which were examined (Campo et al . (1985)). Two plausible 
explanations can be suggested to explain !a result in direct 
contrast to those found in all HPV-associated tumours as well as 
those generated by CRPV: firstly, the carcinomas are of different 
clonal origin to the papillomas and therefore BPV4 has no role in 
the malignant transformation process in the UAC of cattle. 
Alternatively, the presence of BPV4 is not required for the 
progression from papilloma to carcinoma, but is required for an 
early initiating event in the carcinogenesis programme.
As yet, no formal examination of the clonality of tumours has 
been performed: no papilloma-specific markers have been 
identified whose status could be investigated in subsequently 
forming carcinomas (point mutational activation of r a s  
sequences is an obvious candidate: sequence data of bovine ras  
genes is required to examine this. Such work has been carried out 
within the group (McCaffery et al . (1989)). In a detailed abattoir 
survey, however, Jarrett et al . (1978b)) found identical spectra 
of presentation sites for papillomas and carcinomas, indicating 
strongly a common origin of benign and malignant lesions.
This model system is interesting in several regards: firstly, it 
is a large animal model, which may therefore be expected to 
mimic human tumorigenesis more closely than rodent systems; 
secondly, unlike BPV1 but similar to the oncogenic HPVs, the 
virus is strictly epitheliotropic and induces malignant, epithelial 
lesions in its natural host; and thirdly, the system involves the
interaction of a virus, chemical mutagens and immunosuppressive 
agents, three of the classical components associated with cancer 
to date.
In attem pts to elucidate the mechanism of 
BPV4-associated transformation, research has proceeded via two 
pathways: firstly via analysis of the transcriptional pattern of 
BPV4-induced papillomas in vivo and secondly via in vitro 
transformation of tissue culture cells, since the huge time 
periods required for animal experiments was prohibitive in terms 
of cost and practicality. The results of the former approach have 
been described extensively in a recent thesis (A.C. Stamps
(1987)) and will not be described further here. The results of the 
latter approach will now be summarised.
1.11.1 In vitro transformation bv BPV4
Since virions of BPV4 were readily available, it was natural to 
try to induce observable phenotypes via infection of cells in vitro. 
As yet, no primary bovine keratinocytes derived from the UAC 
have been succesfully cultured, and no phenotype could be induced 
by BPV4 using fibroblastic cells of the same origin, unlike the 
cases of BPVs 1 and 2, which readily induced focus formation, 
yielding cells which were tumorigenic in athymic mice (Moar et 
al . (1981)).
The next obvious cell types to try were the murine fibroblast 
lines NIH3T3 and C127. By this stage, the viral DNA had been 
molecularly cloned and thus subsequent experiments involved 
transfection of such DNA. Using NIH3T3 cells, BPV4 DNA was able
to induce foci at a frequency similar to that of BPV1 (Campo and 
Spandidos (1983)) and such cells were fully transformed using 
the criteria  of anchorage-independence of growth and 
tumorigenicity in athymic mice. In light of recent results 
involving HPV-mediated transformation of NIH3T3 cells, it is 
noteworthy that the cloning of BPV4, also a strictly
epitheliotropic virus, involved the interruption of the E1 ORF: the 
low focus-forming activity of HPVs in NIH3T3 assays might 
therefore be increased by interruption of this ORF.
The factors affecting BPV4-mediated transformation of C127 
cells have proven to be much more complex and the results
derived from it much more interesting. Firstly, full focal 
transformation required the separation of the viral DNA from 
plasmid sequences. Recircularisation (i.e. reconstruction of a 
functional E1 ORF) decreased transformation efficiency ten-fold. 
Secondly, transformation induced by complete linear viral DNA 
required either concomitant treatment of cells with the tumour
promoter TPA or a period of exponential growth in the presence of
a critical concentration of growth factors (Smith and Campo
(1988)). Both of these procedures will cause expression of 
endogenous cellular genes, which is presumably required in 
addition to BPV4 in order to elicit the fully transformed 
phenotype. This is directly analagous to the in vivo finding that 
papilloma formation required both viral infection and 
concomitant induction of wound healing responses.
Thirdly, it was found that upon passaging the cells, viral DNA 
was lost, without affecting the transformed phenotype. Indeed, in 
some lines, BPV4 DNA could never be detected even at early
l i t
passage. No correlation between the presence of viral DNA and 
tumorigenicity could be found. The clear indication was that, as 
in vivo , BPV4 was only required for some initial 'hit', after which 
its presence was dispensable.
Recent work has led to the isolation of a !10kb murine sequence 
whose amplification correlates exactly with the tumorigenic 
phenotype of cell lines (Smith and Campo (1989)). This was 
isolated originally as a viral DNA-cellular sequence junction 
point from a cell line, C4Ta2a, which contained several hundred 
copies of integrated, rearranged BPV4 DNA. This murine sequence 
is active in the C127 focus assay and has also been found to be 
activated in chemically induced carcinomas of the laboratory 
mouse strain SenCar (K.T. Smith (unpublished results)). It is 
obviously of interest to determine whether a bovine analogue is 
activated in naturally occuring tumours of the bovine UAC and 
attempts to isolate the bovine equivalent are currently underway.
This system has also been used to determine the regions of the 
BPV4 genome required for transformation. The first approach 
used involved simple digestion of BPV4 DNA with various 
restriction enzymes - the appropriate sites and their relation to 
the genome organisation predicted from the viral nucleotide 
sequence (Patel et al . (1987)) are shown in Figure 1.6. This 
indicated that maintenance of the E7 ORF was essential for 
transformation: digestion with Hindi 11 which leaves a 3.6kb 
sequence spanning this region intact, has no effect, whereas 
additional digestion with EcoRI, which cuts twice within this 
ORF, completely abolishes transformation. Cloning of this 3.6kb 
sequence has shown that this region alone is capable of inducing
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Figure 1.6: Restriction sites within the BPV4 genome
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full transformation of C127 cells and amplification of the 10kb 
murine sequence, at a frequency similar to, or greater than that 
of wild-type DNA. This region of DNA contains three ORFs: the 
predicted amino acid sequence of the first, E8 , has recently been 
proposed to share structural homology to the E5 ORF of BPV1 , and 
thus this gene might also play a part in BPV4-mediated 
transformation. The second, E7, contains the motif cys-x-x-cys 
and is thus presumed to be a zinc-finger protein. The third is the 
5' half of the E1 ORF: the function of this region of PV genomes is 
presumed to be concerned with viral DNA replication: however, 
since in C127 cells, maintenance of episomal BPV4 DNA 
molecules does not occur, any transforming function due to this 
region would be due to aberrant functions as yet not ascribed to 
any other E1 ORF of any PV.
While this system has yielded some very interesting results, it 
is in one way at odds with the in vivo situation: BPV4 in vivo 
acts at the earliest stages of the tumorigenic process, whereas, 
in these assays, the recipient cell lines are already established 
and thus might be considered to be analagous to premalignant 
tumour cells. A better assay system might therefore involve cells 
which have not yet been established as immortalised cell lines. 
This will be returned to a little later.
1.11.2 Cellular changes in the progression to carcinoma
The second major area of study in the field of molecular biology 
of BPV4-associated tumorigenesis has come from an examination 
of the status of cellular proto-oncogenes in naturally occurring
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tumours. NIH3T3 transfection assays using DNA isolated from 
such tumours has, along with Southern blotting, shown that 
activated ras genes exist in at least two cases: in one case, 
amplification had also occurred (Campo et al . (1990)).
The second oncogene studied was that of the Epidermal Growth 
Factor Receptor (EGF-R). Using a f ^ l - ]  EGF binding assay, it was 
shown that a cell line, 88529C, explanted from a naturally 
occurring carcinoma of the UAC, showed levels of receptor 
similar to that of the A431 cell line, which shows a 10-50-fold 
amplification of the EGF-R gene (Smith et al . (1987)). 
Furthermore, primary bovine fibroblasts transformed by the 
f ib ro papillomavirus BPV2 showed a 3-fold increase in EGF 
binding, which in the light of the results described earlier 
concerning the BPV1 E5 gene, may well be ascribed to the 
expression of the analagous gene of this virus.
When I joined the group in Glasgow in late 1986, almost nothing 
was known in detail about the transforming activities of strictly 
epitheliotropic viruses, of which BPV4 was a member. The aims 
of the project, the results of which are described in the 
remainder of this thesis, brought together some of the 
observations described previously in this section: to attempt to 
establish a culture system for the analysis of the transformation 
of non-established bovine cells by BPV4, to investigate the role 
of specific viral functions in such a process, and to investigate 
the effect of such changes on the expression of the EGF-R gene. 
The last part of this has proven to be relatively unproductive, and 
will thus be reported only briefly in this thesis.
1A
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2.1 M a te r ia ls
2.1.1: Chemicals and solution preparation:
i
Analytical grade chemicals were used: most were purchased 
from BCL, BDH Ltd., Gibco-BRL Ltd., Pharmacia or The Sigma 
Chemical Co.. Distilled phenol was purchased from Rathburn 
Chemical Co. and formamide was purchased from Fluka AG. All 
chemicals were weighed in plastic boats on a Mettler PM300 
balance to an accuracy of 0.01 g.
2.1.1 (i): Water:
All water had been purified prior to use by passage through the 
Milli-Q Reagent Grade Water System (Millipore).
2.1.1 (ih :Preparation- and pH of solutions:
All chemicals were dissolved at room temperature by stirring 
generated by a magnetic flea or, if necessary, by heating to 65°C. 
The pH of solutions were adjusted using appropriate acids or 
bases and measured using a Tris electrode Kent EIL 7045/46 
(Russell).
2 .1 .1(iii): Sterilisation of solutions:
Heat-sensitive solutions were passed through a 0 .22pm 
Acrodisc filter (Millipore) into sterile Universals (Millipore).
Other solutions were sterilised by autoclaving in a pressure 
cooker for 15 mins.
2.1.2: P re p a ra tio n - and s to ra g e  o f O rg an ic  reagents :
Phenol, 'phenol/chloroform', 'chloroform' and formamide were 
prepared and stored as described in Maniatis et al (1982).
2.1.3 E n zym e s :
Restriction enzvmes were purchased from BCL, BRL and 
Pharmacia, most of which were supplied “with appropriate buffers.
Other enzvmes were purchased as follows:
Calf Intestinal Phosphatase (CIP) from BCL;
T4 DNA liaase from BRL;
Ivsozvme. proteinase K and ribonuclease A (RNase A) from Sigma;
2.1.4: K its  fo r  m o le c u la r b io lo g y :
Random primer labelling kits were obtained from BCL. 
G en eC lean^- kits were obtained from Bio-101 Inc.
2.1.5: Radioabelled compounds:
These were purchased from Amersham International pic: 
Compound Catalogue No. Specific Activ i ty
[ 3 2 -P]-dCTP PB10205 >111T Bqmmol' 1
D-Threo [dichloroacetyl- CFA515 >1.85 GBqmmor1
1-^  4 C]-chloramphenicol
2 .1.6 . O ther m ate ria ls :
Nucleic acid markers: Hindi I l-digested bacteriophage lambda
Haelll-digested bacteriophage 0X174
Biodvne nvlon transfer membrane was obtained from Pall Process 
Filtration Ltd.
X-Omat XAR5 film was obtained from Kodak.
2.1.7. C e n tr ifu g e s :
For large-scale, low speed preparations (>2 ml), a Du Pont 
Instruments Sorvall RC-5B centrifuge was used. For pelleting 
bacteria and in situations where the use of disposable plastic 
tubes was called for, an MSE Mistral 4L low speed centrifuge was 
used. For small scale centrifugations (<1.6ml), an Eppendorf 5414 
bench-top 'microfuge' was used. Preparative ultracentrifugation 
was performed using a Kontron Instruments Centrikon T-2070.
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2.1.8. Bacterial media and antibiotics:
Luria Broth (L-Broth): 1% (w/v) bactotryptone (Difco)
0.5% (w/v) yeast extract (Difco) 
170mM NaCI
L-Aaar: 1.5% (w/v) agar in L-Broth.
Superbroth: Solution A: 1.33% (w/v) bactotryptone
2 .66% (w/v) yeast extract 
0.44% (v/v) glycerol 
Solution B: 0.54M KH2 PO4
0.27M K2HP04
Each solution was autoclaved separately then 900ml A was 
mixed with 1 0 0 ml B.
After autoclaving of such growth media and cooling to 50°C, 
ampicillin was added if desired to 50 jig/ml.
2 % (w/v) bactotryptone
0.5% (w/v) yeast extract
10mM NaCI
2.5mM KCI
10mM MgCI2
10mM MgS04
2 0 mM glucose
Amoici11in : stock solution: 50mg/ml in water, stored at -20°C .
£2
2.1.9 Plasmid vectors and bacterial strains:
Plasmids used in this study, along with their source, are 
described in Table 2.1. All novel plasmids generated during this 
study will be described in the results section. All plasmids were 
propagated in the E. coli strain DH-5 A ™ , supplied as frozen 
stocks by BRL.
Tahle 2.1: Plasmids used in study (continued overleaf)
PLASMID SOURCE DESCRIPTION
!
pSV2neo Southern and Berg 
(1982)
Neomycin resistance gene 
of Tn5 cloned under control 
of SV40 early promoter with 
3' poly (A) site in a pBR322 
background
pZIPneoSV(X)1 Cepko et al. (1984) Mo-MuLV-derived retroviral 
vector containing neo gene 
and BamH1 cloning site.
pMS-2 M.S. Campo 
(unpublished)
Neomycin resistance gene 
cloned under the control of 
Herpes Simplex Virus thym­
idine kinase gene promoter 
with 3' poly(A) in pBR328
pBV4 B1 Campo and 
Spandidos (1983)
BPV4 cloned in BamH1 
site of pAT153
pBV4 Sst1 M. O'Prey 
(unpublished)
BPV4 cloned in Sst1 
site of pUC19
pBV4AB M.S. Campo (unpublished)
2.0kb H3-E1 of BPV4 
(nt 6110-906) ligated 
to 1.2kb E1-H3 of BPV4 
(nt 1139-2356) cloned 
inpAT153
plC20R.H3-H3 3.6 I. Doherty 
(unpublished)
3.6kb H3-H3 fragment of 
BPV4 (nt 6110-2356) 
cloned in plC20R.
M
Tahla 2.1 (continued)
PLASMID SOURCE DESCRIPTION
pCGBPV-MMTV-
CAT-A2
Matthias et al. 
(1986)
Chloramphenicol acyltrans- 
ferase gene under control of 
MMTV-LTR in a BPV1-based 
vector also containing a 
neomycin resistance gene.
pSVvmyc Land et al (1983) Retroviral gag-myc gene 
under MC29 LTR con tro l 
cloned in pSVgpt
pT24 Santos e ta l(1982) 
and
M. O'Prey 
(unpublished)
6.6kb genomic clone of the 
activated human c-Ha-ras 
gene derived from the T24 
human bladder carcinoma 
cell line cloned in pUC13
pME2.0 Hung et al (1986) 2.5kb EcoRI fragm ent of 
the  m ouse EGF receptor 
gene c lo n e d  in pSP64
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2.2 Methods in recombinant DNA technology
2.2.1 Basic methods:
2 .2.1 ( i): Phenol/chloroform extraction:
Proteins may be removed from DNA-containing solutions by 
extraction with phenol/chloroform. An equal volume of 
phenol/chloroform (see 2.1.2(ii)) was added to the DNA solution 
and the tube was vortexed for 15 secs. After spinning for 5mins 
in the microfuge, the aqueous phase was transferred to a clean 
tube.
2 .2.1 ( i i) :Ethanol precipitation:
Concentration of dilute DNA samples and the changing of a 
sample buffer was achieved by ethanol precipitation. With 
concentrations greater than 1pg/ml, the procedure was almost 
quantitative.
1/10 volume (vol) of 3M NaOAc pH5.2 and 2 volumes of absolute 
ethanol (stored at -20°C) were added. The tube was vortexed, 
placed on ice for 10mins and spun at 4°C for up to 30mins in the 
microfuge. The supernatant(S/N) was carefully poured off. The 
remaining solute was removed by washing with 1ml 70% ethanol 
(stored at -2 0 °C) and centrifuging for 10mins. The S/N was 
poured off and the pellet was drained and dried in a freeze-drier.
afi
2.2.1 ( i i i) : Quantitation of nucleic acids:
For concentrations of DNA greater than 5jig/ml, concentrations 
were determined by optical density readings of solutions at a
wavelength of 260nm. An O-D-260nm ^  'n a cuvette of
pathlength 1cm corresponds to a DNA concentration of =50pg/ml.
For small amounts of DNA (such as that recovered from an
agarose gel) a minigel was run and the intensity of UV-induced
fluorescence was compared to that of standards of known 
concentration.
2.2.1 (iv): Restriction enzvme digestion and Aaarose_ael 
electrophoresis:
The purification of a particular fragment of DNA found in a 
plasmid requires two processes: generating the desired fragment 
and separating it from the remaining unwanted DNA. These can be 
accomplished by restriction enzyme digestion and agarose gel 
electrophoresis.
Restriction enzymes were used according to manufacturer's 
specificities using the buffers provided. Typically, a digest was
performed in 50pl using up to 50pg of DNA.
All agarose gel electrophoresis techniques were carried out 
according to Maniatis et al (1982). Agarose was melted in 
running buffer (TAE) in a microwave oven
[50 x TAE: 2M Tris.CI, 50mM EDTA (pH8.0)
pHed to 7.5-7.8 using 57.1 ml/litre glacial acetic acid]
a1
and poured as a horizontal gel on a 20cm x 14.5cm plate using 
combs with dimensions 18mm x 8mm x 2mm.
One-sixth volume of 6 X Gel Loading Buffer (GLB)
6XGLB: 15% (w/v) Ficoll (w/v)
0.25% (w/v) Bromophenol blue 
0.25% (w/v) Xylene cyanol
was added to the DNA samples to ensure that they remained at the 
foot of the wells. For preparative work, gels were run at 1V/cm 
overnight, while for rapid work, 4V/cm was more usual. In this 
case buffer was recirculated using a peristaltic pump. DNA was 
stained by soaking the gel in running buffer containing 0.5jig/ml 
ethidium bromide for 15 mins. It was visualised and photographed 
using a UV transilluminator.
2.2.2 P ro to c o ls  fo r  re co m b in an t  DNA c lon ing :
Generating novel recombinant DNA molecules involves cutting 
preexisting DNA, isolating the desired fragments, ligating these 
to each other, propagating the new recombinants in bacteria and 
subsequently identifying the desired clones. The following 
methods were used routinely in this process:
2.2.3 Bac te r ia l  g row th  and ha nd l in g :
All bacterial work was carried out under Category 1 
containment. Basic microbiological techniques were performed as
described by Maniatis et al (1982).
Bacteria from frozen stocks were streaked on agar plates and 
grown overnight at 37°C. Single colonies were expanded in liquid 
culture with vigorous shaking until confluent cultures were 
achieved. Frozen stocks were prepared by addition of glycerol to ' 
20% (v/v), flash-freezing in liquid nitrogen and storage at -70°C.
2.2.4 L a rg e -s c a le  p la s m id  p r e p a r a t i o n :
The method used was based on the alkaline lysis procedure 
described by Birnboim and Doly(1979), but using a different 
growth medium.
The plasmid-harbouring bacteria were streaked out on a 1.5% 
agar plate supplemented with antibiotic and incubated O/N at 
37°C . 5ml of Superbroth containing antibiotic was inoculated 
with a single colony and this was placed in a shaker at 225rpm 
for 8 hrs. The culture was then transferred into 500mls of the 
same medium and shaken for 36hrs.
The bacteria were harvested by centrifugation at 4000rpm for 
10 minutes at 4°C . The S/Ns were discarded and the bacteria 
were resuspended in 2 X 30mls of 25mM Tris,10mM EDTA pH8.0, 
50mM glucose to which lysozyme had been freshly added to 
4mg/ml (Solution I). These were left at room temperature for 5 
mins to allow disruption of the peptidoglycan layer of the outer 
cell membrane of the bacteria. To these were added 2 vols (i.e. 
60mls) of ice-cold 0.2N NaOH, 1% SDS (Solution II). The buckets 
were inverted rapidly but gently to ensure a uniform pH of the 
whole solution while minimising the shearing of the chromosomal
DNA.
The addition of this solution has two effects: lysis of the cells 
occurs due to the SDS, and selective denaturation of the 
chromosomal DNA is achieved at the resulting pH of 12-12.5.
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After incubating the buckets on ice for 10 mins, 0.5 vols (i.e. 
45 mis) of ice-cold 3M KOAc pH4.8 (Solution III) was added. The 
buckets were shaken rapidly several times, and the chromosomal 
DNA, upon renaturation, was precipitated. After a further 
incubation on ice for 10 mins, the chromosomal DNA was pelleted 
by centrifugation at 10,000rpm for 10mins at 4°C. The S/Ns were 
filtered through a sterile tissue into 250ml buckets. [The 
resulting nucleic acid solution will be referred to as a CLEARED 
LYSATE]. 0.6 volumes (i.e. 72mls) of isopropanol was added to 
precipitate the nucleic acids. After mixing and standing at room 
temperature for 10 mins, the nucleic acids were pelleted by 
centrifugation at 10000rpm for 10mins at room temperature. 
After decanting the S/Ns, the pellets were washed with 50mls 
70% ethanol (to remove adherent isopropanol and salt therefrom) 
and recovered by. centrifugation at 10000rpm for 10 minutes at 
4°C. After decanting of the S/Ns, these were air-dried for 5 
minutes and resuspended in 8mls of TE.
Further purification was achieved using caesium chloride 
(CsCI) equilibrium density gradient centrifugation: 9.3g of CsCI 
was added and allowed to dissolve. To this solution, ethidium 
bromide was added to 600}ig/ml. The refractive index of the 
solution was then measured using a refractometer and adjusted 
to a value of 1.4000. (This is above the value quoted in Maniatis ei 
al (1982), but using solutions of refractive index 1.3960 as
an
suggested led to contamination of preparations with RNA).
The solution was then transferred to a 13.5ml Kontron tube,
was centrifuged at 38,000rpm at 20°C for 48 hours. The RNA 
pelleted to the bottom of the tube and proteins floated to the top. 
In the intervening space, two red bands were normally visible: the 
lower band corresponds to the closed circular plasmid DNA. This 
was removed by puncturing the tube with a syringe needle and 
drawing the band out by the gentle suction of a 2ml syringe.
Since ethidium bromide in the presence of light induces single­
strand breaks in DNA, the ethidium bromide was rapidly removed 
by 4 extractions with CsCI-saturated isopropanol. Caesium 
chloride was removed by dialysing the solution in Collodion bags 
(Sartorius) against 3 changes of TE. The DNA was then 
precipitated with ethanol and resuspended in 1-5ml of TE, 
according to yield. The solution was aliquoted and stored at 
-20°C.
By this method, routine yields of 5-20mg plasmid/litre of 
culture were obtained. These preparations were free of RNA and 
protein and were good substrates for restriction enzymes.
2.2.5 P re p a ra t io n  o f  v e c to r  DNA fo r  c lo n in g :
50pg of vector was digested for 4 hours at 37°C with 200U of 
appropriate restriction enzyme in a volume of 220pl. 50jil was 
removed to a new tube and returned to 37°C. (This served as a 
control for ligase activity later on). The remaining 170jil was 
incubated twice for 30 minutes at 37°C with 1U of Calf Intestinal
added to fill the tube if necessary and the solution
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Phosphatase (CIP). Both phosphorylated and dephosphorylated 
vector were deproteinised by addition of Proteinase K to 
100pg/ml and incubation for 15min at 37°C. The solution was 
extracted with phenol/chloroform, the DNA precipitated with 
ethanol, resuspended at =200ng/pl in TE pH 8.0 and stored frozen 
in small aliquots at -2 0 °C.
2.2.6 P re p a ra t ion  o f  in se r t  D NAs fo r  c lo n in g :
Recombinant plasmids were digested to completion with 
appropriate restriction enzymes, as checked by running a small 
aliquot on a m inigel. The DNA was extracted with 
phenol/chloroform, then with chloroform and precipitated with 
ethanol. After resuspension in 1 X Gel Loading Buffer (GLB), the 
samples were loaded onto agarose gels of appropriate 
concentration and run overnight at 1V/cm. After ethidium bromide 
staining, the appropriate bands were located using long 
wavelength UV fluorescence and excised using a scalpel. The gel 
fragment was then chopped up into «1mm cubes ready for 
purifica tion.
2.2.7 P u r i f i c a t io n  o f  DNA f ro m  a g a ro s e  ge ls :
DNA was purified using the GeneClean™  kit (Bio-101 Inc.) with 
a few m odifications of the m anufacturer's protocol. The 
principles of the method are as follows:
(I): melt the gel slice containing the DNA at 55°C using a
S2
high concentration of chaotropic agents (in this case 
sodium iodide)
(ii): Bind DNA to a silica matrix under these high salt
conditions.
( ii i) :  Spin down the matrix and remove iodide by washing
with an ice-cold salt/ethanol solution.
(iv): Elute the DNA at 55°C in a low salt buffer.
It was often found that after melting the gel slice, the DNA 
concentration was fairly dilute i.e. < 5pg/ml. As a result, it was 
discovered that efficient binding of DNA to the matrix required 
incubation periods of several hours or even overnight (more 
recent instructions with the kit acknowledge this). The matrix 
suspension was maintained by continuous rotation of tubes using 
a Burlimixer.
DNA recovery was assessed by running a small aliquot on a
minigel using 0X174 markers as indicators of DNA content.
Typical yields were 20-50%.
2.2.8 L ig a t io n  o f  DNA w i th  c o m p a t ib le  ( ' s t i c k y ' )  
e n d s
100fmol of dephosphorylated, linear vector DNA was mixed with 
a three-fold molar excess of insert DNA, ethanol precipitated and 
resuspended in 8pl of TE pH8.0. This was then heated to 65°C for
22
5 minutes to linearise any self-annealed sticky ends. The reaction 
mix was then incubated on ice for 60 mins to allow annealing of 
DNA. 1jul of 10 X ligase buffer:
10 X ligase buffer: 0.66M Tris.CI pH 7.6
0.1MMgCI2 
10mM DTT
was then added, together with 0.5jil of 20mM ATP and 0.5U of T4 
DNA ligase. The mixture was incubated overnight at 14°C. The 
reaction mix was then diluted 5-fold with TE pH 7.4 and 1pl was 
used to transform competent bacteria.
The following controls were routinely performed to pinpoint 
possible causes of failure:
TRANSFORMATION 
CONTROL:
LIGASE CONTROL:
PHOSPHATASE CONTROL:
INSERT PURITY:
100pg of supercoiled vector
100fmol of phosphorylated vector 
was self-ligated.
100fmol of dephosphorylated 
vector was self-ligated.
300fmol of insert was self-ligated 
(any colonies imply contamination 
with vector sequences)
2.2.9 Transformation of competent bacteria:
Competent E. coli strain DH5-A were purchased from BRL and 
stored at -7 0 °C. After thawing on wet ice, 50jil aliquots were 
pipetted into prechilled Falcon 2059 polypropylene tubes. 1jil of 
the diluted ligation reaction was added, gently mixed with the 
cells and left to stand on ice for 30mins. The cells were then 
subjected to a heat shock for 45secs at 4 2 °C, after which they 
were returned to ice for 2 minutes. 950pl of SOC medium was 
added and the cells were incubated for 60mins at 37°C with 
vigorous shaking (275rpm). Cells were then plated on agar 
containing antib io tic and transform ants were selected by 
overnight growth at 37°C.
2.2.10 Screening o f recom binant bacteria :
Colonies were picked and grown overnight as 5 ml cultures. (In 
general, it was found that screening 10-12 recombinants was 
sufficient to identify the desired clones). 1.6ml was then 
transferred to an Eppendorf tube and used to prepare 
mini-preparations of the recombinant DNA. The remainder was 
stored at 4°C .
The method used was that of Birnboim and Doly (1979). This 
produced plasmid DNA within 2hrs reliably free of chromosomal 
contamination which could be cut by a variety of restriction 
enzymes.
Cells were spun down by centrifugation for 2 minutes in a 
microfuge. The S/Ns were poured off, the pellets respun and final
2-5
traces of S/N were removed using a micropipette. Pellets were 
resuspended in 100jil of Solution I (see 2.2.2(ii)). The cleared 
lysate was then prepared as described in 2.2.2(ii). This was then 
extracted with phenol/chloroform and precipitated with ethanol 
at room temperature. The pellet was resuspen'ded in 50jil TE pH8.0 
containing 50jig/ml boiled RNase A.
Typical digests were: 17.5]j.l DNA
2jjJ 10 X restriction buffer 
5U (0.5pJ) restriction enzyme. 
Incubation was at 37°C for 1 hr.
4jjJ of 6 X GLB were added and the digest was loaded onto an
agarose gel containing ethidium bromide. After visualisation and
photography, appropriate recombinants were identified.
U s i n g  t h e s e  p r o t o c o l s ,  2 0 0 -5 0 0  c o l o n i e s  w e re  
o b ta ine d / j i l  o f  d i l u t e d  l ig a t io n  m ix ,  o f  w h ic h  > 90% were 
r e c o m b i n a n t s .
2.3 M e th o d s  in t i s s u e  c u l tu re  t e c h n iq u e s
2.3.1 M a t e r i a l s
2.3.1 ( i): P lasticw are
Nunclon flasks with growth areas of 25-, 80- and 175cm^ 
were obtained from GIBCO, as were 1.8ml ampoules for the 
long-term storage of cell lines.
as
R olle r b o ttle s  of growth area 850cm2 were obtained from 
Falcon Plastics.
24- and  96 -w e l l  C o s ta r  M u l t iw e l l  p la te s  were obtained 
from Northumbria Biologicals Ltd (NBL).
2.3.1 ( i i) :Stock solutions
All media- and nutrient stock solutions were obtained from 
GIBCO, except Foetal Calf Serum (FCS), which was obtained from 
NBL. These were stored at 4°C , except for glutamine, FCS, 
antibiotics and trypsin, which were stored at -20°C.
P h o s p h a te  B u f fe re d  S a l ine  (PBS) pH7.3 was made at the 
Beatson Institute:
NaCI 137mM
KCI 44mM
k h 2po4 1.4mM
Na2HP04.7H20 8.4mM
P B S /E D T A  was identical to PBS, except that it contained 1mM 
EDTA.
T r y p s in  s o lu t i o n  was made fresh from a 2.5% (w/v) frozen 
stock by dilution 1:10 in PBS/EDTA. It was stored at 4°C for up to 
2 weeks.
G e n e t i c i n  (G 418) was made up to 100mg/ml in water and 
stored at 4°C until use.
az
D e xa m e th a so n e  was made up to 100mg/ml in 100% ethanol 
and stored at 4°C until use.
TP A  was made up to 100jig/ml in acetone and stored at -20°C 
until use.
\
2.3.1 ( i i i ) : Cells
P A L  cells were received after primary isolation from Dr J. 
Gaukroger (Dept, of Vet. Pathology, University of Glasgow 
Veterinary School)
C127 cells were obtained from Dr C. Bostock (M.R.C. Mammalian 
Genetics Unit, Edinburgh)
NIH3T3 cells were obtained from C. Marshall (Chester Beatty 
Institute, London)
2.3.1 (iv ): Other materials
H a e m o c y t o m e t e r s  were obtained from Weber Scientific Int. 
Ltd.
E le c t r o p o r a t i o n  c u v e t t e s  were obtained from BioRad.
T h in  L a y e r  C h r o m a t o g r a p h y  (TLC) p l a t e s  were obtained 
from Camlab.
2.3.2 B as ic  m e th o d s  in t i s s u e  c u l tu re
2.3.2(i) S te r il ity  
All work was carried out in vertical laminar flow hoods under
as
Category 2 containment. Aseptic techniques were performed as 
described by Freshney (1987).
2 .3 .2 (ih :Growth medium preparation
Cells were routinely grown in Dulbecco's Modified Eagle Medium 
(DMEM) containing 10% FCS. This was prepared as follows:
w a te r 738.5m l
10 X DMEM 100ml
0.1 M sodium pyruvate 10ml
7.5% (w/v) sodium bicarbonate 30ml
0.2M glutamine 10ml
penicillin (10000U/ml) 5ml
Foetal Calf Serum 100ml
The medium was pHed by the addition of 6.5ml 1N sodium 
hydroxide. It was routinely prewarmed to 37°C before use.
2.3 .2(iii): Initiation of cultures
Stocks were recovered from liquid nitrogen storage and thawed 
rapidly at 37°C. The cell suspension was transferred to an 80cm^ 
flask and 15ml of medium was added. The flask was placed 
loose-capped in a 37°C incubator with an atmosphere containing 
5% CO2 and the cells were left overnight to seed onto the plastic 
surface.
2.3.2(iv): Propagation and passaging of cultures
Cells were routinely fed twice a week with fresh medium 
warmed to 37°C, old medium having been removed by aspiration. 
For the purposes of this project, it 'was important that cells 
never remained at confluence (i.e. covering the entire surface) for 
any length of time. The cells were thus passaged once a week. 
Passaging involves two processes:
Removal of the cells from the plasticware by trypsinisation
Reseeding the cells at an appropriate density.
The medium was removed from the cells and they were then
rinsed, first with PBS and then with the trypsin diluent (both
prewarmed to 37°C). After removal of the trypsin, the flask was
transferred to the 37°C room for 1 minute, then returned to the 
hood and growth medium was added to wash the cells off the 
growth surface. (The growth medium contains a trypsin inhibitor
which prevents further damage to the cells). The cells were then
transferred to a Universal, the flask was rinsed with PBS and the 
cells reseeded at an appropriate density.
C127 and NIH3T3 cells were replated at a 1:30 dilution
Pal cells were replated at a 1:10 dilution.
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2.3.2(v): Long-term storage of cells
Cells may be stored frozen under liquid nitrogen for several 
years, maintaining their characteristics when recovered to active 
growth.
Cells were trypsinised and resuspended at =106 cells/ml in 
growth medium. DMSO was added to 10% (v/v) (this acts as a 
cryoprotectant, preventing the formation of ice crystals within 
the cells), the cells were aliquoted into plastic ampoules, 
wrapped in cotton wool, placed in a polystyrene box and left at 
-70°C overnight. (This ensures a slow rate of cooling, which has 
been shown to enhance cell viability upon recovery), The next day, 
ampoules were transferred to racks which were stored under 
liquid nitrogen at -196°C.
2.3.3 T r a n s f e c t i o n  o f  c e l l s  w i t h  r e c o m b in a n t  DNA 
m o l e c u l e s
2 .3 .3 (i) Calcium ohosphate-mediated transfection
DNA may be taken up by eukaryotic cells when it is added to a 
subconfluent m onolayer as a coprecip itate with calcium 
phosphate. The final pH of the solution overlying the cells is 
critical for the success of the procedure. It was thus crucial that 
both the pH of the solutions used in the preparation of the 
precipitate and that of the growth medium be correct. 
Furthermore, the process is inhibited by common contaminants of 
plasmid preparations such as tRNA and proteins. The following
is u
precautions were thus routinely taken: firstly, plasmid DNA 
molecules were purified on tw o succesive CsCI gradients; 
secondly if DNAs were digested prior to transfection, the 
restriction enzymes were digested with proteinase K and the 
solutions were extracted with phenol/chloroform. This was 
followed by two ethanol precipitations; thirdly all solutions used 
for the formation of precipitates were warmed to room 
temperature before use; and fourthly, cells were not fed 
immediately prior to transfection to ensure that the pH of the 
growth medium was absolutely correct.
Stock solutions 
2.5M CaCI2 :
Since the dihydrate form of CaCI2 absorbs water very rapidly,
weighing out the correct amount of salt may in fact yield a 
solution more dilute than 2.5M. Thus the refractive index was 
measured and adjusted to 1.401: this has been shown to give 
CaCl2 su'table f ° r transfection studies.
2 X H e p e s -B u f fe re d  Sa l ine  (HBS) pH7.12:
HEPES 50mM
NaCI 280mM
Na2HP04 1.5mM
10 2
The solution was adjusted to pH 7.12 using 0.1 N NaOH, filter 
sterilised and used immediately.
Subconfluent cells were trypsin ised, counted using a 
haemocytometer (as described in Freshney (1987)) and replated at 
3 X 105 cells/T25 (C127 or NIH3T3) or 5 X 105 ce!ls/T80 (Pal). 
They were incubated overnight before addition of the calcium 
phosphate-DNA coprecipitate.
The precipitates were formed in a total volume of 0.1 X volume 
of growth medium (i.e. 0.5ml for C127 and NIH3T3 and 1ml for 
Pal) at a DNA concentration of 20pg/ml. DNA was diluted in 0.1 X 
TE pH8 and CaC^ was added to 0.25M. This was added dropwise
to an equal volume of 2 X HBS and left to stand for 30mins. This
was then added dropwise onto the cells, which were then
incubated for 16-20hrs at 37°C.
If left for a substantial time period, Ca2+ at such 
as
concentrationsj^used in transfections is toxic to cells. Thus after 
removal of the precipitate, the cells were washed twice in serum 
free medium. They were then refed and left for 24hrs before 
selection was started (see 2.3.3(v)).
2.3.3( ii) :Transfection of cells bv electroporation
At first, great problems were encountered with the calcium 
phosphate protocol. An alternative means of transfection, namely 
electroporation (EP), was therefore employed. The method used 
followed the protocol of Chu et al . (1987).
3 X 10^ to 10^ exponentially growing cells were resuspended in
1M
1 ml of EP buffer containing an appropriate amount of DNA (as 
described in the results section).
EP buffer: HEPES 20mM
NaCI 137mM
KCI 5mM
Na2HP04 0.7mM
dextrose 6mM
The solution was adjusted to pH 7.1 with 0.1 N NaOH, filter 
sterilised and stored at 4°C .
The cells were transferred to a sterile single-use cuvette and 
subjected to a single electrical pulse (using the Gene Pulser™  
(BioRad)) at a capacitance of 960pF using voltages determined 
empirically (see results section). After standing for 10mins at 
room temperature, cells were plated out in T75s and grown for 
48hrs at 37°C. Cells were then either harvested (for transient 
expression) or placed under appropriate selection.
2.3.4: Chloramphenicol Acetvltransferase (CAT) assays
48hrs after transfection, cells were washed twice with 
ice-cold PBS and 1.5ml of 40mM Tris.HCI pH7.4, 1mM EDTA, 
150mM NaCI was added. After incubation for 5mins at RT, cells 
were scraped off the surface using a rubber policeman. The cell 
suspension was transferred to an Eppendorf and the cells pelleted 
by centrifugation for 1min in the microfuge. The cells were
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resuspended in 100jil 0.25M Tris.CI pH8.0 and subjected to 3 
cycles of freeze-thaw (5mins on dry ice followed by 5mins at 
37°C).This causes lysis of the cells, allowing the nuclear and 
membranous fractions to be pelleted by centrifugation for 10mins 
in ’ the microfuge. The supernatant (the CAT extract) was 
transferred to a fresh tube and stored at -20°C until use.
5 0 jl l I  of extract were added to 1jil of [1 4 C] - 1 abe  11 ed 
chloramphenicol and the volume made up to 150jil with 0.25M 
Tris.HCI pH 8.0. The reaction was started by the addition of 20 jjJ  
of 4mM acetyl CoA (made fresh in distilled water). The reaction 
was allowed to proceed for the desired time period at 37°C. This 
was stopped by addition of 1ml ethyl acetate, vigorous vortexing 
and separation of the phases by centrifugation. The upper organic 
layer was transferred to a fresh tube and freeze-dried using a 
SpeedVac. Samples were resuspended in 15jil ethyl acetate and 
loaded onto a TLC plate and the products were separated for 
45mins using chloroform:methanol 95:5 as a solvent. The plates 
were air-dried and exposed overnight to X-Ray film.
2.3.5: Selection schemes
If selected for f o c u s  f o r m a t i o n ,  cells were trypsinised, 
replated at 1:6 and grown until confluence was reached. The cells 
were fed for up to 21 days, when plates were scored for dense 
foci of non contact-inhibited cells.
If selected for n e o m y c in  re s is ta n c e ,  cells were trypsinised, 
and replated at 1:6. (Pal cells) or 1:15 (C127- or NIH3T3 cells) in 
medium conta in ing G418 at a concentration determined
lfl5
empirically for Pal cells (as described in the results section), at 
1.2mg/ml for C127 cells or 800pg/ml for NIH3T3 cells. Cells 
were selected for 21 days, with weekly changes of medium for 
C127- and NIH3T3 cells, or twice weekly for Pal cells, at which 
time colonies were counted and either picked or stained.
2.3.6: Picking of colonies
Colonies or foci were ringed with a fe lt-tip  pen for 
identification and the top of the flask was cut away using a 
red-hot scalpel. Cells were washed with PBS and sterile stainless 
steel cloning rings of diameter 6mm were adhered around the 
desired area using high vacuum silicone grease. Cells were 
trypsinised and transferred to appropriately sized multiwell 
plates for expansion into cell lines.
2.3.7: Cell staining
Cells were washed with PBS and fixed for 10mins with 
ice-cold methanol. The methanol was removed and 0.1ml Giemsa 
stain was added per cm^ of growth surface. After shaking gently 
for 5 mins at RT, the dye was diluted 5-fold with tap water and 
shaken for a further 5 mins. The dye was poured off and the flask 
washed with tap water to remove background dye. The flasks were 
dried overnight at 37°C and then scored.
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2.3 8: Cell tumoriaenicitv in athvmic mice
Cells were harvested and resuspended at 2.5- to 5 X 107 
cells/ml in PBS and stored on ice. 0.2ml of this suspension was
S
inoculated subcutaneously into each of five athymic mice and 
animals were observed for up to 20 weeks for signs of tumour 
form ation.
2.4. M e th o d s  in e u k a ry o t i c  n u c le ic  ac id  ana lys is
A n a ly s is  o f  g e n o m ic  DNA by S ou the rn  b lo t t in g
The screening of cell lines for the presence of DNA sequences 
of interest, the detection of gene am plification and/or 
rearrangement may be performed by the hybridisation of 
single-stranded radiolabelled DNA sequences to single stranded 
genomic DNA. The most suitable methods currently available 
involve preparation of high molecular weight genom ic DNA, 
digesting this DNA with restriction enzymes, separating this DNA 
on an agarose gel, denaturing the DNA and transfer to a nylon 
membrane, to which DNA may be covalently cross-linked by
baking. This maintains the DNA in a stable form for repeated
rounds of hybridisation with radiolabelled probes.
The following protocols were found to be reliable in the
achievement of the above aims:
1QZ
2.4.1: Preparation of high molecular weight cellular DNA
In order to generate pure cellular DNA of high molecular 
weight, steps must be taken to avoid shearing of the DNA during 
preparative manipulations. Two salient measures are significant 
in this regard:
(a): the cutting of the ends of disposable pipette tips to widen 
their entrance.
(b): the precautions taken for phenol extraction: the DNA solution 
was transferred to a 50ml Falcon tube and an equal volume of 
phenol/ chloroform was added. The flask was no! vortexed, but 
rather was rotated on a Burlimixer for 20mins. The phases were 
separated by centrifugation at 3000rpm for 20mins at 20°C. The 
upper aqueous phase was transferred carefully to a fresh Falcon 
tube.
Cells grown in culture were washed once with PBS and were 
lysed and deproteinized in the plastic flask by addition of 5mls of 
0.3M NaOAc pH7.5, 5mM EDTA, 0.5% SDS containing 10Ojxg/ml 
Proteinase K. After incubation at 37° C for 1 hr, the viscous 
solution was transferred to a 50ml Falcon tube, the flask was 
washed with a further 5ml of lysis buffer and the two solutions 
pooled. The solution was extracted once with phenol/chloroform 
and -80% of the aqueous phase was transferred to a fresh tube. By 
this means, no contaminating protein was carried through, and 
thus further extractions were unnecessary. The DNA was then
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precipitated by addition of two volumes of ethanol. Gentle 
inversion of the tube for 5mins completed the precipitation. The 
DNA was pelleted by centrifugation at 3000rpm for 30mins at 
4°C. The precipitate was washed once with 70% ethanol and left 
to air-dry for 5 minutes. The pellet was resuspended in 1ml 
TEpH8.0 containing 100mM NaCI by incubation for 15mins at 37°C 
folowed by gentle pipetting up and down. RNase A was then added 
to 100pg/ml and the solution was incubated at 37°C for 1 hr. The 
so lu tion  was then d ilu ted  to 10ml to ta l volume, 
phenol/chloroform extracted, ethanol precipitated and washed as 
before. The DNA was then resuspended to at ~500jig/ml in 
TEpH8.0 and stored at 4°C.
Running of an aliquot of such DNA on a 0.3% agarose gel showed 
the DNA to have a molecular weight of 30 - 100kb.
2.4.2: Restriction digests, gel electrophoresis and Southern
Transfer
20pg of genomic DNA was digested overnight with 100U 
restriction enzyme, extracted with phenol/chloroform  and 
precipitated with ethanol. The DNA was resuspended in 60 jlx I 1 X 
GLB, loaded onto a 250ml 0.8% agarose gel and electrophoresed 
overnight at W/cm. The gel was stained and photographed before 
preparation for Southern transfer.
The gel was placed for 10mins in 0.25N HCI, causing partial 
depurination of the DNA. After rinsing briefly in water, the gel 
was transferred to a 0.5N NaOH, 1.5M NaCI solution for 30mins. 
This causes two things: hydrolysis of the DNA at the sites of
1M
depurination - resulting in fragmentation of high molecular 
weight DNA, easing its transfer from the gel - and denaturation of 
the DNA. After further rinsing with water, the gel was 
neutralised by soaking for 1 hr in 0.5 M Tris.HCI pH 7.4, 3M NaCI.
A large tray was filled with a reservoir of 20 X SSC (3M NaCI, ' 
0.3M NaCitrate pH7.0) and an inverted, flat-bottomed baking dish 
was placed thereon. A sheet of 3MM paper, presoaked in 20 X SSC, 
was placed over the dish, ensuring that its sides extended down 
into the reservoir. Any air bubbles underneath it were removed by 
rolling a Corex tube gently over the top of the dish. The gel was 
then placed on the filter paper. The area surrounding the gel was 
made water tight using X-Ray film. (This prevents any transfer of 
buffer not passing through the gel). On top of the gel was placed a 
sheet of Pall Biodyne membrane, precut to the dimensions of the 
gel and presoaked in 2 X SSC. Air bubbles were again carefully 
removed. Three identically sized pieces of 3MM paper, presoaked 
in 2 X SSC were then placed over the membrane and these were 
covered with a 10-15cm pile of paper towels. A large baking dish 
was placed over these and four filled 500ml bottles were placed 
on the top.
The effect of this set-up is to induce capillary flow of buffer 
from the reservoir, through the gel and into the paper towels. The 
DNA is concomitantly transferred to the biodyne membrane. The 
transfer was allowed to proceed overnight, to allow complete 
transfer of large-molecular weight DNA.
After transfer the membrane was carefully peeled from the gel, 
air-dried and baked at 8 0 °C for 2hrs to elicit cross-linking of the 
DNA to the membrane. It was then stored dry in a heat-sealed
H Q
plastic bag until hybridisation to suitable probes was performed.
2.4.3: Preparation and labelling of DNA hybridisation probes
DNA probes were labelled according to the method of Feinberg 
and Vogelstein (1983) using a kit supplied by BCL.
The probe-containing recombinant plasmid was digested with 
an appropriate restriction enzyme, separated on an agarose gel 
and the probe DNA was purified using the GeneClean kit (as 
described in 2.2.2(iv)). 50ng was then taken, the volume was made 
up to 9pl with water, and the DNA was denatured by boiling for 
10mins followed by rapid cooling on ice. 2pl of 10 X buffer:
10 X buffer: 0.5M Tris.HCI pH 7.4
50mM MgC^
2M HEPES pH 6.6 
120mM B-mercaptoethanol 
600jig/ml random hexanucleotides from 
calf thymus
was* added along with 3|il of a mixture containing 500}iM dATP, 
dGTP, and TTP. 1.85MBq of [ 32P-]dCTP was then added followed 
by 1U of the Klenow fragment of E. coli DNA polymerase I. The 
reaction mix was incubated for 4hrs at 37°C. The unincorporated 
nucleotides were then removed using Elutip-d columns according 
to the supplier's instructions. DNA was then denatured as 
described above in preparation for hybridisation to the 
immobilised DNA.
I l l
2.4.4: Prehvbridisation and hybridisation of probes to filters
The aim of any hybridisation protocol is the specific annealing 
of the radiolabelled probe to homologous (or semi-homologous) 
DNA with as little non-specific hybridisation as possible. The 
hybridisations were therefore carried out «5°C below the melting 
temperature of the homologous (or semihomologous) hybrids.
10ml of hybridisation solution (5 X Denhardt's (100X Denhardt's: 
2%(w/v) Ficoll, 2%(w/v) Polyvinylpyrrolidone, 2% (w/v) BSA), 5 X 
SSC, 0.1% SDS, 500pg/ml denatured salmon sperm DNA) was 
added to the bag containing the filter, air bubbles were removed 
and the bag was heat-sealed. This was incubated at an appropriate 
temperature for 3hrs before addition of the radiolabelled probe. 
The bag was then hybridised overnight at the same temperature 
before washing the next day.
Stringent hybridisation: 65°C
Relaxed hybridisation: 42°C
2.4.5: Washing of filters and autoradiography
By washing the filters, it is desir&ua to remove non-specifically 
bound probe, whilst leaving the specific binding unaffected. The 
stringency of washing is thus determined by the stringency of 
hybridisation. Filters were first washed twice for 5mins at room 
temperature in 2 X SSC, 0.1% SDS to remove unbound probe. The 
washes were then carried out as follows:
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Stringent washing: 1 hr at 65°C in 0.1 X SSC, 0.5% SDS with 3
changes of buffer
Relaxed washing: 1 hr at 6 0 °C in 2X SSC, 0.1% SDS with 3
changes of buffer
After washing, the filters were air-dried and exposed to X-Ray 
film at -70 °C for up to 14 days.
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3 .  B P V 4 - a s s o c ia t e d  t r a n s f o r m a t i o n  o f  p r im a r y  b o v i n p
f i b r o b l a s t s
3.1 I n t r o d u c t i o n
Although much valuable information has been obtained from the 
studies of BPV4-mediated transformation of the established 
murine fibroblast cell lines NIH3T3 and C127, these lines suffer 
two distinct disadvantages when trying to extrapolate results to 
the developm ent of m alignant tumours in vivo : firstly, 
BPV4-mediated transformation of the ceils in vitro leads to the 
development of the fully tumorigenic phenotype. In these systems, 
therefore, BPV4 is acting at a late stage of the carcinogenic 
process. In vivo , viral infection leads to the development of benign 
lesions (i.e. an e a r l y  event): in the fully malignant tumours the 
virus is always absent; and secondly, the cell lines are fibroblastic 
and derived from a heterologous species: in vivo , the virus is 
species-specific and strictly epitheliotropic.
The ideal system for the study of BPV4-associated 
transform ation in vitro , therefore, would be primary bovine 
keratinocytes derived from the UAC. At present, however, such 
cells are not available. It was therefore decided to use 
non-established bovine fibroblasts derived from the palate of a 
late term foetus (Pal cells) as a tool for further studies. The 
usefulness of such fibroblastic systems in the study of a strictly 
epitheliotropic virus has recently been demonstrated for HPV16 
using secondary Rat Embryo Fibroblasts (REFs)(Chesters and 
McCance (1989)) and embryonic human lung fibroblasts (Watanabe 
et a l .  (1989).
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Results obtained several years ago (Moar et a l . (1981) and M.S. 
Campo (pers. comm.)) indicated that while the infection of Pal 
cells with virions of the fibropapillomaviruses BPV1 and -2 could 
induce complete tumorigenic conversion, no such activity could be 
obtained with BPV4 virions. Several possibly explanations spring 
to mind:
(i): No viral infection was possible (For example, due to the lack of 
virion receptors on the cell surface). *
(ii): Maintenance of viral DNA after infection was not possible in
fibroblastic cells.
(iii): Expression of the required transforming genes could not be
induced in the fibroblastic background.
(iv): The BPV4 genome does not encode transforming genes 
sufficient for the transformation of primary fibroblasts in vitro .
In this study it was decided to address the following questions: 
firstly, does BPV4 encode any genes c a p a b l e  of participating in 
the tumorigenic conversion of primary bovine fibroblasts and if so, 
what cooperating genes and/or cofactors are required to elicit this 
conversion?; and secondly, are these genes expressed efficiently in 
fibroblasts when placed in the context of the full viral genome and 
if not, does this have any significance for the epitheliotropic 
nature of the virus?
The following strategy was therefore decided upon, based on 
two broad themes: firstly, an analysis of the ability of the full
viral genome to elicit phenotypic alterations of Pal cells in
cooperation with chemical cofactors and/or activated cellular 
protooncogenes; and secondly, the cloning of subgenomic fragments 
of BPV4 into expression vectors and subsequent analysis of their 
activity in the above assay.
3.2 I s o la t io n  and c h a ra c te r i s a t io n  o f  Pal c e l ls
The cells were obtained at passage 6 (p6) from Dr. J. Gaukroger 
(Dept, of Vet. Path., University of Glasgow Vet. School), were 
expanded until p9 and frozen down in bulk as aliquots of 5 x 105 
cells in 0.5ml. Individual aliquots were passaged routinely until 
p 12 for experimental purposes, after which they were discarded 
and fresh stocks recovered.
3.1 -2(i): Growth characteristics and passaging
Since the cells were not established, it was important to
determine a suitable dilution factor for their passaging. It was 
decided that weekly passaging was appropriate, and that since the 
cells were to be used in assays concerning altered growth 
properties after DNA transfection, it was important that no 
inadvertent selection for such properties should take place prior to 
transfection, which could occur upon prolonged maintenance of the 
cells as a confluent monolayer, it would thus be optimal for the 
cells to just return to confluence after seven days growth.
A confluent cell monolayer was trypsinised and plated at 
various dilutions in T25 flasks containing 5ml of growth medium. 
Cells were fed on days 2 and 4 after seeding and scored on day 7.
Confluence was judged by viewing the cells under the light 
microscope. From this simple experiment, it was determined that a 
1:10 d i l u t io n  fa c to r  was appropriate for these cells.
The density of Pal cells at confluence was measured routinely 
at each passage: this appeared to vary slightly from aliquot to 
aliquot, possibly being affected by different batches of serum. This 
confluent density was normally between 3.0 and 4.5 x 104 
ce lls /cm 2 .
3.1 .2 (ii): Sensitivity toward qeneticin fG4181
Since it was hoped to use the cells in cotransfection
experiments involving the dominant selectable marker n e o  (which
confers resistance to the antibiotic analogue geneticin), it was 
necessary to determine the concentration of drug which would kill 
the parental cells within a suitable time period (this was decided 
to be 7 days).
3 x 10^ cells were plated in T75 flasks containing 0, 200-, 
400-, 600-, 800-, 1000- or 1200jig/ml geneticin. These were fed 
on days 2 and 4 with the same concentration of drug and the plates 
were scored on day 7. The results are shown in Table 3.1. These 
show that at 400}ig/ml G418, only *80% of the cells were killed, 
whereas at 600{ig/ml 95% of cells died. The 5% surviving cells all 
appeared to be dying, appearing very elongated and vacuolar.
5 0 0 j j .g /m l  was thus decided to be the working concentration of 
G418, since the minimum concentration required for the killing of 
normal cells would allow the maximum survival of cells which
were expressing the neo  gene.
Table 3.1: G418 kill curve for Pal cells
G418 conc./mg/ml
- ■ ......................... r  —
Cell viability
0 Cells confluent
0.2 Cells confluent
0.4 20% confluent
0.6 5% survival
0.8 ALL DEAD
1.0 ALL DEAD
1.2 ALL DEAD
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3.3: E ar ly  t r a n s f o r m a t io n  e x p e r im e n ts  o f  Pal c e l ls
by  BPV4 and c o o p e ra t in g  fa c to rs
As described in the introduction to this section, attempts to 
induce morphological transformation of Pal cells by BPV4 virion 
infection were re p e a te d ly  unsuccesjjful. To elim inate the 
possibility that infection was simply not possible due to a lack of 
virus receptor, it was decided to introduce linearised BPV4 DNA 
into ce lls  by transfection. At firs t, great d ifficu lty  was 
encountered using the calcium phosphate coprecipitation method: 
the technique of electroporation was thus employed. Since, using 
this technique, transfection efficiency at a given capacitance 
varies with the applied voltage, it was necessary to perform a 
calibration curve. The most convenient method of doing this 
involves chloramphenicol acetyltransferase (CAT) assays using 
cytoplasmic protein extracts from cells transiently transfected 
with CAT expression vectors. (Although the ultimate goal was 
stable transfection, published data indicated that results of 
transient assays could be succesfully extrapolated to more 
long-term selection systems (Chu et al . (1987)).
125
3.1 .3 ( i): Calibration of electroporation conditions
As a first experiment to check transfection- and CAT assay 
technique, NIH3T3 cells were used as recipients. The CAT 
expression vector used was pCGBPV-MMTV-CAT-A2 (Matthias et a l .
(1986)), whose structure is shown in Figure 3.1. The reporter gene 
in this construct may be induced by the synthetic glucocorticoid 
dexamethasone.
Duplicate aliquots of 3 x 10® exponentially growing cells were 
resuspended in 1 ml of transfection buffer containing 1, 10 or 20pg 
of plasmid DNA. Using the optimal conditions published by Chu et al.
(1987), a voltage of 290V was used using the highest capacitance 
available (960jiF). 24hrs after transfection, dexamethasone was 
added at a concentration of 2pM to one of each duplicate flask. 
(Such a concentration has been shown to induce maximal expression 
of the N-ras gene cloned under the control of the complete 
MMTV-LTR (McKay et al . (1986)). CAT extracts were harvested 
48hrs post-transfection and the reaction was allowed to proceed 
for 1 hr at 37°C. The results of the CAT assays are shown in Figure 
3.2. These indicated that for NIH3T3 cells:
(a): The technique was effective at a DNA concentration of
10jig/ml, but not at 1 jig/ml.
(b): In transient assays, the absolute requirement for — *
dexamethasone is overcome, presumably due to the
titration of some negative trans-factor.
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Figure 3.1: Structure of DCG-BPV-MMTV-CAT-A2
BamHIBamHI
CAT POLY(A)
HindlllHindlll
Legend: BPV1 69T refers to the 69% of the BPV1 genome
capable of transforming NIH3T3- or C127 cells 
after transfection as a linearised recombinant DNA 
molecule (Law et al . (1981)).
MMTVLTR: Mouse Mammary Tumour Virus Long
Terminal Repeat.
CAT: Chloramphenicol Acetyltransferase 
poly(A): polyadenylation signal
neor: neomycin resistance gene
Plasmid received from U. Boger-Brown and described in Matthias 
et al. (1986).
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Figure 3.2: CAT assays of N1H3T3 cell extracts
t r a n s fe c te d  w i th  PC GBPV-MM TV-CAT-A2 bv 
e l e c t r o p o r a t i o n
Exponentia lly  grow ing NIH3T3 cells were harvested and duplicate a liquots were 
resuspended in 1ml of e lectroporation  buffer conta in ing either 1, 10 or 20p.g of 
pCGBPV-MMTV-CAT-A2 DNA. The cells were transferred to electroporation cuvettes and 
exposed to a voltage of 290V using a capacitance of 960(iF. After a 10 minute incubation 
period at room temperature, the cells were plated in T75 flasks and grown overnight. 24hrs 
after electroporation, dexamethasone (2(iM) was added to one of each of the duplicate flasks. 
48hrs a fte r e lectropora tion , ce lls were harvested, cytoplam ic protein extracts were 
prepared and 50% of the extract was used in the CAT assays.
10 20
Legend: the numbers refer to the number of microgrammes of
plasmid DNA used in the electroporation.
- and + refer to the absence or presence of 2pM -  , 
dexamethasone added 24hrs prior to harvesting the cells.
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(c): Dexamethasone, nevetheless, did induce a 3-5-fold
increase in CAT activity.
Since the technique appeared to be working succesfully, a voltage 
calibration for the Pal cells was then constructed. In the study of 
Chu et al . (1987), optimum voltages were always found to reside 
between 200- and 300V, 6 voltages equally spaced between 210V 
and 310V were chosen. The protocol was as for the 3T3 cells, 
except that 20jig of DNA was used in all cases. As the 
electroporation technique causes cell death, activities were n o t  
corrected for protein content: rather, 50% of the extract was used 
in the assay. This thus gives absolute levels of transfection. The 
results are shown in Figure 3.3. These indicated that:
(a): Below 250V, no significant CAT activity could be 
observed.
(b): The optimum voltage for transfection was 290V.
(c): CAT activity was *  5-10 fold less than in NIH3T3 cells.
The final observation could be partially explained by comparing 
absolute levels of protein of the extracts: due to the slower growth 
rate of the Pal cells, considerably less cells were harvested when 
compared to the NIH3T3s.
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Figure 3.3: Calibration of electroporation conditions
f o r  Pal c e l l s
Exponentia lly growing Pal cells were harvested, resuspended at 3 x 106 cells/ml in 
electroporation buffer containing 20^g/m l pCGBPV-MMTV-CAT-A2 and 1ml aliquots were 
transferred into electroporation cuvettes. Duplicate cuvettes were exposed to 210, 230, 250, 
270, 290 or 310V using a capacitance of 960fiF. Subsequent treatment was identical to that 
described in Figure 3.2.
210
*  *  *  *
+  -  +  
2 3 0  25 0
ft If
+ + 
2 7 0  2 9 0
tf T
+  -  +  
310 2 9 0
NIH3T3
Legend: the numbers refer to the applied voltage across the
electroporation cuvette.
- and + refer to the absence or presence of exogenously 
added dexamethasone (2jiM) 24hrs after electroporation.
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3.3 (ii): Transformation of Pal cells bv BPV4 in the ahsenna and
presence of TPA
The first attempts to generate morphologically transformed cells 
were transfection experiments using BPV4 DNA linearised at the
I
BamHI site of pBV4 B1 (the BamHI site interrupts the BPV4 genome 
in the E1 ORF as shown in Figure 1.6), both in the presence and 
absence of 20ng/ml TPA. This tumour promoter has been shown to 
induce BPV4 gene expression in the murine fibrolast cell line C127 
(Smith et a l . (1987)) and, under certain conditions stimulates 
BPV4-mediated morphological transformation of such cells (Smith 
and Campo (1988)). Using the electroporation technique, with 20pg 
of linearised DNA and 5 x 106 cells, such experiments gave negative 
results (see Table 3.2); it was noted that the cells treated with TPA 
returned to confluence more slowly than the untreated controls, but 
appeared otherwise normal. This indicated that BPV4 DNA is unable 
to induce the full morphological transformation elicited by BPV1 
and -2 virions at any measurable frequency, even in the presence of 
chemical cofactors.
Table 3.2: Electroporation of Pal cells bv BPV4 in the
p resen ce  o f  TPA
Exponentially growing Pal cells were harvested and resuspended at 10^ 
cells/ml in EP buffer in the presence or absence of 20pg linearised BPV4 DNA. Cells 
were electroporated at 290V using a 960p.F capacitance. After 10 minutes incubation 
at room temperature, cells were plated in duplicate T75 flasks and grown at 37°C for 
48hrs. Cells were then split 1:6 and fed twice weekly for up to 8 weeks. Where 
appropriate, cells were treated with TPA at 20ng/ml for 48hrs prior to transfection 
with subsequent treatment twice a week throughout the period of selection.
DNA added Foci
Calf thymus 0
BPV4 B1 0
BPV4 Bl n
+ TPA u
Legend: Bl: DNA digested with BamHI prior to transfection.
+ TPA: Treatment with 20ng/ml TPA 48hrs prior to
transfection and subsequently twice a week during 
selection.
Foci expressed per 10^ cells.
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3 .3 (iii): Cooperation between BPV4 and activated
proto-oncogenes in the transformation of Pal cells.
It was considered a possibility (since the BPV4 virus appears to 
lack an E6 ORF - see Figure 1.6) that the virus contained only one 
transforming gene and that this gene, when expressed in 
conjunction with an activated proto-oncogene, might cause full
transformation of Pal cells. Such a finding has subsequently been 
shown to be the case for HPVs 16, 18, 31, 33 and 35 in rat kidney 
epithelial cells (Storey et al . (1988)) and for HPV16 in secondary 
rat embryo fibroblasts (Chesters and McCance (1989)). Following a 
similar strategy to these two groups led to the decision to
cotransfect linearised BPV4 with either activated c -H a -ra s -  
(contained in the pT24 plasmid) or retroviral m yc (contained in the 
plasmid pSVvmyc) genes. The structure of these plasmids are shown 
in Figures 3.4 and 3.5. Furthermore, since it was wished to exclude 
the possibility that interruption of the E1 ORF of BPV4 by cloning 
into the BamHI site caused an alteration in the transformation 
characteristics of the cloned viral DNA,- a second BPV4 clone, pBV4
Sstl (shown in Figure 3.6), which leaves the entire Early region of
the virus intact, was used in identical transfection experiments.
107 cells were electroporated with 25jig of each linearised 
plasmid in ail experiments. 48hrs after electroporation, the cells
were split 1:6, grown to confluence and maintained thus for up to
10 weeks. The results are summarised in Table 3.3. After 
approximately 3 weeks, enlarged cells (as shown in Figure 3.7d, 
control cells shown in Figure 3.7a) began to appear in flasks
containing ras alone, ras and m yc or ras and BPV4, but not BPV4
alone, m yc  alone or BPV4 and m yc. The results with both BPV4
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clones were essentially identical. In the cases of BPV4 + ras ,  but 
not r a s  alone, these developed over the next 5 weeks into small
'foci' of enlarged cells (shown in Figure 3.7c). Similar 'foci' were
observed in the r a s  + m y c  control (see Figure 3.7b). Explanting 
these 'foci' led to cell lines which at first appeared morphologically 
altered, but which rapidly reverted to a normal phenotype: they
were contact-inhibited, did not display anchorage-independent 
growth and were non-tumorigenic in nude mice. Although these 
experiments did not yield conclusive results, they are interesting in 
two respects:
(a): any alteration in cell morphology was found only in flasks 
■ transfected with the activated c - H a - ra s  oncogene.
(b): * the process of transformation is very slow.
This could be due to inefficient expression of the BPV4
transforming gene, either due to the lack of activity of a positive 
trans-reguiatory factor, or the presence of a trans-repressor. In the 
reports concerning HPV cooperation with r a s ,  efficient 
transformation required expression of HPV gene functions either 
from a retroviral LTR (Matlashewski et al . (1987a)) or via steroid 
hormone induction (Pater et al . (1988)). it could therefore be the 
case that expression of the BPV4 transforming gene(s) is (are) 
naturally inefficient in bovine fibroblasts, when in the context of 
the full viral genome.
Alternatively, expression of the transforming function(s) of 
BPV4, even in the presence of an activated c -H a - ra s  gene, may not 
be sufficient for cellular transformation in this assay. To try to
12A
distinguish between these possibilities, two separate strategies 
were followed: firstly, the cloning of subgenomic fragments of 
BPV4 into expression vectors in order to determine whether any 
BPV4 genes are capab le  of cooperating with activa ted  
proto-oncogenes in the transformation of Pal cells; and secondly 
the use of neomycin resistance assays to try to detect transforming 
gene(s) within the context of the complete BPV4 genome.
This second assay allows the growth of clonal cel! lines at low 
density in the absence of surrounding untransformed cells: since 
such untransformed cells have in certain cases been shown to exert 
inhibitory effect on focal growth of transformed cells (Dotto et a l .
(1988)), it might be the case that this assay would be more✓
sensitive than that of the focus assay.
At this stage, technical problems concerning the calcium 
phosphate coprecipitation method of eukaryotic cell transfection 
were overcome. Since this technique requires 10- to 20-fold fewer 
cells per experiment as compared to the electroporation method, it 
was far more suited to the requirements of Pal cell growth, which 
exhibit low cell density at confluence. As a result, all further 
experiments described used the calcium phosphate coprecipitation 
technique in preference to that of electroporation.
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Figure 3.4: Structure of the p T24 plasmid
Exon:  1 2  3 4
6.6kb human c-Ha-ras
BamHI
Mult iple
Cloning
Site
pUC13
The 6.6kb insert was isolated as DNA from the human bladder 
carcinoma T24 by virtue of its ability to transform NIH3T3 cells to 
the tumorigenic phenotype (Santos et al .(1982)). It was originally 
cloned in pBR322 and subsequently transferred to pUC13 (M. O'Prey 
(unpublished results)).
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Figure 3.5: Structure of the pSVvmvc plasmid
LTR gag myc LTR
pSVvmyc
ampr ori SV40 gpt polyA 
Early 
Promoter
Legend: The gag-myc fusion protein expressed from this construct is the
transforming protein of the acutely transforming retrovirus MC29. It 
has been shown to be active in the malignant transformation of primary 
Rat Embryo Fibroblasts in cooperation with the plasmid pT24 
(described in Figure 3.60.
LTR: Long Terminal Repeat.
gpt: Hypoxanthine phosphoribosyl transferase gene,
ori: Origin of plasmid replication in E. coli.
ampr: Ampicillin resistance gene.
SV40: Simian Virus 40.
poly(A): Polyadenylation signal.
Plasmid first described in Land et a l . (1983).
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Figure  3.6: S t ru c tu re  o f  p BV4 Bl and pBV4 Sstl  p la s m id s  
nt 6147 nt 6146
Mult iple
Cloning
Site
nt 2597
pUC19
nt 2596
E2 L1
T| § | L 2
BamHI
pAT153
pBV4 Bl
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Table 3.3: Focus formation assays of Pal cells electropor­
a ted  w i t h  BPV4 a n d /o r  a c t i v a t e d  p r o t o - o n c o -  
g e n e s
Cells were electroporated as described in Table 3.2, 20|ig of each linearised 
plasmid being used where appropriate. '
DNA added Foci
Calf Thymus 0
BPV4 Bl 0
BPV4 SI 0
pT24 B1 
(ras)
0
pSVvmyc E1 0
BPV4 Bl + ras 12
BPV4SI + ras 10
BPV4 Bl + myc 0
BPV4 SI + myc 0
ras + myc 15
Legend: B I/S I/E I: Prior digestion with BamHI/Sstl/EcoRI
Foci expressed per 107 cells.
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F iaure3 .7 : Foci and g ian t ce lls  induced after e le c tro ­
poration of Pal cells w ith  BPV4 and ras
Co nt ro l
,
' 1 •
<
V'.1
B P V 4 - B I  +■ ras
Magnifications: 
Control: x18 
BPV4-BI + ras: x45
t as + myc
B P V 4 - S s l  + ras
ras + myc: x45 
BPV4-Sstl + ras: x45
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3.1.4: Use o f neomycin coselection assays in the
ana lys is  o f BPV4 transfo rm ing  fun c tion s
3.1 -4(i): Cotransfection of pal cells with BPV4. ras and a
neomvcin resistance gene
In these experiments involving coselection with a neor marker 
gene, the plasmid pSV2neo (Southern and Berg (1982)) was used (a 
map of the plasmid is shown in Figure 3.17). This plasmid has been 
shown to confer neomycin resistance to fibroblastic cells of both 
human and murine origin and was thus considered likely to be active 
in bovine cells as well.
5 x, 105 Pal cells were plated in T75 flasks and incubated 
overnight at 37°C . DNA-calcium phosphate coprecipitates were 
prepared the next day: in all cases, 5|ig of pSV2neo was used; 10|ig 
of linearised pBV4 Bl and/or pT24 was used where appropriate and 
the DNA content of each precipitate was normalised to 25jig using 
plC20H as a filler plasmid. 48hrs after addition of the precipitates 
the cells were split 1:6 and were grown for 21 days in medium 
containing 500pg/ml G418. The results are shown in Table 3.4.
Using only the neomycin resistance plasmid, several colonies 
were visible after 14 days, whereas after 21 days, only a few, very 
small colonies survived: these all showed a flat morphology and 
none of these could be established in 24-Multiwell plates. Similar 
results were obtained when cotransfecting the activated c-Ha-ras 
gene. Upon cotransfection of linear BPV4, however, *  20 flat 
colonies greater than 5mm in diameter (subsequently called 
'macrocolonies') per 5 x 10^ cells could be readily visualised after 
21 days selection. Representative colonies are shown in Figure 3.8a
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and -b. Cotransfection of both BPV4 and the activated c -H a -ras  
gene gave results essentially similar to those for BPV4 alone: the 
great majority of colonies formed had a diameter >5mm and all 
showed a flat phenotype (see Figure 3.8c and-d).
These results may indicate that in the presence of G418, the Pal 
cells are undergoing senescence in the period between 14 and 21 
days after the beginning of selection, a process which can be 
delayed by the presence of BPV4. The results do not address the 
question of immortality: such a question requires continuous 
passaging of cells for greater than twelve months.
The results also indicated that even in the absence of surrounding 
normal cells, cotransfection of BPV4 and the activated ras gene is 
not sufficient to induce a morphologically transformed phenotype. 
This experimental protocol cannot distinguish whether this is due 
to inefficient expression of the transfected genes or simply due to 
the inability of this combination of genes to transform bovine 
fibroblasts. This question has been addressed in subsequent 
sections.
These results are similar to those of Pirisi et al . (1987) and 
M atlashewski et a l . (1988), obtained after transfection of 
HPV16-containing plasmids into human genital fibroblasts. Firstly, 
the papillomavirus DNA, when transfected in the presence of a neor 
plasmid, is able to prolong the proliferative capacity of the 
recipient fibroblastic cells in the presence of G418. Secondly, 
cotransfection of papillomaviral- and activated ras  DNA is not 
sufficient to induce a non-contact-inhibited phenotype, even in the 
absence of surrounding normal cells.
[Since it appears that BPV4 shows similar properties to HPV16 in 
homologous fibroblastic systems, it would perhaps be of interest to
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determine whether BPV4 is similar to HPV16 in transformation 
assays using Rat Embryo Fibroblasts as recipients, since in these 
cells the complete tumorigenic phenotype may be induced by HPV16 
in cooperation with an activated ras gene (Chesters and McCance
(1989)). This pro ject was, however, concerned with the
i
development of an homologous cell system and this question was 
thus not addressed.]
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Table 3.4: N eo- colony formation after cotransfection of
Pal cells with pSV2neo and linear BPV4 and/or 
activated c-Ha-ras DNA
Exponentially growing Pal cells were harvested and plated at 5 X 10^ /T75 
flask. 24hrs later, calcium phosphate-DNA coprecipitates were added dropwise and left 
on the cells at 37°C overnight. Cells were then washed and refed. 48hrs after addition 
of the precipitates, cells were harvested, replated at a 1:6 dilution in the presence of 
500p.g/ml G418. Cells were refed twice weekly for 21 days, when . colony formation 
was scored.
Plasmid DNA
V
Macrocolonies/ 
total colonies
% morphologically 
transformed
Experiment
1 2 3
pSV2neo 0/3 0/0 0/2 0
pSV2neo + 
pT24 Bl 0/3 0/1 0/0 0
pSV2neo + 
BPV4 Bl 20/20 17/18 24/26 0
pSV2neo+ 
pT24 Bl + 
BPV4 Bl
20/24 11/12 17/18 0
Legend: 'Macrocolony': colonies of diameter > 5mm
Bl: prior digestion of DNA with BamHI
Macrocolony formation expressed per 5 X 10^ cells.
Figure 3.8: ,M acroco lon ies, produced after cotransfection
of pSV2neo and linear BP4 w ith or w ithout 
activa ted  ras.
a:
b:
Magnification: x60 
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3.1.4(ii): The effect of TPA on BPV4-mediated transfo rm ation  in
neomvcin resistance assays
Although TPA was unable to induce focus formation in 
BPV4-transfected Pal cells, it was considered possible that 
TPA-mediated phenotypes might be observed upon coselection with 
neomycin resistance plasmid. The protocol used was identical to 
that in Section 3.4(i), adding 20ng/ml TPA throughout the selection 
process where appropriate. In such assays, all cells treated with 
TPA died even more quickly than controls receiving no neomycin 
plasmid but not exposed to TPA: such control cells took 14 days to 
die, whereas all cells treated with TPA were dead within one week.
One possible reason for this is that downregulation of neo  gene
expression might occur. The action of TPA has been shown to be
mediated by modulation of gene transcription, which has been
further localised to a control of the activity of a protein complex
5
term AP-1, which binds to the DNA concensus sequence 5’-TGACTCA. 
Since such sequences exist within the SV40 early promoter, it was 
possible that TPA induced a downregulation of ne o  expression. A 
second neor-encoding plasmid was the^ore tested: this plasmid, 
pMS-2, utilises the Herpes Simplex Virus (HSV) thymidine kinase 
promoter to drive n e o  expression; the activity of this promoter has 
been reported to be stim u la ted  by addition of TPA when used in 
LATK' cells (Campo and Roe (1986)). The structure of pMS-2 is 
shown in Figure 3.9. Nevertheless, again all the cells died faster 
than the untreated controls.
Another possible explanation of the phenomenon is that the 
treatment sensitises the cells to the effects of neomycin. However,
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Figure 3.9: Structure of the plasmid p MS-2
\
HSV-1
tk  HSV-1
promoter NEO poly(A)
pBR328
The plasm id was orig ina lly  constructed by M.S.Campo (unpublished).
Abbreviations: poly(A): polyadenylation signal
NEO: neom ycin resistance gene from  Tn5
HSV-1: Herpes S im plex Virus Type 1
in the absence of observable phenotypes, the approach was not 
carried fu rthe r.
3 .1 .4 ( i i i ): The effect of the E2 ORF on BPV4-associated 
transfo rm ation  of Pal cells
It has recently  been shown tha t s tim u la tion of m orphological 
tra n s fo rm a tio n  o f p rim a ry  ra t e p ith e lia l ce lls  induced by 
cotransfection of HPV16 and activated ra s  genes was enhanced by 
the presence of the HPV16 E2 gene product (Lees et a l . (1990)).
In order to exam ine whether this was the case for BPV4, the 
plasmid pSVE2B was used, the structure of which is shown in Figure 
3.10. This plasm id contains the E2-E5 region of the BPV4 genome 
expressed under the control of the SV40 promoter, and has been 
shown to induce a 3-fo ld increase in transcriptional activity of the 
BPV4 early  p rom oter in Pal ce lls in trans ien t CAT assays (M. 
Jackson, Beatson Institu te , pers. com m .), a level of stimulation 
similar to that seen with the analogous constructs of HPV18 on its 
own early promoters (Thierry and Yaniv (1987)).
Cells were transfected with 5 jig of pSV2neo along with 10jig of 
BPV4, pT24 and pSVE2B, using all possible permutations of these 
three plasm ids. No obvious effect of E2 could be discerned. In focus 
assays a single area of more densely growing cells was identified 
in the flask  transfected  with BPV4, pT24 and pSVE2B, but upon
Ur
picking th is  co lony and a llow ing f ther grow th, the phenotype 
appeared ind istingu ishab le  from the parental cells and showed no 
increased cell dens ity  at confluence. It was noted tha t all neor 
colonies form ed a fte r cotransfection of BPV4 and pSVE2B were 
smaller than those formed by BPV4 alone, but the number of
H a
Figure 3.10: Structure of the plasmid PSVE2B
BPV4 early 
poly(A)
E2
nt 2741 nt 4327
SV40
Early
Promoter
ampr— >
BPV4 E2 ORF
pAT153
The plasmid was constructed by M. Jackson (Beatson institute) 
(unpublished results).
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colonies was too small to be of real significance. Again, in the 
absence of readily scorable phenotypes it was decided not to follow 
up this line of enquiry.
3.1.5: C lo n in g  o f BPV4 su b g e n o m ic  fra g m e n ts  in to
e x p re s s io n  v e c to rs
To determ ine whether ineffic ient expression of putative 
transforming genes of BPV4 was the reason for the lack of 
appearance of fu lly  morphologically transformed cell after 
transfection of Pal cells with BPV4 and activated r a s ,  it was 
decided to clone individual regions of the BPV4 venome into two 
plasmids: pSV2neo (Southern and Berg (1982)) and pZIPneoSV(XI) 
(Cepko et aI . (1984)). The former requires the use of BPV4 
promoter, but contains the 72bp repeat of the SV40 early promoter 
which acts as a strong enhancer (see Figure 3.17). The latter 
contains two Moloney Murine Leukaemia Virus (Mo-MuLV) Long 
Terminal Repeats (LTRs) flanking the cloned sequences (see Figure 
3.18): since these contain both enhancer and promoter functions, the. 
use of BPV4 promoters is not necessarily required for expression of 
BPV4 functions. It was predicted therefore that all BPV4 ORFs 
cloned into pZIPneoSV(XI) should be expressed efficiently, whereas 
cloning of fragments into pSV2neo should lead to levels of 
expression s im ila r to that of th e . fu ll genome, unless 
transmodulation by virally-encoded factors occurs to a significant 
degree in the context of the full viral genome. Both plasmids encode 
the neomycin resistance (neor) gene, thus allowing selection both 
for focus- and colony formation.
The restriction enzyme Xholl conveniently cleaved BPV4 DNA at 
three sites (see Figure 3.11): two regions are of interest:
E7/8 (nt 6487 - 1275 - d e s ig n a te d  2.0)
and
E2-E5 (nt 2597 - 6487 - d e s ig n a te d  3.9).
These could simply be cloned straight into the BamHI sites of the
n*
two vectors since the 5' overhangs ge^ated by Xholl- and BamHI 
digestion are identical.
A third recombinant plasmid was also produced: this was 
identical to the E7/8 construct, excerpt that it lacked a 233bp 
EcoRI fragment (nt906 - 1139), thus interrupting the E7 ORF. (T h is  
w as  d e s ig n a te d  1 .8 ). This construct was predicted to be
informative, since digestion of BPV4 DNA with Eco Rl abolishes
transforming activity in NIH3T3 cells (M.S. Campo (pers. comm.)).
The E7/8 fragment was isolated from plC20R.H3-H3 3.6 (shown in 
Figure 3.12), the analogous fragment lacking E7 was isolated from 
pBV4 AB (shown in Figure 3.13) and the E2-E5 fragment was 
isolated from pBV4 Bl. After purification of fragment and ligation 
to dephosphorylated linear vector DNA, E.Coli strain DH5-a ■ 
transformed and grown on L-amp plates overnight. The results are 
listed in Tables 3.5 and 3.6.
The efficiency of transformation by the supercoiled vectors 
pSV2neo and pZIPneoSV(XI) was 10-fold less than that claimed for 
pUC19 by the suppliers: this is not surprising since it is a commonly 
known phenomenon that the transformation efficiency of competent 
bacteria decreases as the molecular weight of the plasmid 
increases (5.7kb and 10.1 kb respectively as compared to 2.7kb of 
PUC19). Routine use of pUC19 as a control in early experiments 
consistently gave transformation frequencies between 8 x 10^ and
2 x 108 : this indicated that the observed decreases in
153
transformation efficiency were not likely to be due to poor 
experimental technique.
Religation of linearised, non-phosphatased vectors showed a 
10-20 fold decrease in efficiency as compared to supercoiledi
vector control: this could be due firstly to the presence of protein 
(DNA ligase), but could also be due to possible non-linearity of 
colony formation with increasing DNA concentration and/or near 
saturation of plates with ampiciHinr colonies. Since, however, a 
decrease in transformation efficiency of greater than two orders of 
magnitude was observed after prior treatment of linearised vectors 
with Calf Intestinal Phosphatase ( denoted by DP in the Tables), it 
was considered that ligase activity was more than satisfactory forj
the current purpose. The lack of transformants after ligation of 
inserts in the absence of vector sequences also indicate that such 
inserts had been satisfactorily separated from any possible 
residual vector DNA.
The relatively large number of colonies seen on the experimental 
plates thus indicated that the vast majority of transformants were 
likely to be recombinants: Grunstein-Hogness screening procedures 
were unlikely to be necessary and they were thus screened by 
miniprep. analysis.
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Figure 3.12: Structure of the plasmid plC20R.H3-H3 3.6
Xholl Xholl
L1
E l
n t 6110
E7
[E8~
M ultip le
Cloning
Site
E1
nt 2356
H ind lll
plC20R
The plasmid was constructed by I. Doherty (Beatson Institute) 
(unpublished results).
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Figure 3.13: Structure of the plasmid pBV4 AB.
BPV4 SEQUENCES
L1
L3
nt 6110 
H indi!!
I
Xholl 
(nt 6487)
□ 7
m  C E1
906/1139
EcoRI
I
Xholl 
(nt 1275)
2356
H indlll
H ind lll
(nt29)
pBV4 AB (6.8kb)
pAT153
The plasmid was constructed by M.S. Campo (unpublished results).
Tab le  3 .5 : T ra n s fo rm a tio n  o f E. c o li DH5-a bv pS V 2neo- 
d e r iv e d  c lo n e s .
200ng of linearised, dephosphorylated vectorDNA and a threefold molar excess of insert 
were ligated overnight at 14°C  in a volume of 10|il. The reaction mix was diluted 5-fold and 
1p.l was used to transform 50|il of freshly thawed, competent E. coli strain DH5-a. The 
bacteria were selected overnight on agar plates containing 50|ig/ml ampicillin and scored the 
next day.
DNA in transfo rm ­
ation reaction
Colon ies/
plate
Colon ies/ 
ug DNA
pSV2neo 50pg 214 2.1 X 107
pSV2neo Bl 
se lf 4ng
>500 > 6 .2 X 1 0  5
oSV2neo Bl DP 
se lf 4ng
2 2.5 X 103
BPV4 Xholl 2.0 
se lf 4ng
0 < 2 .5 X 1 0  3
BPV4 Xholl 3.9 
se lf 8ng
0 < 2 .5 X 1 0  3
pBV4AB Xholl 1.8 
se lf 4ng 0
< 2 .5 X 1 0  3
pSV2neo B1DP + 
BPV4 Xholl 2.0
112 1.4 X 1 0 5
pSV2neo Bl DP+ 
BPV4 Xholl 3.9
103 1.3 X 1 0 5
pSV2neo Bl DP + 
pBV4AB Xholl 1.8
56 8.0 X 1 0 4
For legend see foot of Table 3.6 overleaf.
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T a b le  3 .6 : T ra n s fo rm a t io n  o f E. c o li DH5-a bv oZ IP neo - 
S V (X 1 )d e r iv e d  c lo n e s .
200ng of linearised, dephosphorylated vector DNA and a three-fold molar 
excess of insert were ligated overnight at 14°C in a volume of 10p.l. The reaction was 
diluted 5-fold and 1jil was used to; transform 50jil of freshly thawed, competent E. coli 
strain DH5-a. The bacteria were selected overnight on agar plates containing 50pg/ml 
ampicillin and scored the following day.
DNA in transform ­
ation reaction
C olon ies/
p late
Colonies/ 
ug DNA
pZIPneoSV(XI) 50pg 84 8.4 X 1 0 6
pZIPneoSV(XI) Bl 
se lf 8ng
>500 >3.1 X 1 0 5
pZIPneoSV(XI) Bl DP 
se lf 8ng
0 < 1.3 X 10 2
pZIPneoSV(XI) Bl D P + 
BPV4 Xholl 2.0
104 6.5 X 1 0 4
pZIPneoSV(XI) Bl D P + 
BPV4 Xholl 3.9
86 5 .7 X 1 0  4
pZIPneoSV(XI) Bl D P + 
pBV4 AB Xholl 1.8
120 7.5 X 10 4
Legend: Bl: Digestion with BamHI prior to ligation
DP: Treatment with Calf Intestinal Phosphatase prior to 
ligation
self: ligation in the absence of heterologous DNA 
molecules
Note: the colonies/jig quoted refers to jig of vector DNA.
1£2
3.5(i): Analysis of pSV2neo-derived recombinants
The enzym e EcoRI was use fu l in th is  an a lys is : it cuts 
asym m etrica lly  w ith in  all the inserts, and at a single site within 
the parent vector. These are shown in Figure 3.14. The predicted 
size bands for parenta l vector and ‘each recom binant are listed 
below: (the + and - refer to the re lative direction of transcription 
of BPV4 ORFs with respect to the direction of transcription of the 
neor gene).
p S V 2 n e o : 5 .7 k b
p S V 2 n e o 2 .0 (+ ) :  6 .7kb, 0 .8kb  and 0 .2kb
p S V 2 n e o 2 .0 ( - ) :  5.1 kb, 2 .4 kb  and 0 .2kb
p S V 2 n e o 1 .8 (+ ) :  6 .7kb  and 0 .8kb
p S V 2 n e o 1 .8 ( - ) :  5 .1kb  and 2 .4kb
p S V 2 n e o 3 .9 (+ ) :  5 .4kb  and 4 .2kb
p S V 2 n e o 3 .9 ( - ) :  8 .3kb  and 1 .3kb
Recom binants were identified and prepared in bulk. These were 
digested with EcoRI to confirm  the ir identity. A photograph of the 
gel is shown in Figure 3.15.
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Figure 3.14: Location of EcoRI sites within Xholl
fra g m e n ts  o f BPV4
Xholl 2.0kb
L1
n t: 6487
E8
E7
E1
oEcoRI E coR I\
. 906 1139 1275
L1
nt: 6487
E8
Xholl 1.8kb
E7
: e t
EcoRI 
906/1139 1275
r E2
E4
ET| E5
EcoRI
n t:  2597 3147
Xholl 3.9kb
L1
L2 I
6487
Figure 3.15: EcoRI digests of pSV2neo-derived BPV4
re c o m b in a n t c lo n e s
2jig  of purified plasmid digested with 20U EcoRI. for 1 hr at 37°C. The 
samples were then separated by electrophoresis through a 1% TAE agarose gel at 
4V/cm.f using Hindlll-djgested bacteriophage lambda as markers. The gel was stained 
for 15mins with ethidium bromide and visualised using a UV transilluminator.
M 1 2 3 4 5 7 6
V 23.1 — j f r j f e . 1 .  j p -  :| |
9.4 —
6.6 —
4.4 —  
2.3 _
2.0 —
0.6 —
Legend: M: HindiIl-digested bacteriophage lambda markers
1: pSV2neo 
2,3: pSV2.0(+), pSV2.0(-)
4,5: pSV1.8(+), pSV1.8(-)
6,7: pSV3.9(+), pSV3.9(-)
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3 . 5 ( ii): Analysis of pZIPneoSVfXH-derived recomhinants
The enzyme EcoRI was again used to identify the desired 
recombinants: two sites exist in the parent vector, but again 
relative orientations of inserts could be determined. The expected 
restriction fragment sizes are:
p Z IP n e o S V (X I) :  7 .7kb  and 2 .4kb
p Z IP n e o .2 .0 (+ ) :  7 .4kb , 2 .4kb, 2 .1kb  and 0.2kb
p Z IP n e o .2 .0 ( - ) :  5 .8kb, 3 .7kb, 2 .4kb and 0.2kb
p Z IP n e o .1 .8 (+ ) :  7 .4kb , 2 .4kb and 2.1kb
p Z IP n e o .1 .8 ( - ) :  5 .8kb , 3 .7kb  and 2.4kb
y
p Z IP n e o .3 .9 (+ ) :  6 .3kb , 5 .3kb and 2.4kb
p Z IP n e o .3 .9 ( - ) :  9 .0kb, 2 .6kb and 2.4kb
Again, recombinants were identified and purified in bulk. A 
photograph of a gel showing the EcoRI digests of these 
recombinants is shown in Figure 3.16.
These plasmids could then be used in cooperativity assays with 
the activated ra s  gene in Pal cells. The physical map of the 
recombinant plasmids is shown in Figures 3.17 and 3.18.
1 6 3
Figure 3.16: EcoRI d ig e s ts  o f pZIPneoSV(X1 )-derived
BPV4 recom binant clones
2 |ig  of purified plasmid digested with 20U EcoRI. for 1 hr at 37°C. The 
samples were then separated by electrophoresis through a 1% TAE agarose gel at 
4V/cm., using Hindlll-digested bacteriophage lambda as markers. The gel was stained 
for 15mins with ethidium bromide and visualised using a UV transilluminator.
Legend: M: Hindill-digested bacteriophage lambda markers
1: pZIPneoSV(XI)
2,3: pZIP2.0(+), pZIP2.0(-)
4,5: pZIP1.8(+), pZIP1.8(-)
6,7: pZIP3.9(*"), pZIP3.90
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F ig u re  3 .17 : S u m m a ry  o f BPV4 re c o m b in a n ts  c lo n e d  in to  
p S V 2 n e o .
pSV2neo.3.9(+) nt 2597 «
pSV2neo.3.9(-) nt 6487 <
nt 6487 
nt 2597
pSV2neo.1.8(+) nt6487
pSV2neo.1.8(-)
nt 906 ^ ------7  nt 1139
^  n t1275
nt 1139 nt 906
nt 1275 nt 6487
pSV2neo.2.0(+) nt 6487
pSV2neo.2.0(-) nt 1275
£
E8 E7
E71 l~E8l
—
n t1275 
nt 6487
SV40
EARLY NEO P0LY 
PROM. A
BamHI 
nt 3369
nt 1
EcoRI 
nt 2618
'vul
1992
pBR322
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Figure 3.18: Summary of BPV4 recombinants cloned into
pZ lP n eo S V fX D
E2 L1
L3
E1 L2
I_____I_____I J_________L Intact ORFs
E2 - E5
E7/E8
E8
Barr
MLV
LTR
3'SS NEO SV40 pBR MLV 
LTRORI
pBR322
Legend: SS: Splice site.
MLV LTR: Moloney Murine Leukaemia Virus
Long Terminal Repeat.
ORI: origins of DNA replication.
NEO: Neomycin resistance gene.
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3.6 A c t iv ity  o f  p S V 2 n e o -d e rive d  c lo n e s  in
t r a n s fe c t io n  a s s a y s
3.6(i): Transfection of C127 murine fibroblasts
Since transfection of primary cell lines is inherently less 
efficient than when using established lines, it was decided to test 
experimental technique and the purity of plasmids using the 
established C127 murine fibroblast cell line, since this is known to 
be transfected efficiently using the calcium phosphate 
coprecipitation procedure. (At this stage, the pSV3.9 clones had not 
been obtained: when they were, confidence in the transfection 
procedure meant that such C127 control experiments were not 
important).
3 x 105 cells were plated in T25 flasks and transfected with 
10pg of appropriate plasmid DNA. Two days after addition of the 
DNA-calcium phosphate coprecipitate, the cells were split: half 
were plated at 2 x 10^ cells/cm2 in medium containing 1.2mg/ml 
G418. The medium was changed weekly and after 21 days, the
i
number of neor colonies were scored by Giemsa staining. The other 
half were plated at 5 x 10^ cells/cm2 in growth medium containing 
10% FCS, grown to confluence and maintained for 4 weeks with 
changes of medium twice a week, after which they were scored for 
focus formation. (This is the Protocol 2 described by Smith and 
Campo (1988)). The results are shown in Table 3.7a.
In the experiments involving neomycin selection., the 
colony-forming efficiency was between 5 x 10"^ and 10"^. This 
indicated that the transfection system was working adequately and 
that any negative results obtained using Pal cells would not be due
lfiZ
to any trivial technical problems. All colonies showed a flat 
morphology, similar to that obtained by cotransfection of pSV2neo 
with linear BPV4 genome (K.T. Smith (pers. comm.)).
The lack of any detectable focus-forming activity was 
unexpected: even the positive control of linear BPV4 DNA failed to 
induce foci after maintenance at confluence for up to 5 weeks. The 
reasons for this were unclear: the possibility that the digestion 
process had resulted in impure DNA could at this stage not be 
discounted, but use of the same sample in experiments involving Pal 
cells (see Section 3.4) indicated that this was not the case. In the 
cases other than the positive control, one possible reason could 
involve the use of circular DNA: BPV4-induced transformation of 
C127 cells has been shown to be inhibited when using DNA 
covalently linked to pAT153 (Smith and Campo (1988)).
It was thus decided to separate the BPV4 DNA from the pSV2neo 
vector sequences, since, during the cloning step, the joining of 
Xholl- to BamHI ends resulted in the regeneration of a 
hexanucleotide sequence recognised by no restriction enzyme, the 
best available linearisation strategy involved cutting with two 
restriction enzymes, Pvul and Hpal, which cut on either side of the 
BPV4 sequences while maintaining an intact ne o  gene (at nts 1992 
and 3502 of pSV2neo repectively). The position of the restriction 
enzyme sites within pSV2neo are shown in Figure 3.17. Transfection 
of linearised plasmids into C127 cells was performed as before and 
the results are shown in Table 3.7b. Once again, no focus formation 
was discernible, although again, neomycin-resistant colonies 
appeared, albeit at a reduced frequency, as compared to the circular 
DNA. Either, therefore, the sequences of pSV2neo still linked to the 
BPV4 DNA inhibited transformation, or the E8 + E7 sequences were
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not sufficient for fo\cus formation, or some unidentified parameter 
concerning the susceptibility of the C127 cells to BPV4-induced 
morphological transformation was affected. At this stage, however, 
this point was not pursued further, as the transformation of C127 
cells was not central to the body of work in this thesis.
Since the transfection technique appeared to be working 
satisfactorily, it was decided to proceed to the transfection of Pal 
cells both with the BPV4 recombinants alone as well as in 
cooperation with the activated ra s  gene.
Table 3.7a: Transfection of C127 cells with pSV2neo-
derived clones.
DNA Foci Neo colonies % transformed
pSV2neo 0
!
>100 0
pSV2.0(+)
(E7/E8)
0 >100 0
pSV2.0(-) 0 >100 0
pSV1.8(+) 
(E8)
0 >100 0
pSV1.8(-) 0 >100 0
BPV4 B1 0 0 -
Table 3.7b: Transfection of C127 cells with linearised
pSV2neo-derived clones.
DNA Foci Neo colonies % transformed
pSV2neo 0 67 0
pSV2.0(+)
(E7/E8)
0 79 0
pSV2.0(-) 0 45 0
pSV1.8(+)
(E8)
0 39 0
pSV1.8(-) 0 54 0
Legend: neor colonies expressed per 2 X 1 0 ^  cells
DNAs linearised with Pvul and Hpal
m .
3 .6 ( ii) : Transfection of Pal cells with pSV2nen-derived clones
in cooperation with an activated human c-Ha-ras aene
The ability of the subgenomic fragments of BPV4 cloned in 
pSV2neo to cooperate with the activated c-Ha-ras gene encoded by 
the plasmid pT24 in the transformation of Pal cells was examined 
using calcium phosphate-mediated transfection procedures. In all 
cases only the (+) clones (those containing BPV4 sequences whose 
putative direction of transcription is the same as that of the 
neomycin resistance gene) were used.
Two days after transfection, the cells were trypsinised and split 
into two halves: one half was diluted 1:6 and grown for 21 days in 
normal growth medium conta in ing 500pg/ml G418, whereupon 
flasks were scored for neor colonies and the morphological 
appearance of such colonies. The other half was diluted 1:2, grown 
to confluence and maintained for 3 weeks, again in normal growth 
medium and scored for the formation of foci. In both cases, medium 
was changed three times a week. The results are shown in Tables 
3.8a and 3.8b.
In the focus formation assays, no foci were induced during the 
(extended) 6 week period of observation of the cells at confluence. 
In flasks transfected with the activated ras gene, the elongated 
cells were observed as before, but none developed into the small 
colonies found in the initial cotransfection experiment with BPV4 
full genome plus ras (see Section 3.4). In the case of cotransfecting 
pSV2.0(+) and ras, a single area of cells showing greater density 
(but not piling up) was observed. This was picked and grown on 10% 
serum. Upon return to confluence, the cell density was identical to
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Table 3.8a:Transform inq activities of pSV2neo-derived
c lo n e s  o f BPV4 in Pal ce lls .
Cells were transfected as described in Table 3.4, except that 10jig of all neor- 
encoding plasmids were used.
Plasmid
DNA
Foci Macrocolonies/ 
total colonies
Colony
morphology
Experiment 
1 2 3
pSV2neo 0 0/3 0/1 0/0 NA
pSV2neo + 
BPV4 Bl
0 20/20 17/18 .24/26 Flat
pSV2.0(+)
(E7/E8)
0 16/16 23/24 13/14 Flat
pSV1.8(+)
(E8)
0 0/3 0/1 1/3 NA
pSV3.9(+) 
(E2 - E5)
ND ND ND 13/20 Elongated,
criss-cross
Legend: ND: not done
NA: not applicable 
Focus- and macrocolony formation expressed per 5 X 10^ cells.
Table 3 .8b:Transform ina activities of pSV2neo-derived
c lo n e s  o f BPV4 in co o p e ra tio n  w ith  the  
a c tiv a te d  c -H a -ra s  aene in Pal ce lls .
Plasmid
DNA
Foci Macrocolonies/ 
total colonies
Colony
morphology
Experiment 
1 2 3
pSV2neo 
+ pT24
0 0/1 0/2 0/0 NA
pSV2.0(+) 
+ pT24
0 20/23 16/1817/19 2 colonies piling 
up; others flat
pSV1.8(+) 
+ pT24
0 0/0 0/0 2/2 Criss-cross, but 
not piling up
pSV3.9(+) 
+ pT24
ND ND ND 6/10 Various(see text)
Legend: ND: not done
NA: not applicable 
Focus- and macrocolony formation expressed per 5 X 10^ cells.
that of the parental cells, but further analysis was prevented due to 
fungal contamination of the nascent cell line.
In the neomycin resistance assays, novel observations were made 
which will be described in two parts (for comments on the control 
plates, see Section 3.4).
3 .6 (ii)A : Comparison of activity of dSV2.0(hT and oSV1.8f+^
Transfection of Pal cells with pSV2.0(+) led to macrocolony 
formation at a frequency of = 20 per 5 x 105 cells, similar to those 
observed with complete, linear BPV4. Two representative colonies 
are shown in Figure 3.19a and -b. In two independent experiments, 
such a phenotype was absent when pSV1.8(+) was used: the results 
using this latter plasmid were identical to transfection with 
pSV2neo or cotransfection of pSV2neo with pT24. A more recent 
experiment, however, yielded a single colony of significant 
diameter (~5mm) whose morphology appeared to be different from 
that of cells transfected with pSV2.0(+), in that the cells showed a 
more elongated criss-cross pattern, in contrast to the tight, more 
square-like shape of cells found in macrocolonies induced by BPV4 
or pSV2.0(+). Attempts to expand this colony, however, were 
unsuccesful: presumably, therefore, continued growth of the cells 
also requires the presence of the E7 gene product.
Comparison of these results indicated two things: firstly, the 
macrocolonies induced by the complete BPV4 genome could be 
reproduced by the region of the virus encoding the E7 and E8 ORFs; 
and secondly, the presence of the E7 ORF was required for the 
generation of macrocolonies: in the absence of functional E7, E8
12£
Fiqure3.19: NeoL co lon ies produced after transfection  of
Pal ce lls  w ith  pSV2.0(+>
a:
b:
Magnification: x60
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could not induce macrocolony formation. Also, since the 
macrocolonies induced by the complete BPV4 genome could not be 
induced by any other plasmid but pSV2.0(+), it can be predicted that 
expression of E7 is able to occur within the context of the full 
genome. This prediction could be tested by the reconstruction of a 
recombinant BPV4 genome lacking the 233bp (nts 906 - 1139) 
deleted in pSV1.8(+). Should such a linearised construct prove 
defective in macrocolony formation, the above hypothesis would be 
proven.
These data do not prove that the E7 ORF is s u ff ic ie n t for 
macrocolony formation: in the background of the pSV2neo vector, 
such a question could be addressed by making nonsense mutations 
within the E8 ORF and assaying the activity of the resulting 
recombinants for their ability to induce macrocolony formation. 
Cloning the E7 ORF alone into pSV2neo might not be useful, since it 
is presumed that E7 transcripts initiate near the as yet poorly 
mapped promoter 5' to the E8 ORF (TATAA box at nt 115); such E7 
constructs might thus lack a promoter to drive expression in Pal 
cells.
Upon cotransfection with the ras oncogene, a few further novel 
phenotypes became apparent. Cotransfection of pSV2.0(+) with pT24 
led to large colonies at a frequency similar to that found for 
pSV2.0(+) alone (see Table 3.8b). Sometimes, however, these were 
of obviously higher cell density than the analogous colonies induced 
by pSV2.0(+) alone and occasionally the colonies displayed 
criss-cross patterns at their edge (see Figure 3.20a and -b). Two 
colonies showed cells obviously piling up highly, but the rarity of
lZfi
Figure 3.20: Neo^ colonies produced after cotransfection 
of Pal ce lls w ith  pSV2.0(+) and activated ras
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Magnification: x90
such a finding (2 in over 100 colonies screened) indicated that a 
rare additional event had occurred rendering the cells less 
contact-inhibited and more overtly transformed than the majority 
of other colonies. The failure of ras  alone to induce any measurable 
phenotype in neomycin’ resistance assays indicates that the primary 
requirement to elicit such measurable effects in this assay is that 
induced by the BPV4-encoded function. In the presence of such a 
function, however, the ra s  oncogene mav enhance in subtle ways 
the effect with regard to the morphological phenotype of surviving 
colonies. The rarity of induction of overtly non-contact-inhibited 
morphology indicated that in these cases, rare secondary changes 
had occurred.
Macrocolonies resulting from cotransfection of pSV2.0(+) and 
activated ra s  were readily expanded into cell lines and two (those 
derived from the two colonies shown in Figure 3.20a and -b) were 
frozen down *  25 population doublings after transfection.
Cotransfection of pSV1.8(+) with r a s  in two consecutive 
experiments led to no development of colonies at all at the 21 day 
stage. In the third experiment, 2 colonies of ®5mm diameter were 
apparent, each showing the criss-cross morphology seen for the 
single pSV1.8(+) colony; no additional phenotype due to the ra s  
oncogene could be seen and again, such colonies could not be 
expanded succesfully.
Comparison of these two experiments again indicates that the 
macrocolony formation observed in cotransfections of linear BPV4 
and r a s  requires the presence of the E7 ORF. Furthermore, 
comparing the results obtained when cotransfecting pSV2.0(+) with 
ras  with those of complete BPV4 genome and ras  indicate that E7
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gene expression in Pal cells is not overtly affected by the presence 
either of an activated r a s  gene or the remaining 5.2kb of viral 
genomic DNA.
3.6(ii)B : Activity of dSV3.9(+1 in transfections of Pal cells
[The results in this section concern‘only a single experiment and 
and should thus be interpreted with care. The fact, however, that no 
background colonies have eve r been seen in transfections of 
pSV2neo alone or upon cotransfection with an activated ra s  gene, 
would indicate that the effect is n g i artefactual.]
Transfection of Pal cells with pSV3.9(+) gave rise to ten colonies 
(equivalent to 20 colonies/5 x 10^ cells) after 21 days of selection. 
Of these, three were appearing to be dying, three were small, flat 
and sparse (<5mm diameter) whereas four showed a criss-cross 
pattern and were large in size (8 - 10mm diameter). A 
representative colony is shown in Figure 3.21a.
This phenotype induced by the E2-E5 region plus part of the late 
region of BPV4 was not observed when the complete linear BPV4 
genome was used upon screening of « 100 colonies: this indicates 
that suffic ient expression of whichever gene mediates this 
phenotype cannot normally be achieved after transfection of the full 
viral genome under the conditions used. This inhibition might be due 
to a virally- or cellularly-encoded transrepressor acting on an 
unknown viral promoter or enhancer sequence, or the lack of a 
required transactivator. Alternatively, the phenotype seen might be
t
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the result of the expression of a single domain of a protein, due to 
the loss of exons normally expressed in intact viral DNA. Further 
analysis would be necessary to distinguish between the above 
p o ss ib ilitie s .
i
Cotransfection of pSV3.9(+) with r a s  gave three obvious 
phenotypes: one was that of a small colony (<5mm diameter) of flat, 
sparse phenotype which was presumed to be senescing, another was 
that of large colonies (8 - 10mm diameter) similar to those of 
pSV2.0(+) + ra s ,  of obviously high cell density, but not piling up 
overtly, whereas in a single colony, a very obvious piling up of 
criss-crossed cell (see Figure 3.21b) was observed.
All attempts to expand such colonies, including the one displaying 
piled-up cells, were unsuccesful, but from this single experiment, 
no firm conclusions can be drawn with regard to the extended 
lifespan of the surviving colonies.
What the mechanism of induction of the observed phenotypes 
induced by pSV3.9(+) might be is unclear, but alteration of cellular 
gene expression by transmodulation is an obvious possibility. The 
region certainly encodes putative DNA-binding proteins: the E2 ORF 
has been shown in several PVs to encode multiple transmodulators 
of viral (and possibly cellular-) gene expression (Spalholz et a!,. 
(1987)) and the expression vector pSVE2B, which expresses the 
BPV4 E2 ORF from the SV40 early promoter, is able to activate the 
BPV4 NCR in transient reporter gene assays (Maria Jackson, Beatson 
Institute (pers. comm.)), while the E4 ORF of BPV4 has been 
predicted recently to contain a 'leucine zipper' motif (M.S. Campo 
(pers. comm.) similar to those found in several well-characterised
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DNA-associated proteins (for review, see Abel and Maniatis (1989)).
Although no mapping of BPV4 promoters used in the generation of 
the full-length E2 gene product has been performed to date, the 
presence between nts 2686 and 2692 of a TATA box-like element 
(5'-TATTAAT-3') with two CCAAT box-like elements ® 30nts 
upstream (S'CCAAT-S* (between nts 2658 and 2662) and 
5'-CAAAT-3' (between nts 2647 and 2651)) may indicate a site for 
transcript initiation of the full-length E2 protein mRNA within 
pSV3.9(+).
Two initiation sites for a putative E2 repressor-encoding mRNA 
have previously been mapped to nts 3069 and 3093 (Stamps and 
Campo (1988)). This message is expressed at very low levels in 
virally-induced papillomas, but could possibly, in the context of 
pSV3.9(+), allow macrocolony formation by some unknown means.
The BPV4 E4 ORF is predicted from transcriptional analysis to be 
expressed as an E1-E4 fusion protein in papillomas and the 1 kb
i
transcript which encodes this protein is the major BPV4-encoded 
message found in such lesions (Stamps and Campo (1988)). As yet, 
nothing is known about the role of the short leader peptide derived 
from the E1 ORF in the functioning of this protein, so were the E4 
ORF to be transcribed from pSV3.9(+), it would not be possible to 
exclude possible artefacts due to the absence of this leader peptide. 
The fusion protein is presumed to subvert the keratin expression 
programme within normal keratinocytes, possibly via an interaction 
with cytokeratin promoters. Since in fibroblasts keratins are not 
expressed, presumably alterations in expression of other genes 
would have to be postulated to explain any action of the E4 protein 
in such a scheme. Obvious candidates are the other cytoskeletal
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elements, since the cellular morphology of Pal cells transfected 
with pSV3.9(+) is clearly different from those transfected with 
pSV2.0(+) or BPV4.
The overtly transformed appearance of the single colony induced 
by pSV3.9(+) and ras was a completely novel phenotype: in repeated 
cotransfections of linear BPV4 + ras, no such cells were ever seen 
in « 100 colonies screened. This is further evidence that the 
functions expressed in the context of the pSV3.9(+) plasmid are not 
expressed in the context of the full viral genome in Pal cells. No 
direct comparison with other papillomaviruses is possible in this 
case, however, since no phenotypes attributable to the E2-E5 region 
of other PV genomes have been reported in primary cells. A weak 
transforming activity of the E2-E5 region of HPV16 has, however,
i
been reported in NIH3T3 cells (Vousden et al .(1989)). One analogy 
which can be drawn is the transfection of an activated ras gene 
into SV40-transform ed human fib rob lasts : m orphologically
transformed foci developed but resulting cell lines senesced more 
rapidly than non-transfected controls (O'Brien et al . (1986)). The 
apparently transformed colony induced by pSV3.9(+) and ras could 
not be expanded: it is possible therefore that BPV4 encodes a second 
transforming function, which does not efficiently prolong the 
lifespan of bovine cell in vitro .
A possible explanation of these facts may be put forward using 
analogies with recent results obtained with HPV16 (T. Crook (pers. 
comm.)). Using primary Baby Mouse Kidney (BMK) epithelial cells, it 
was found that HPV16 encoded a m yc-like  function which, when 
overexpressed, could cooperate with an activated ras gene in the 
tumorigenic transformation of the recipient cells. Cotransfection of
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such overexpressing HPV16 constructs with an activated m yc gene, 
however, led to no observable phenotype. However, cotransfection of 
the linear viral genome (which does not express its products at high 
levels within cells) witfi an activated m y c  gene d id  lead to 
tumorigenic transformation. If one were to postulate that the 3.9kb 
Xholl fragment of BPV4 contained a ras-like  function, then one 
could predict that cotransfection of two ras-like  functions could 
lead to the piled-up phenotype observed upon cotransfection of 
pSV3.9(+) and ra s . The lack of a m yc -like  function capable of 
extending the life-span of the cells, in vitro could explain the 
failure to expand such colonies into cell lines.
If the hypothesis that the 3.9kb fragment encodes a ra s -like  
function is correct, then overexpression of such a gene should 
induce focus formation in NIH3T3 cells. Lack of time prevented such 
experiments being performed. Clearly, such theories would need to 
be tested using a larger body of data than that which was obtained 
in this study. If this is indeed the case, identification of the ORF 
responsible for inducing such a phenotype could be pursued by 
engineering specific STOP codons into individual ORFs and assaying 
the resultant plasmids in Pal cells for colony formation.
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Figure 3.21: Neo^ co lon ies produced after transfection  of
Pal ce lls  w ith pSV3.9(+) in the absence- or 
presence of activated ras
pSV3.9(+)
b: pSV3.9+) + ras
Magnification: x90
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3.7: A n a ly s is  o f  pZ IP n e o S V (X 1 )-d e r ive d  c lo n e s  in
t r a n s fe c t io n  a s s a y s
All transfections were done using identical protocols to those 
described in 3.6 and these will thus not be repeated again here.
3.7(i): Transformation of C127- and N1H3T3 cells bv
oZIPneoSVfXD-derived clones
The results of this transfection are shown in Table 3.9a: once 
again, no foci could be induced after transfection with any of the 
constructs, but the results from the flasks which underwent 
selection with neomycin showed again that the transfection 
procedure was working efficiently. However, pZIP3.9(+) gave no neor 
colonies at all. This was also shown to be the case in NIH3T3 cells 
(see Table 3.9b), indicating that it was not a cell-line-specific 
effect. Two possible reasons were considered: firstly, that 
expression of the n e o  gene was inefficient or absent: this could be 
due to a small alteration in the DNA sequence of the plasmid 
undetectable by the restriction mapping used in the identification 
of the recombinant, or due to some inhibitory effect of the 3.9kb 
sequence of DNA. The possibility of this latter occurrence, although 
rare, was reported by the authors who originally described the 
pZlPneoSV(XI) plasmid (Cepko et al . (1984)); the second possibility 
considered was that overexpression of some gene in the 3.9kb 
fragment was lethal to cell growth in vitro .
Table 3.9a: Transfection of C127 ceils with pZIPneo-
SV(X1)- d e r iv e d  c lo n e s .
Plasmid DNA Foci Neo colonies % transformed
pZIPneoSV(XI) 0 81 0
pZIP2.0(+)
(E7/E8)
0 123 0
pZIP1.8(+)
(E8)
0 68 0
pZIP3.9(+)
(E2-E5)
0 0 -
T a b le 3 .9 b :T r a n s fe c t io n  o f  N IH3T3 c e l ls  w i th  p Z lP n e o S V - 
(X1)- d e r iv e d  c lo n e s .
Plasmid DNA Foci Neo colonies % transformed
pZIPneoSV(XI) - 73 0
pZIP2.0(+)
(E7/E8)
- 90 0
pZIP1.8(+)
(E8)
- 33 0
pZIP3.9(+)
(E2-E5)
- 0
Legend: Neor colonies are expressed per'2 X 10® cells
Since it was found that the pSV3.9(+) clone was able to induce 
measurable phenotypes in Pal cells using a neor assay, it was 
decided to try to distinguish between these two possibilities by 
cotransfecting pSV2neo and pZIP3.9(+) into Pal cells; it was known 
that pSV2neo alone was unable to induce colonies in Pal cells (see 
Section 3.4), and from the lack of neor colony formation after 
transfection of either C127- or NIH3T3 cells with pZIP3.9(+), it 
was predicted that pZIP3.9(+) would also be unable to induce neor 
colony formation in Pal cells. It was thus reasoned that if any neor 
colonies were induced after cotransfection of both plasmids, it 
would have to be assumed that pZIP3.9(+) was inducing the 
phenotype, and could not therefore be lethal to cells. The results of 
such a transfection experiment are shown in Table 3.10.
The formation of 13 colonies/5 x 10^ cells upon cotransfection 
of pSV2neo and pZIP3.9(+) indicated that the reason for the lack of 
neor colony formation after transfection of pZIP3.9(+) into C127- or 
NIH3T3 cells was not due to lethality of the pZIP3.9(+) construct, 
but rather to the lack of neo gene expression in this construct. Two 
representative colonies are shown in Figure 3.22.
4
Once again, since transfections into established cell lines was 
relatively efficient, the analagous experiments in Pal cells were 
carried out.
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Tab le  3 .10 : T ra n s fe c t io n  o f  Pal c e l ls  w ith  pS V2neo an d /o r 
P Z IP 3 .9 ( ,+).
Plasmid DNA Foci Neo colonies % transformed
pSV2neo - 0 -
pZIP3.9(+)
(E2-E5)
- 0 -
pSV2neo + 
pZIP3.9(+)
- 13 0
Legend: Neor colonies are expressed per 5 X 1 0 ^  cells
Figure 3.22: N eoL-co lon ies p roduced  a fte r tra n s fe c tio n
of Pal ceils w ith pSV2neo and pZ1P3.9(+L
Magnification: x90
3.7 (ii): Transformation of Pal ce lls ‘bv oZlPneoSV(X1 1-derived
clones
The results of transfection of the various pZIPneoSV- 
(Xl)-derived clones into Pal cells are shown in Table i3.11 a.
The results of cotransfections of the pZIPneoSV(X1)-derived 
clones with the activated ras genes are shown in Table 3.11b: 
discussion of the results will again be dealt with in two parts.
3 .7 (ii)A : Comparison of the activities of dZ1P2.QM and pZIP1.8f-<-1
Once again, as in the case of the pSV2neo-derived clones, the 
presence of the E7 ORF was required for colony formation in neor 
assays. Whilst pZIP2.0(+) induced colonies at a frequency of >100 
colonies/ 5 x 10^ cells, pZIP1.8(+) was unable to induce any 
colonies. Similar to the case of pSV2.0(+), all colonies were flat, 
with morphologies identical to those shown for pSV2.0(+) in Figure 
3.19. The frequency of colony formation induced by pZIP2.0(+) was 
3-6-fold greater than with either pSV2.0(+) or linear BPV4 genomic 
DNA, and may reflect more efficient expression of BPV4 ORFs in the 
retroviral vector environment.
Upon cotransfection of pZiP2.0(+) with ras,  « 60% of neor 
colonies were morphologically transformed., Some representative 
colonies, stained with Giemsa are shown in Figure 3.23. Also focus 
formation could be induced when cotransfecting pZIP2.0(+) and pT24 
at a frequency *  3-fold less efficient than that of neor colony 
formation. Representative foci are shown in Figure 3.24. No such 
foci were obtained in the pZIPneoSV(XI) + ras control, indicating
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Table 3.11 a:Transformina activities of pZ lPneoSVfXD-
derived clones of BPV4 in Pal cells.
DNA added Foci Neo colonies % transformed
Experiment 
1 2
Experiment 
1 2
pZIPneoSV(XI) 0 0 0 0 NA
pZIPneoSV(xl) 
+ ras
0 1 0 0 NA
pZIP2.0(+) 0 0 >100 >100 0
pZ!P1.8(+) 0 0 0 0 NA
pZIP3.9(+) 0 0 0 0 NA
Legend: NA: not applicable
ND: not done
Foci and neor colonies expressed per 5 X 10^ cells.
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Table 3.11b: T ransfo rm ing  a c tiv itie s  o f pZIPneoSV(X1 )-
derived c lones o f BPV4 in coopera tion  w ith  
the activated c-Ha-ras gene in Pal cells.
DNA added Foci Neo colonies % transformed
Experiment 
1 2
Experiment 
1 2
pZIP2.0(+) 
+ ras
18 6 >100 74 60
pZIP1.8(+) 
+ ras
0 0 0 0 NA
pZIP3.9(+) 
+ ras
ND 0 ND 0 NA
Legend: NA: not applicable
ND: not done
Foci and neor colonies expressed per 5 X 1 0 ^  cells.
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F igure 3._23_; Neo^ co lon ies produced a fte r tran s fe c tion  of
Pal ce lls  w ith pZ1P2.0(+) and activated ras
Magnification: x60
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Figure 3.24: Foci induced after transfection  of Pal cells
w ith  pZ!P2.0(+) and activated ras
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that it was unlikely that such foci arose from recombination events 
leading to overexpression of activated ras genes from a retroviral 
LTR. Furthermore, none were induced after cotransfection of 
pZIP1.8(+) with ras,  which implicates a requirement for the 
presence of the E7 ORF for focus formation. In this case, indeed, it 
was noted that in both transfections, the cell died faster than cells 
transfected simply with carrier DNA.
Comparing the activities of pZIP2.0(+) and pSV2.0(+) upon 
cotransfection with ras into Pal cells (from the Results in Section 
3.7) implies that somehow the retroviral vector environment of the 
2.0kb fragment in pZIP2.0(+) enhances the transforming activity of 
this region of BPV4. The most likely explanation to be put forward 
is that the presence of retroviral LTRs leads to more efficient 
expression of E7 and/or E8 and that this, in the presence of an 
ac tiva ted  r a s  gene, is sufficient to drive the cells to a 
non-contact-inhibited phenotype. Similar results have been obtained 
in cotransfections of HPV16 and ras (Matlashewski et al . (1987b)), 
with the major difference that such experiments were performed in 
epithelial cells rather than fibroblasts.
3 .7 (ii) B : Activity of pZIP3.9(+)
As expected, no colonies were obtained when transfecting the 
pZIP3.9(+) construct. Also, in the analagous selections for focus 
formation, no transformed foci were ever observed. In hindsight,
selection with neomycin after cotransfection of pZIP3.9(+) + ras
«
was superfluous, since it had by then been shown that no neo gene 
expression was possible from pZIP3.9(+). To assess any possible
lflS
phenotypes attributable to pZIP3.9(+) in the context of a neomycin 
resistance assay, pZIP3.9(+) and pT24 could be cotransfected with 
pSV2neo, as previously described for pSV2neo and pZIP3.9(+) alone. 
Due to lack of time, however, no data on this were obtained.
i
3.8: The BPV4 E7 ORF: its possible functions in cells
grown in vitro
\nThe results described in 3.6(ii)A ar^id 3.7(ii)A indicated that the 
BPV4 E7 ORF was required for Pal cell macrocolony formation. 
Similar results have been obtained using HPV16 in human fibroblast 
cells in vitro (Watanabe et al . (1989)). In the case of HPV16, the E7 
gene product has been shown to bind to the 105kDa product of the 
tumour suppressor gene Rb1 (Dyson et al .(1988)). It was thus of 
interest to analyse the putative amino acid sequence of the BPV4 E7 
gene product to determine whetjpr this protein might have a similar 
function. A computer alignment of the two putative amino acid 
sequences (starting at the first methionine within the respective 
ORFs)using the ALIGN function of 'MicroGenie' (Queen and Korn 
(1984)) revealed three well-conserved motifs, as shown in Figure 
3.25:
Firstly, a pair of cys-x-xcys motifs towards the C-termina! 
region. These have been proposed to be 'zinc fingers', and mutation 
of such cys residues in HPV16 E7 expression vectors leads to loss 
of transform ing activ ity  in NIH3T3 cells (Edmonds and 
Vousden(1989)).
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Secondly, a region of 5 amino acids, four of which are negatively 
charged glutamic acid residues.
Thirdly, a series of conserved hydrophobic residues (mainly 
leucine, but also isoleucine and valine) found in the C-terminal 
third of the putative protein sequences.
What of the regions of HPV16 E7 predicted to be required for Rb1 
binding? In the region of HPV16 (amino acids 1-26) concerned, BPV4 
E7 showed little homology using this programme with the proteins 
lined up from the first methionine. By visual inspection, however, it 
was possible to identify within the BPV4 E7 sequence the two 
groups of residues absolutely conserved between HPV16 E7, 
adenovirus E1a and Sv40 large T antigen; all of which have been 
shown to bind to pp105^b in vitro . These are shown in Figure 3.26.
In the case of adenovirus E1a, the regions denoted as 1 and 2 have 
also been shown to be required for Rb binding.
Two points should however be made. Firstly, region 1 and region 2 
(the two domains required for the Rb binding function of E1a) are 
not separated at all in BPV4 E7, whereas in the other 3 proteins the 
two are separated by at least 6 amino acids. Secondly, region 2, 
namely leu-x-cys-x-glu, is found completely separated from the run 
of acidic residues in HPV16, adenovirus E1a and the large T antigen 
of SV40, whereas in BPV4, the two motifs merge with one another.
Neverthelesss, it is likely, on the basis of this analysis, that the 
structure of the BPV4 E7 protein shares similar domains to those of 
HPV16 E7, adenovirus E1a and the large T antigen of SV40 and it 
may therefore be predicted that one of the functions of the protein
1SZ
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is an interaction with the prouct of (a) bovine tumour suppressor 
gene(s). With the development of both prokaryotic- and eukaryotic 
expression vectors for the E7 ORF as well as anti-E7 antibodies 
(G.J. Grindlay, Beatson Institute (pers. comm.)), it should in future 
be possible to analyse any protein-binding activities of the BPV4 E7 
protein using immunoprecipitation assays, just has been done for 
the E7 proteins of the oncogenic HPVs (Dyson et a l . (1989)).
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F igu re  3.25: A m in o  ac id  se q uen ce  h o m o lo g y  be tw een  the  E7 
ORFs o f  BPV4 and HPV16.
BPV4 E7 aa 1 M K G Q N V T L  Q D I A I E L E
HPV16E7 aa 1 M H G D T P T L H E Y M L D L Q P E T T
BPV4E7 aa17 
HPV16E7 aa21
D T I S P I N L H C  
D L Y C Y E Q L N D S S
E E E I E 
E E E D El
T E ACIDIC
D G RESIDUES
BPV4 E7 aa34 
HPV16 E7 aa41
E V D T P N P  F A  I T A T
P A G Q A E P D R A H Y N I V T F
C Y A C  
C C K C
CYS-X-X-CYS
BPV4 E7 aa51 EQ  V L R L A V V T S 1 E G I HQ L
HPV16 E7 aa62 D S T L R L  C V Q S T H V D I R T L
HYDROPHOBICS
BPV4 E7 aa69 Q Q L L F D N L F L L
HPV16 E7 aa80 ED L L M G T L G I V
C A  A 
C P I
S K Q V  
S Q K P CYS-X-X-CYS
BPV4 E7 aa88 F C N R R P E R N G P
The alignment of amino acid sequences was performed using the 
ALIGN function of 'Microgenie' (Queen and Korn (1984)).
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F igure  3.26: H o m o lo g y  o f BPV4 E7 to  th e  Rb b in d in g  
d o m a in s  o f v a r io u s  DNA tu m o u r  v i ru s  
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3.9 Screening of bovine UAC tumours for altered EGF-receptor
gene activity
As described in Section 1.11.2, preliminary experiments using the 
cell line 88529C (derived from a carcinoma of the UAC) indicated 
very high levels of EGF binding to the cell surface of these cells. In 
order to analyse the reasons for this, it was thus desirable to 
analyse the nucleic acid levels of tumours for evidence of any gene 
am p lifica tion .
3.9.1 Identification of a suitable EGF-receptor probe
Since no bovine EGF-receptor probe was available, it was 
necessary to identify a suitable heterologous probe for the analysis. 
The murine genomic probe pME2.0 (generously provided by M. Hung 
and described in Hung et al .(1986)), as shown in Figure 3.27, was 
found to be of use in the analysis of bovine DNA.
20jig of calf thymus DNA was digested with either BamHI or 
EcoRI, separated on a 0.8% agarose gel, transferred to nylon 
membrane and hybrid ised under s tringen t conditions to 
radiolabelled 2.5kb EcoRI insert purified from pME2.0. As a positive 
genomic DNA control, NIH3T3 cell DNA was used. In addition, 25pg 
and 50pg of pure plasmid DNA (equivalent to 1 and 2 genome 
equivalents) were also used. The result is shown in Figure 3.28.
The strong hybridisation to the bovine DNA (lanes 6 and 7) 
indicated that the probe was indeed of use as a cross-species probe. 
The fact that the hybridising fragment was also similar to that of
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mouse was a further confirmation of the evolutionary conservation 
of this region of the EGF receptor gene. The additional weak 
hybridising bands may be other related genes, possibly other 
members of the family of transmembrane tyrosine kinases, of which 
the EGF receptor is perhaps ‘the best characterised member at 
present.
3.9.2 Use of dME2.0 to screen bovine UAC tumours for EGF 
receptor aene amplification.
Since pME2.0 appeared to be capable of hybridisation to bovine 
sequences, tumour DNAs were screened for any evidence of 
amplification. 34 DNAs were screened in total, but no evidence for 
gene amplification could be established. A typical Southern blot 
tumour DNA is shown in Figure 3.29.
The screening of 88529C cell line DNA could not be done as the 
line was lost due to freezer malfunction, and thus the role of gene 
amplification in the high level of EGF binding remains unclear.
2 0 2  '
Figure 3.27: Structure of the plasmid pME2.0
EcoRI EcoRI
SP6
prom oter
Murine EGF- 
receptor
pSP64
Legend: SP6 promoter: The DNA sequence recognised by the
RNA polymerase encoded by the 
bacteriophage SP6 d irecting the 
initiation site for mRNA trans­
crip tion .
The plasmid was kindly donated by M. Hung and was originally 
described in Hung et a l . (1986), where its usefulness as a 
cross-species probe was first reported.
Figure 3.28: Cross-hvbridisation of pME2.0 to bovine DNA
20|ig of NIH3T3 (murine) or calf thymus (bovine) DNA digested with EcoRI or BamHI, 
separated on a 0.8% agarose gel, transferred to Pall membrane and hybridised O/N under 
stringent conditions to the 2.5kb insert (labelled to a specific activity of 2 x 108 d p m /|ig ). 
0.4, 1 and 2 genome equivalents of purified plasmid DNA was run as a positive control. The 
membrane was washed under stringent conditions (0.1 X SSC, 0.5% SDS at 65°C  for 1 hr) and 
exposed to X-Ray film for 11 days.
Lane: 1 2 3 4 5 6 7
Lanes: 1-3, 4, 6: digested with EcoRI
5, 7: digested with BamH!
1-3: pME2.0 (50pg, 25pg and 10pg)
; ^  NIH3T3
v.
calf thymus 
ZM
Figure 3.29: Hybridisation of pME2.0 to bovine UAC
tumour DNA
20|ig of calf thymus and various tumour DNAs were digested with EcoRI, separated on a 
0.8% agarose gel, transferred to Pall membrane and hybridised O/N under stringent conditions 
to the 2.5kb insert of pME2.0 (labelled to a specific activity of 1.6 X 10® dpm /|ig). The 
membrane was washed under stringent conditions (0.1 X SSC, 0.5% SDS at 65°C  for 1 hr) and 
exposed to X-ray film for 11 days.
Lanes: 1 2 3 4 5 6  7 8
Lanes: 1: Calf thymus
2-8: UAC tumours
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SECTION 4 
SUMMARY AND CONCLUSIONS
2M
4. Summary and conclusions
The broad aims at the beginning of this study were to develop a 
bovine in vitro system for the analysis of BPV4-mediated 
alterations in cellular proliferation, the identification of the viral 
gene products mediating those alterations and to analyse the means 
by which such changes were brought about.
A tissue culture system utilis ing non-established bovine 
fibroblasts derived from the palate of a bovine foetus has been 
developed. Using coselection with the dominant selectable marker 
neo, an assay system sensitive to BPV4-encoded functions has been 
devised and used to identify two regions of the genome capable of 
inducing measurable phenotypes. These regions were shown to 
cooperate with the activated ra s  gene in the induction of more 
transformed phenotypes, but the system appeared to differ from the 
primary rodent fibroblast systems previously described in the 
literature, in that cotransfection of activated ra s  and m y c  
oncogenes did ng i appear to induce efficient focus formation.
The analysis of EGF-receptor genes in BPV4-associated 
tum origenesis was lim ited to the identification of suitable 
non-homologous probes and the screening of tumour DNA, which 
indicated that amplification of the gene did not take place in the 
thirty samples screened and is not therefore a frequent event.
The results obtained will now be discussed as a whole and placed
into context in the overall view concerning BPV4-associated
6
carcinogenesis; finally, suggestions will be ma^e for future work.
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4.1 Bovine fibroblasts as a tissue culture system for the
analysis of BPV4 functions
A new assay system for the analysis of BPV4-encoded 
transforming functions has been developed. The cells used, namely 
non-established bovine fibroblasts derived from the palate of a 
bovine foetus, display two distinct advantages as compared with 
the previously used established murine fibroblast cell lines C127 
and NIH3T3: firstly, the cells are derived from the species which 
the virus infects; and secondly, the cells are not converted to a 
tumorigenic phenotype after transfection with BPV4, just as in 
vivo  , BPV4 infection does not lead directly to carcinomatous 
development. The cells are not, however, of epithelial origin, and 
thus wil not u ltim ate ly  be the best model system for the study of 
BPV4 in vitro .
The BPV4-bovine fibroblast system shows many similarities to 
analogous systems involving HPV16 and human embryonic 
fibroblasts (Pirisi et al . (1987)) and in future years, comparisons 
of this system with epithelial cell systems may lead to a greater 
understanding of the tissue specificity of BPV4 action.
The bovine cells appear to display differing susceptibility to 
conversion to a non-contact-inhibited phenotype when compared to 
their rodent counterparts: cotransfection of activated ras and myc  
oncogenes does not lead to stable morphological transformation. 
This correlates with the increased latency period of malignant 
progression observed in cattle as compared to mice and hamsters - 
in the UAC, carcinomas take a minimum of seven years to develop, a 
time greater than the complete lifespan of an average mouse. Whilst
this difference makes for more subtle changes in morphological 
phenotype, in time these systems may be of much use in the 
analysis of the events occurring in human tumour progression, the 
ultimate aim of all cancer research.
4.2 Identification of transforming activity of BPV4 in vitro
The use of a neomycin resistance coselection assay (see Section 
3.4) showed that BPV4, but not an activated ras oncogene, is able to 
prolong the lifespan of Pal cell in vitro . The formation of large 
macrocolonies of > 5mm diameter after 3 weeks selection in G418 
was only observable when BPV4 DNA was present in the 
transfection. The fact that results were essentially identical upon 
cotransfection with an activated ras gene indicated that expression 
of the BPV4 transforming genes was unaffected by the presence of 
such an activated oncogene. Furthermore, bovine cells were 
apparently not susceptible to morphological transformation to a 
n o n -c o n ta c t- in h ib ite d  phenotype  a fte r tra n s fe c tio n  of 
papillomaviral- and activated ras DNAs within the selection period 
described. Such results are sim ilar to those obtained by 
M atiashewski et a l . (1988) upon transfection of HPV16 and 
activated ras into human cervical fibroblasts.
As yet, no reports exist of direct cotransfection of PV DNA and 
activa ted  ras into human e p ith e lia l cells, so the relative 
susceptibilities of the two human cell types to PV-associated 
transform ation cannot be assessed. Nevertheless, in rodent 
systems, both fibroblastic (Chester and McCance (1989)) and 
epithelial cells (Matiashewski et al (1987b)) appear to be equally
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susceptible to conversion to a non-contact-imjhibited phenotype 
using such a transfection protocol.
4.3 Identification of the E7 ORF as a transforming function
of BPV4
Using this same neomycin resistance assay, subciones of BPV4 
DNA were assayed for their activity in the prolonging of Pal cell 
growth in vitro . The activity induced by BPV4 could be reproduced 
by a 2.0kb Xholl fragment (nts 6487 - 1275), which contains the 3' 
end of L1, the NCR and the complete E8 and E7 ORFs, when cloned 
into either pSV2neo or pZIPneoSV(XI). This activity was lost in 
analagous constructs lacking a 233bp sequence (nts 906 - 1139), 
which caused an interruption in the E7 ORF. This implied that the E8 
ORF alone was unable to induce macrocolony formation, but that the 
presence of both the E7 and E8 ORFs was sufficient. The E7 ORF of 
BPV4 was shown to contain motifs within its amino acid sequence 
identical to those present within the adenovirus E1a protein which 
are responsible for binding to the product of the tumour suppressor 
gene Rb1. Such motifs are highly conserved within the E7 ORFs of 
the oncogenic HPVs. It could be predicted therefore that the binding 
of E7 to an unknown bovine tumour suppressor gene product may 
well be necessary for the prolonging of Pal cell growth in vitro .
The lack of activity in this assay of the clones containing only 
the E8 ORF indicate that any transforming activity of this protein is 
masked by the presumed senescence of Pal cells in the absence of 
E7. Since the E8 protein has been predicted to show structural 
homology with the BPV1 E5 ORF, which appears to sensitise cells to
£1Q
growth factors, it may be the case that the E8 gene product may 
also contribute to BPV4-mediated hyperproliferation in vivo . Novel 
assays will have to be developed in order to study this further.
4.4 A novel transforming function of BPV4 within the
E2-E5 region
The colony-forming activity of pSV3.9(+) or the combination of 
pSV2neo and pZIP3.9(+) in neomycin resistance assays after 
transfection into Pal cells indicated that a second activity capable 
of prolonging the lifespan of Pal cells upon selection in medium 
containing neomycin was present within the BPV4 genome. Such 
cells, in a single experiment, were incapable of being further 
expanded. The ORF(s) responsible for this phenotype have not been 
iden tified .
The cha racte ris tics  of this (as yet) unidentified function 
differed slightly from those encoded by the E7/E8 region. Firstly, 
transfection of Pal cells with pSV3.9((+) alone lead to large 
colonies of elongated cells, a phenotype never seen with pSV2,0(+). 
Secondly, cotransfection of pSV3.9(+) with ras led to rare colonies
On
of elogated and piled-up morphology, a phenomen^ never seen upon 
cotransfection of pSV2.0(+) with ras.
The data are consistent with the hypothesis that the 3.9kb Xholl 
fragment of BPV4 encodes a ras-like function, which upon 
cotransfection with activated ras could lead to the piled-up 
phenotype. The lack of a m yc-like function capable of significantly 
extending the life-span of the cells in vitro would explain the 
failure to expand such colonies into cell lines.
2 1 1
Two likely candidates for the ORF responsible for the 
transforming properties of the 3.9kb fragment are E2 and E4. The 
transactivator properties of the BPV4 E2 ORF indicate that, like the 
E1a gene products of adenovirus, modulation of cellular gene 
expression may play a role in the transforming activity of the 3.9kb 
fragment. The BPV1 E2 ORF has been shown to activate the promoter 
of the haemopoietic growth factor Granulocyte Macrophage Colony 
Stimulating Factor (GM-CSF) in transient CAT assays performed in 
lymphoid cells (Miyatake et al . (1988)), but as yet, no data 
concerning cellular gene activation by E2 gene products of any PV in 
more natural cell systems has been obtained.
The E4 ORF has no known molecular function as yet but is 
presumed to be involved in the alteration of keratin gene expression 
found in PV-induced papillomas (Breitburd et al .(1987)). It is 
predicted to contain the 'leucine zipper' motif found originally in 
the transcription factor C-EBP (Landschulz et al . (1988)). This 
motif has been shown to be necessary for the dimerisation of many 
transcription factors, either as homodimers or in combination with 
distinct proteins (such as the fos-jun complex, which binds to the 
AP-1 element responsible for responsiveness to TPA (for review, 
see Vogt and Tjian(1988)). It may be the case, therefore, that 
interaction of E4 with other DNA-binding proteins leads to an 
alteration of cellular gene expression resulting in altered cell 
morphology.
212
4.5 Further work
The development of an in vitro model system for the 
transformation of primary bovine fibroblasts has opened a new 
avenue for studies on BPV4-mediated transformation. Much work 
can now be undertaken using such assays. This section will firstly 
propose some direct experiments ,to continue the strategies 
employed in this project and secondly look in a more long-term way 
at the developm ent of studies into the BPV4-associated 
carcinogenesis of the UAC.
The role of the E7 ORF in the extension of in vitro lifespan of Pal
cells could be further examined by the reconstruction of a
recombinant BPV4 lacking the 233bp deleted in pSV1.8(+) and 
analysis of its neor colony-forming activity upon cotransfection 
with pSV2neo into Pal cells. The requirement for the E8 ORF could 
also be examined by the introduction of STOP codons within the E8
coding sequence, either in pSV2.0(+) or within BPV4 itself. With the
cloning of a sequence containing only the E7 ORF into pZIPneoSV(XI) 
(G.J. Grindlay, Beatson Institute (pers. comm.)), a direct test of 
whether E7 is su ffic ien t for the induction of neor macrocolonies 
can now be performed without further ado. This construct could also 
be used to test whether cotransfection of E7 and ras will induce 
full morphological transformation in the absence of the E8 ORF. The 
system also offers possibilities for a structural analysis of the E7 
ORF by Site-Directed Mutagenesis (SDM).
The induction of neor macrocolonies obtained after transfecting 
the E2-E5 region (encoded by pSV3.9(+)) should be repeated and 
confirmed. Should the data prove to be repeatable, the ORF
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responsible could be identified by the introduction of STOP codons 
into each of the possible transforming ORFs.
The reasons for the lack of neor colony formation in any cell line 
after transfection of pZIP3.9(+) could be further investigated by 
two experiments in C127 cells. Firstly, pZIP3.9(-) could be 
transfected into C127 cells. Secondly, pSV2neo and pZIP3.9(+) could 
be cotransfected at a molar ratio of perhaps 1:20. Should both these 
experiments yield neor colonies, then one could deduce that the 
presence of the 3.9kb fragment of BPV4, within the context of the 
pZIPneoSV(XI) plasmid, was not lethal to C127 cells. Since it has 
been shown that these sequences are apparently not lethal in Pal 
cells, it could then be deduced that the reason for no neor colony 
formation in any cell line after transfection with pZIP3.9(+) would 
be due to the lack of neo gene expression in this construct.
With a reliable assay system capable of generating neor cell lines 
now available, a correlation between cellular physiology and viral 
gene product expression will now be possible. In particular, the 
question as to whether the rare incidence of non-contact-inhibited 
cell lines upon cotransfection of BPV4 or pSV2.0(+) with ras is due 
to poor expression of transfected genes, lack of maintenance of (a) 
transfected gene(s) or inability of these genes to fully transform 
primary bovine fibroblasts is of importance. A start can be made 
with a detailed analysis, at the levels of DNA and RNA, of BPV4 
E7/E8 and ras gene expression in the two cell lines generated after 
transfection of Pal cells with pSV2.0(+) and ras.
This primary bovine fibroblast system represents an intermediate 
step towards the development of the ideal tissue culture system for 
the study of BPV4-associated carc inogenesis. W ith the
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ever-increasing standardisation of epithelial cell culture, it would
appear that the time is now ripe for the development of such a
system for the bovine papillomaviruses and in particular BPV4. With
the development of such a system, the relative susceptibilities of
fibroblasts and epithelial cells could be analysed using assays
similar to those described in this project. In particular, it would be
h
of interest to know whetjpr introduction of BPV4 and ra s  into 
keratinocytes could lead, in contrast to the case of fibroblasts, to 
the development of a fully non-contact-inhibited phenotype.
The recently developed collagen raft system could provide a 
means for analysing the effect of BPV4 upon bovine keratinocyte 
differentiation, and the plasmids constructed during this study 
could act as useful tools in the elucidation of specific ORF 
functions in such a process.
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